data_2lew_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lew _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.567 0.699 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.2 m -78.21 154.02 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.994 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.597 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 3.1 p90 -135.89 140.5 44.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.726 0.774 . . . . 0.0 112.516 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.595 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 40.4 t -94.55 122.95 37.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.871 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.595 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 28.2 mmm180 -132.8 133.52 43.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.59 128.49 35.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.964 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.35 -53.12 4.8 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.307 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.85 138.49 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.827 0.314 . . . . 0.0 110.616 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.597 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 61.4 m -61.2 143.44 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.418 ' H ' ' HG3' ' A' ' 7' ' ' ARG . 75.4 mmtt -92.81 140.43 29.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 43.89 49.6 7.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.212 0.945 . . . . 0.0 112.356 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.07 128.69 1.4 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.631 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.78 42.83 1.74 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.485 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 5.6 mmp_? -125.6 63.3 1.2 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 110.427 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.589 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 4.2 p -61.89 130.34 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.447 0.641 . . . . 0.0 110.696 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.639 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 1.9 tpm_? -96.94 -26.71 14.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.35 43.39 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -82.7 135.85 34.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.963 0.411 . . . . 0.0 111.051 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 45.8 t -95.21 49.64 1.22 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.67 0.748 . . . . 0.0 109.028 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.2 -137.77 13.69 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.201 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.647 ' H ' HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -98.37 125.62 51.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 62.47 20.56 12.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.723 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.582 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -129.45 141.73 50.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD11 ' N ' ' A' ' 26' ' ' LEU . 9.9 mp -114.68 137.85 51.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.845 0.355 . . . . 0.0 110.5 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 8.5 t80 -111.45 114.95 28.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.589 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 83.0 m -117.87 143.79 45.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.374 . . . . 0.0 112.005 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.0 m -120.3 126.65 26.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.075 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.531 0.36 0 C-N-CA 122.981 2.454 . . . . 0.0 112.704 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 11.7 m -64.73 157.09 28.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.898 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.422 ' HE1' ' HA ' ' A' ' 11' ' ' CYS . 2.5 p90 -131.36 141.73 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 0.0 112.323 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.599 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 48.5 t -87.41 128.91 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.093 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.8 mmm180 -132.28 136.82 47.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 111.455 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -68.81 -36.2 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 109.964 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.47 -87.38 0.46 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.684 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.451 ' HB3' HD22 ' A' ' 26' ' ' LEU . 32.4 p-80 -179.36 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.781 0.433 . . . . 0.0 109.929 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.422 ' HA ' ' HE1' ' A' ' 5' ' ' TYR . 12.9 m 56.07 -155.74 0.29 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.373 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 4.9 mmmt -151.81 40.71 0.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 49.3 mmt-85 72.2 -58.23 0.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.013 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.53 47.91 3.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.677 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -165.32 142.51 7.77 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.032 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -103.09 134.81 45.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.471 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 3.5 p -57.32 127.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.593 0.711 . . . . 0.0 110.996 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -95.81 -27.17 15.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.566 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.36 -155.5 26.37 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.834 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -88.26 138.03 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.385 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.685 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.9 t -103.68 49.19 0.83 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.517 0.675 . . . . 0.0 109.824 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.37 -141.48 15.59 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.502 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.7 mt -86.78 112.77 23.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.49 34.96 20.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.496 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -132.89 146.65 51.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 10' ' ' HIS . 7.5 mp -112.99 133.55 54.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.333 0.587 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.418 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 7.2 t80 -103.41 128.42 50.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 m -135.14 146.18 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.57 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 64.3 m -110.09 131.55 21.93 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.699 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.477 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 81.5 Cg_endo . . . . . 0 N--CA 1.461 -0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.539 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.449 ' CD1' ' HG2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.372 0.606 . . . . 0.0 110.817 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.86 159.77 33.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.179 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.497 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 0.9 OUTLIER -144.46 141.82 29.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.909 0.862 . . . . 0.0 112.864 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.59 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 39.5 t -91.37 126.86 36.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.711 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.9 mmm180 -131.69 137.15 48.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 111.211 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.44 128.0 34.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.988 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.04 -51.6 3.2 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.515 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.49 ' HA ' HD12 ' A' ' 26' ' ' LEU . 27.7 p-80 -169.21 146.62 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.51 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 71.3 m -66.55 142.72 57.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.034 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 129.25 39.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.578 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 68.56 -51.25 0.56 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.989 0.916 . . . . 0.0 112.515 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -143.47 8.57 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.059 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.23 169.76 15.09 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -87.66 114.42 24.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.77 124.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.898 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.676 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 52.3 ttt85 -90.33 -35.69 15.09 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.095 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.95 -166.51 39.19 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.599 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 p -86.9 137.9 31.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.753 0.311 . . . . 0.0 110.998 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 35.8 t -99.6 42.6 1.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.62 0.724 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -144.37 16.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.911 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tt -90.45 118.67 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.02 0.438 . . . . 0.0 111.801 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 62.98 32.79 15.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.976 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.701 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 13.2 m-85 -137.09 139.02 40.98 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 10' ' ' HIS . 73.8 mt -115.77 138.27 51.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.013 0.435 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 9.9 t80 -110.7 116.79 31.91 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.29 156.46 41.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.952 0.406 . . . . 0.0 111.949 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.676 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 58.3 m -122.69 113.29 30.43 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.935 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 3' ' ' LEU . 59.4 Cg_endo . . . . . 0 N--CA 1.46 -0.48 0 C-N-CA 122.505 2.137 . . . . 0.0 111.639 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 3' ' ' LEU . 11.0 mp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.857 0.36 . . . . 0.0 110.832 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.1 m -66.26 161.21 22.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.495 ' OH ' ' HA3' ' A' ' 15' ' ' GLY . 4.6 p90 -149.45 141.75 24.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.537 0.684 . . . . 0.0 112.029 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.656 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 44.5 t -93.52 119.47 32.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.577 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.656 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.3 mmm180 -135.16 138.99 44.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.062 0.458 . . . . 0.0 111.433 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 8' ' ' LYS . 13.9 ttpp -83.44 52.24 2.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.482 0.658 . . . . 0.0 109.608 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.3 -159.15 18.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.958 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -85.45 64.11 8.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.3 m 59.18 -149.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.118 0.485 . . . . 0.0 111.951 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 25.5 mtpp -136.02 65.79 1.52 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 69.15 -100.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.479 0.487 . . . . 0.0 111.123 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.36 66.91 2.24 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.877 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -149.46 132.71 4.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.142 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -95.45 131.92 41.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.22 124.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.602 0.715 . . . . 0.0 110.806 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -90.59 -27.74 18.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.05 -157.16 28.45 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.201 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -94.37 138.81 31.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.017 0.437 . . . . 0.0 111.225 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 47.2 t -100.03 55.0 0.92 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.558 0.694 . . . . 0.0 109.212 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.66 -134.06 12.08 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.665 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.588 HG13 ' HG3' ' A' ' 24' ' ' ARG . 7.2 tp -101.65 124.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.886 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.588 ' HG3' HG13 ' A' ' 23' ' ' ILE . 59.5 mtp85 59.87 27.91 17.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.671 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.0 m-85 -135.57 143.06 45.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 26' ' ' LEU . 7.2 mp -112.3 137.96 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.229 0.538 . . . . 0.0 110.864 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -106.39 123.27 47.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.448 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 22.4 m -131.99 154.96 48.8 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.921 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.5 m -127.71 127.9 23.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.268 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.615 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 25.8 Cg_endo . . . . . 0 C--O 1.233 0.271 0 C-N-CA 122.785 2.324 . . . . 0.0 112.381 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.496 ' H ' HD22 ' A' ' 3' ' ' LEU . 2.4 pt? . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.034 0.445 . . . . 0.0 111.368 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.631 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 32.2 m -76.29 161.67 28.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.736 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -125.3 136.13 53.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.871 0.843 . . . . 0.0 112.598 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.576 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 51.7 t -81.02 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.769 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.576 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.2 mmm180 -132.01 140.5 48.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.088 0.47 . . . . 0.0 112.064 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.545 ' HD3' ' CE1' ' A' ' 25' ' ' PHE . 21.3 tptm -86.8 49.36 1.8 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.161 0.981 . . . . 0.0 109.228 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.62 -161.94 35.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.483 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.88 64.11 1.79 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 112.023 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.455 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 11.4 m 59.45 -153.94 0.38 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.405 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.631 ' HZ2' ' HB3' ' A' ' 12' ' ' LYS . 10.5 mtpm? -80.3 56.39 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.331 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 66.67 51.75 1.05 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.508 0.671 . . . . 0.0 109.865 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.68 -131.4 1.24 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.015 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 65.12 0.19 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.418 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.6 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 4.9 mmp_? -117.87 37.08 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.488 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 6.6 p -72.6 136.84 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.601 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.505 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 43.0 mtp85 -124.55 -2.65 7.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.69 178.09 48.38 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.38 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -95.13 139.36 31.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.864 0.364 . . . . 0.0 110.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.2 t -104.56 48.11 0.85 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.538 0.685 . . . . 0.0 109.845 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.38 -138.88 14.32 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.302 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.77 120.21 39.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.346 0.593 . . . . 0.0 112.143 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 56.36 38.13 29.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.559 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.78 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 11.7 m-85 -138.01 138.82 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 HD11 ' N ' ' A' ' 26' ' ' LEU . 7.4 mp -106.08 133.85 50.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.077 0.465 . . . . 0.0 111.311 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 11.6 t80 -97.96 101.09 12.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 57.7 m -105.45 141.37 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.776 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 80.6 m -108.22 143.82 28.19 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.745 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.631 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 55.2 Cg_exo . . . . . 0 C--N 1.343 0.266 0 C-N-CA 123.034 2.489 . . . . 0.0 113.578 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.504 ' N ' HD23 ' A' ' 3' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.865 0.364 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.49 164.37 18.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.494 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.478 ' CD1' ' HD3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -150.04 147.05 27.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.914 0.864 . . . . 0.0 113.026 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.612 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.0 t -77.49 128.99 35.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.597 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.612 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.2 mmm180 -129.56 136.38 49.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -69.67 125.98 28.35 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.124 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.13 -141.26 29.89 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.854 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.06 144.93 56.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.83 0.315 . . . . 0.0 110.317 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.0 m -47.81 139.02 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.701 0.626 . . . . 0.0 112.208 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.611 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . 49.2 mmtm -112.02 120.68 42.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.232 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 71.42 -48.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.968 0.792 . . . . 0.0 111.962 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.917 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -59.57 -41.03 97.09 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.745 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.89 -56.57 3.52 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.774 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -89.89 119.63 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.441 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 18' ' ' ARG . 5.6 p -72.58 138.3 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.997 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.442 ' N ' HG23 ' A' ' 17' ' ' VAL . 6.7 tpm_? -98.68 -30.46 12.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.422 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.06 -168.55 41.69 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.596 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 p -88.63 142.33 27.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.921 0.361 . . . . 0.0 111.2 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.3 t -113.98 47.58 1.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.6 0.714 . . . . 0.0 109.253 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 -137.8 14.0 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.894 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 pt -98.31 126.89 51.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.937 0.398 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 61.39 20.55 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.351 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 14.8 m-85 -134.44 139.42 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 25' ' ' PHE . 10.5 mp -121.82 135.63 54.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.304 0.574 . . . . 0.0 110.507 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 122.93 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.2 m -135.53 152.58 51.45 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.133 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 66.5 m -110.23 123.67 35.37 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.634 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.917 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 39.6 Cg_endo . . . . . 0 C--O 1.234 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.969 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.424 ' HA ' HD22 ' A' ' 3' ' ' LEU . 93.7 mt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 121.296 0.57 . . . . 0.0 109.555 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 36.2 m -88.81 164.89 15.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.28 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -139.34 128.86 24.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.464 0.65 . . . . 0.0 110.713 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.572 ' C ' ' HD2' ' A' ' 7' ' ' ARG . 24.0 p -94.19 134.68 36.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.572 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.3 mpt_? -135.29 138.76 43.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.185 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HD3' ' C ' ' A' ' 8' ' ' LYS . 1.7 tmtm? -74.63 -43.95 52.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.368 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.94 -61.56 3.71 Favored Glycine 0 C--N 1.319 -0.395 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.512 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -174.71 149.95 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.434 ' SG ' HG13 ' A' ' 17' ' ' VAL . 8.5 m -52.31 142.48 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.576 0.548 . . . . 0.0 110.678 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.95 138.05 34.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 63.23 -143.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.748 0.655 . . . . 0.0 110.744 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.61 43.34 3.14 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.874 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 134.58 12.6 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.585 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -111.81 139.22 47.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.434 HG13 ' SG ' ' A' ' 11' ' ' CYS . 19.7 m -62.47 139.2 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.315 0.579 . . . . 0.0 112.118 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -129.93 -32.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.33 -150.33 6.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.839 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -127.72 142.54 51.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 111.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.931 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 13.2 t -91.02 42.61 1.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.19 -135.63 12.43 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.039 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 118.59 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.166 0.507 . . . . 0.0 112.252 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 60.44 27.24 16.84 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.931 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 7.9 m-85 -122.69 138.61 54.56 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 17' ' ' VAL . 6.5 mp -101.22 132.37 46.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.846 0.355 . . . . 0.0 111.398 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 t80 -98.65 113.37 25.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.06 147.16 40.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.133 0.492 . . . . 0.0 112.235 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.6 m -120.55 140.04 29.78 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo . . . . . 0 C--N 1.342 0.207 0 C-N-CA 122.653 2.236 . . . . 0.0 112.622 -179.252 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.943 0.401 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.1 m -99.74 160.74 14.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -145.07 148.82 34.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.637 0.732 . . . . 0.0 112.381 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.634 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 7.8 p -93.81 124.98 38.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.634 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.6 mmm180 -128.58 141.84 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 39.5 ttpt -66.23 -29.08 69.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.386 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 -158.87 25.54 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.321 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -81.26 58.6 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.623 -0.339 . . . . 0.0 110.556 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.407 ' SG ' HG22 ' A' ' 17' ' ' VAL . 15.8 m 60.82 -153.28 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.766 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 8.7 mmmm -156.84 135.87 11.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.978 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.598 ' HD2' ' HB3' ' A' ' 30' ' ' PRO . 44.1 ttm180 75.63 -34.5 0.25 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 111.9 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.48 -146.8 4.53 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.756 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.94 43.83 0.69 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.216 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.727 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 78.1 ttt180 -88.63 70.58 8.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.407 HG22 ' SG ' ' A' ' 11' ' ' CYS . 11.7 t -67.91 132.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.994 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -115.2 -23.45 8.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.055 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.56 -143.89 7.83 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.343 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 p -128.91 156.19 44.11 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.753 0.311 . . . . 0.0 110.526 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 6' ' ' CYS . 1.6 t -88.62 40.56 0.97 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.88 -57.78 3.51 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-O 121.872 0.707 . . . . 0.0 111.925 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.435 ' HB ' ' H ' ' A' ' 24' ' ' ARG . 8.8 pt -83.32 -160.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 114.359 -0.921 . . . . 0.0 110.396 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 15.8 mmp_? -80.86 51.06 1.46 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.043 0.449 . . . . 0.0 111.734 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 6.3 m-85 -129.23 135.66 49.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 26' ' ' LEU . 6.5 mp -89.28 128.69 35.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 32.4 t80 -89.75 112.55 23.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 m -135.51 153.27 51.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 111.562 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.727 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 79.6 m -98.86 142.12 24.06 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 54.1 Cg_exo . . . . . 0 C--N 1.343 0.284 0 C-N-CA 122.93 2.42 . . . . 0.0 113.092 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 48.6 tp . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.6 m -89.52 165.84 14.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.812 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.465 ' HD1' ' O ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.82 142.48 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.229 0.538 . . . . 0.0 110.592 177.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.616 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 17.6 p -90.33 127.98 36.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.023 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.616 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.8 mmm180 -130.55 149.99 51.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.27 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -69.41 113.53 6.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.43 178.5 17.56 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -76.62 69.53 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.109 0.454 . . . . 0.0 111.706 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.463 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 32.5 m 69.93 147.94 0.07 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.625 0.578 . . . . 0.0 112.085 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.491 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 30.3 mmtp -132.5 117.19 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.148 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 56.29 44.17 25.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.918 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.13 -133.21 2.9 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.264 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.53 -46.37 0.23 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.384 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.699 ' HG3' ' HB2' ' A' ' 29' ' ' CYS . 23.7 ptt-85 -89.3 99.53 12.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.415 0.626 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.463 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 p -92.82 142.88 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.063 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 23.07 0.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.441 ' C ' ' HB3' ' A' ' 27' ' ' TYR . . . -178.0 -169.86 39.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.13 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 p -141.57 157.62 44.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.408 . . . . 0.0 109.914 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.928 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 3.8 t -117.21 38.8 3.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.98 -144.63 16.38 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.435 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 10.6 tt -82.76 123.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.203 0.525 . . . . 0.0 112.015 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HG2' HG12 ' A' ' 23' ' ' ILE . 26.2 mmm180 61.0 36.35 18.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.448 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.928 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.0 m-85 -137.58 127.02 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -110.67 137.99 47.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 0.0 111.387 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 42.6 t80 -98.81 103.13 15.06 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 1.5 m -133.33 155.74 48.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.151 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.699 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.6 m -88.18 142.99 32.17 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.893 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 123.283 2.655 . . . . 0.0 112.662 -179.645 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.853 0.359 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.1 m -71.5 161.47 30.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.492 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.96 146.5 30.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.837 0.827 . . . . 0.0 112.664 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.642 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.7 t -80.93 126.06 30.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.209 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.642 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.3 mmm180 -130.72 128.49 40.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.956 0.408 . . . . 0.0 111.165 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 36.1 ttpt -83.03 85.04 7.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.02 -111.27 0.45 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.338 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -142.61 53.57 1.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.746 0.308 . . . . 0.0 110.565 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.548 ' SG ' HG12 ' A' ' 17' ' ' VAL . 56.7 m 63.48 -163.91 0.26 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.909 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.463 ' C ' ' H ' ' A' ' 14' ' ' GLY . 65.2 mmtt -155.88 146.07 21.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 17.5 mmt85 73.91 -24.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.076 0.551 . . . . 0.0 111.356 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 12' ' ' LYS . . . 170.76 149.49 6.48 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.08 53.62 2.2 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.825 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -89.24 65.41 7.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.018 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.548 HG12 ' SG ' ' A' ' 11' ' ' CYS . 17.9 m -62.05 132.5 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.425 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -102.67 -35.45 8.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.436 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.04 -167.98 40.62 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 p -90.82 139.4 30.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 48.1 t -106.89 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.72 0.771 . . . . 0.0 109.24 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.67 -136.92 13.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.56 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.79 125.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 60.88 25.72 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.687 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.1 m-85 -135.16 136.55 41.95 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -114.5 135.03 54.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.176 0.512 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -93.97 121.54 35.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.4 m -132.16 156.35 46.57 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.707 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.6 m -118.94 128.8 25.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.666 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo . . . . . 0 N--CA 1.457 -0.635 0 C-N-CA 122.847 2.365 . . . . 0.0 112.234 179.798 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.533 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 6.9 mp . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 72.6 m -150.95 167.73 26.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.922 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.67 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.5 p90 -153.59 133.81 13.39 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.789 0.804 . . . . 0.0 111.743 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 24.6 t -92.2 120.94 33.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.077 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.616 ' HD3' ' CD1' ' A' ' 5' ' ' TYR . 11.4 mtp-105 -151.11 141.42 22.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.863 0.363 . . . . 0.0 111.731 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 35.0 ttpt -82.18 52.07 1.92 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.729 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.86 159.74 27.47 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.969 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -49.64 148.33 3.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 111.687 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -56.99 161.41 3.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.159 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.61 128.32 35.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.229 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.82 23.58 12.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.05 -137.48 4.69 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.821 -1.18 . . . . 0.0 113.07 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.66 56.73 0.3 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.272 -0.489 . . . . 0.0 111.963 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -87.72 63.09 7.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.513 0.673 . . . . 0.0 109.828 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.89 131.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.162 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.428 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 41.7 mmm-85 -106.33 -23.64 12.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.882 0.372 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.81 -171.35 38.87 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.842 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -104.25 140.64 37.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.728 0.299 . . . . 0.0 110.313 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 34.7 t -104.65 47.9 0.86 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.605 0.717 . . . . 0.0 109.668 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.23 -137.08 13.04 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.178 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.419 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 64.3 mt -90.95 116.6 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HG2' HG23 ' A' ' 23' ' ' ILE . 56.2 mmm-85 66.59 -0.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.672 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 10.2 m-85 -95.07 135.42 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.823 0.344 . . . . 0.0 110.511 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.58 133.62 45.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.553 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -100.61 91.25 4.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.67 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 66.7 m -96.62 149.87 21.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.489 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.5 m -133.33 118.86 15.11 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 95.9 Cg_endo . . . . . 0 C--N 1.344 0.341 0 C-N-CA 122.901 2.401 . . . . 0.0 112.282 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.451 ' N ' HD11 ' A' ' 3' ' ' LEU . 6.9 mp . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.6 m -83.14 166.22 18.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 33.2 p90 -135.27 127.24 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.891 0.853 . . . . 0.0 111.601 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.692 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 15.8 t -87.13 115.45 24.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.319 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.692 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.8 mmm180 -141.07 142.68 34.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.693 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -90.23 122.33 33.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -102.81 0.27 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.853 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -159.44 40.63 0.21 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.564 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 83.2 m 69.66 150.06 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -104.59 131.59 51.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.311 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 65.24 56.77 0.97 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.542 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.26 134.77 8.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.645 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 11' ' ' CYS . . . -77.64 66.44 3.02 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.921 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -88.14 58.84 4.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.622 -0.34 . . . . 0.0 110.7 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.473 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 20.7 t -71.38 127.2 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.885 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HD2' ' C ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -130.19 2.53 4.72 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.75 -178.68 48.44 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.878 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -109.84 139.51 44.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.636 0.255 . . . . 0.0 110.327 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.1 t -104.35 111.66 24.38 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -126.68 35.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.222 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 23' ' ' ILE . 10.9 tp -140.75 37.39 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.334 1.064 . . . . 0.0 109.543 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.7 ' HG3' ' HD1' ' A' ' 25' ' ' PHE . 38.7 ptt180 -172.26 2.11 0.01 OUTLIER 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.273 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HD1' ' HG3' ' A' ' 24' ' ' ARG . 5.6 m-85 -129.91 160.06 34.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 110.631 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 26' ' ' LEU . 7.1 mp -102.1 134.77 44.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.085 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.53 96.13 8.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.0 m -94.61 139.18 31.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.662 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.1 m -134.68 120.44 14.44 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.716 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo . . . . . 0 N--CA 1.465 -0.202 0 C-N-CA 122.251 1.968 . . . . 0.0 110.582 179.357 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.804 ' H ' HD22 ' A' ' 3' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 111.195 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.2 m -77.88 164.53 25.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.663 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.0 p90 -157.23 137.17 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.632 0.73 . . . . 0.0 111.808 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 52.9 t -89.58 121.95 32.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.214 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.1 mmm180 -136.0 132.29 36.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 36.2 ttmt -70.14 -29.69 66.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.31 0.576 . . . . 0.0 110.629 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 -110.16 0.2 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -143.1 67.41 1.3 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.468 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.2 m 63.9 -150.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 14.3 mmmt -136.14 44.08 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.615 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -168.4 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.643 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.83 -62.86 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.829 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.81 52.04 0.16 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HG2' ' HA ' ' A' ' 30' ' ' PRO . 36.1 tpt85 -89.45 44.7 1.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 t -63.89 137.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.897 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -107.18 -33.59 7.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.325 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.37 -163.46 29.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.535 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 p -92.4 140.5 29.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.994 0.426 . . . . 0.0 111.371 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.695 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 46.8 t -108.51 44.94 1.06 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.624 0.726 . . . . 0.0 109.475 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.8 -139.86 14.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.14 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.711 ' H ' HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -92.88 123.86 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 111.861 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 54.68 42.84 30.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.409 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.695 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -148.1 134.79 19.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.653 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HA ' HD11 ' A' ' 26' ' ' LEU . 3.3 mm? -109.04 132.2 54.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.996 0.427 . . . . 0.0 110.136 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -97.3 115.9 28.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.9 m -112.61 148.09 35.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.953 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.2 m -142.02 112.66 6.26 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.775 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.543 ' HA ' ' HG2' ' A' ' 16' ' ' ARG . 19.9 Cg_exo . . . . . 0 C--O 1.233 0.246 0 C-N-CA 122.884 2.389 . . . . 0.0 111.566 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.486 ' N ' HD23 ' A' ' 3' ' ' LEU . 3.4 mm? . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.797 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m -72.19 161.75 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.612 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -152.34 138.6 18.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.146 0.498 . . . . 0.0 111.043 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 27.2 p -107.15 117.77 34.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.999 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.437 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -144.18 150.46 38.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.792 0.329 . . . . 0.0 110.718 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -68.85 104.16 1.98 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.417 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.11 -117.59 0.77 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.342 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.406 ' HA ' HD22 ' A' ' 26' ' ' LEU . 32.1 p-80 -166.87 57.08 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m 74.28 146.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.639 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 14.5 mmmm -93.54 112.97 24.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.47 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 55.2 mmt-85 71.09 -53.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.88 0.737 . . . . 0.0 112.269 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.13 140.89 5.49 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.379 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -150.34 10.68 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.658 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.3 mmt-85 -146.85 131.81 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.449 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 22.5 t -78.59 126.93 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.77 0.319 . . . . 0.0 110.192 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.821 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -115.85 -13.85 11.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.576 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.57 -149.79 8.9 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.289 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.4 p -140.71 153.16 45.82 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.752 0.311 . . . . 0.0 110.64 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 1.6 t -88.55 60.15 5.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.3 -59.0 3.84 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.163 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 tp -174.58 145.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.833 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 71.58 -39.7 0.46 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.719 0.807 . . . . 0.0 112.949 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m-85 -89.31 130.8 35.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.364 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 9.5 mp -91.62 137.01 32.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -96.01 101.56 13.25 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 91.7 m -100.61 142.77 31.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.838 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.821 ' HB2' ' HD3' ' A' ' 18' ' ' ARG . 70.1 m -121.84 116.07 30.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.03 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo . . . . . 0 N--CA 1.464 -0.26 0 C-N-CA 122.907 2.405 . . . . 0.0 111.864 -179.785 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.9 tp . . . . . 0 C--O 1.234 0.274 0 CA-C-O 120.813 0.339 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 12.7 m -86.38 158.15 19.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.572 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.9 p90 -98.95 136.46 38.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.977 0.894 . . . . 0.0 112.952 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.677 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 37.8 t -93.78 121.69 35.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.509 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.677 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.2 mmm180 -133.1 141.73 48.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -82.98 47.76 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.757 0.789 . . . . 0.0 109.715 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.82 -148.87 7.11 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.209 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -94.11 67.75 3.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.1 m 60.15 -151.75 0.4 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.546 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -149.19 110.62 4.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 54.08 45.67 27.05 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.649 0.593 . . . . 0.0 111.836 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.42 132.79 1.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.96 153.85 14.73 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -88.65 117.65 27.77 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.997 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -61.14 129.83 24.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.423 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 7.6 tpt180 -101.76 -40.41 6.97 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.568 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.7 -159.82 27.76 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.583 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 p -94.95 140.2 30.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 0.0 110.922 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.922 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.5 t -104.81 39.08 1.77 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.628 0.727 . . . . 0.0 109.81 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.83 -145.27 16.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.543 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 23' ' ' ILE . 4.1 mp -85.15 118.36 31.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.745 0.307 . . . . 0.0 110.968 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 57.05 46.38 19.34 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.657 0.741 . . . . 0.0 110.829 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.922 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.3 m-85 -144.6 133.34 22.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.868 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.17 133.49 54.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 9.5 t80 -100.74 106.52 17.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.564 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 4.8 m -114.85 142.37 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.404 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 61.1 m -99.09 132.98 22.53 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 N--CA 1.463 -0.273 0 C-N-CA 122.894 2.396 . . . . 0.0 112.269 -179.68 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.221 0.534 . . . . 0.0 111.563 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.67 159.15 26.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.537 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -132.73 142.9 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.902 0.858 . . . . 0.0 112.042 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.686 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 22.8 t -103.93 113.94 27.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.041 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 1.032 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 27.8 mmm180 -137.12 139.43 41.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.927 0.394 . . . . 0.0 110.877 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 37.5 ttmt -68.87 148.92 49.52 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.75 -65.7 2.33 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.792 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 0.5 OUTLIER 179.58 48.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.137 0.494 . . . . 0.0 109.894 179.412 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 1.032 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 75.6 m 59.2 -158.91 0.3 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.8 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -151.92 147.83 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.4 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 61.14 42.63 12.07 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.832 0.708 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.96 7.91 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.536 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 148.74 19.18 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.282 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -88.7 107.56 19.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 17' ' ' VAL . 10.8 t -60.83 125.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.617 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 52.3 mmm-85 -99.44 -31.06 11.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.506 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.75 -155.58 26.56 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.52 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 p -91.52 140.85 29.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.839 0.352 . . . . 0.0 111.438 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.51 ' HB3' ' CB ' ' A' ' 25' ' ' PHE . 37.0 t -93.57 -137.52 0.19 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' N ' ' SG ' ' A' ' 21' ' ' CYS . . . -73.25 -147.87 0.98 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 113.464 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.848 ' H ' HD12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -65.64 99.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.442 0.639 . . . . 0.0 112.325 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 64.34 46.68 3.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.156 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 20.7 m-85 -131.83 150.01 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.787 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.457 ' N ' HD23 ' A' ' 26' ' ' LEU . 4.3 mm? -107.85 143.2 36.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -111.77 112.79 24.73 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.955 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -129.97 145.98 51.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.429 . . . . 0.0 111.238 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.467 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 51.9 m -115.32 121.34 34.98 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 C-N-CA 122.318 2.012 . . . . 0.0 111.271 -179.869 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.0 pt? . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.063 0.459 . . . . 0.0 111.006 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 62.5 m -82.6 155.85 24.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.096 0.474 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 2.3 p90 -108.32 138.96 43.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.967 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.704 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.1 t -87.77 117.76 26.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.704 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.6 mmm180 -133.81 125.38 28.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.985 0.421 . . . . 0.0 111.641 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -84.42 71.85 10.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.343 0.592 . . . . 0.0 109.41 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.37 -82.25 0.06 OUTLIER Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.861 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . 0.489 ' HA ' HD23 ' A' ' 26' ' ' LEU . 11.3 p80 -172.97 61.87 0.03 OUTLIER 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.164 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.415 ' HA ' ' HE1' ' A' ' 5' ' ' TYR . 13.3 m 59.61 -159.62 0.3 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.883 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.523 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 51.9 mtpt -145.17 131.44 19.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.94 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 21.8 ttt85 60.38 29.4 18.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.462 0.649 . . . . 0.0 111.134 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.42 43.75 86.34 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.376 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.88 167.46 51.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.342 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -88.29 117.45 27.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.409 HG21 ' SG ' ' A' ' 11' ' ' CYS . 8.0 t -63.3 131.2 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.244 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.8 tpt85 -104.16 -31.69 9.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.443 179.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.1 -152.47 20.09 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.727 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -108.48 140.65 41.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.539 0.17 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 24.7 p -116.27 30.45 7.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.22 0.534 . . . . 0.0 111.333 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -166.61 28.41 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.32 98.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.548 0.689 . . . . 0.0 110.688 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.64 34.51 4.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.253 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.777 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 19.6 m-85 -112.66 130.46 56.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.055 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.495 HD11 ' N ' ' A' ' 26' ' ' LEU . 7.1 mp -98.97 129.88 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 0.0 111.346 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 4' ' ' CYS . 2.4 t80 -104.04 112.02 24.84 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 m -131.39 142.09 49.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.081 -177.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -98.68 138.04 20.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.162 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--O 1.235 0.327 0 C-N-CA 122.398 2.065 . . . . 0.0 112.003 -179.884 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.638 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 4.6 m -69.63 151.26 46.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.011 0.434 . . . . 0.0 110.674 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.643 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 2.5 p90 -107.58 140.64 40.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.846 0.832 . . . . 0.0 113.109 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.615 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.4 t -87.96 119.66 28.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.615 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.5 mmm180 -129.55 138.96 51.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.419 0.628 . . . . 0.0 112.338 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.522 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 1.8 tmtp? -90.16 118.3 29.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.569 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.44 -52.21 3.72 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.424 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -161.59 145.87 12.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.07 0.935 . . . . 0.0 112.562 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.643 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 1.6 m -65.63 154.37 38.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.287 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 16.4 ptmt -119.44 48.69 1.46 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -174.6 -42.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.086 0.47 . . . . 0.0 110.289 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.13 138.06 5.08 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.934 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 51.11 2.79 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.063 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 16' ' ' ARG . 19.8 mmt180 -111.1 70.12 0.7 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.049 0.452 . . . . 0.0 110.475 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 22.3 t -63.96 123.32 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.644 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.529 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 9.9 tpt85 -89.87 -32.14 17.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.776 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.31 -168.55 37.25 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -93.45 138.07 32.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -102.89 120.68 41.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.18 -126.62 31.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.419 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 23' ' ' ILE . 17.6 pt -136.64 40.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.739 0.304 . . . . 0.0 110.893 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 9.5 tpt180 179.27 -24.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.226 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 1.9 m-85 -88.69 155.33 19.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 26' ' ' LEU . 6.2 mp -102.11 131.1 48.79 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -101.13 90.12 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 1.8 m -100.34 142.84 31.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 18' ' ' ARG . 61.5 m -89.85 145.48 33.4 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.638 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 63.4 Cg_endo . . . . . 0 CA--C 1.53 0.28 0 C-N-CA 122.563 2.175 . . . . 0.0 113.709 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.2 tp . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.5 m -73.83 163.66 27.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -149.41 137.81 20.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.905 0.86 . . . . 0.0 112.528 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.678 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 53.9 t -88.71 124.72 34.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.351 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.1 mmm180 -132.52 141.12 48.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.319 0.581 . . . . 0.0 112.334 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HD3' ' CZ ' ' A' ' 25' ' ' PHE . 51.3 tptt -86.42 53.11 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 122.142 0.972 . . . . 0.0 109.156 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.38 -150.12 8.81 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.911 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -91.56 20.21 5.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.58 0.69 . . . . 0.0 111.154 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.431 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 75.8 m 66.36 143.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.795 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.86 158.44 16.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.955 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.7 ttm105 78.44 -45.49 0.4 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.144 0.978 . . . . 0.0 111.254 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.13 131.18 2.22 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.881 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.5 51.59 3.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.668 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -87.92 69.18 9.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.107 0.48 . . . . 0.0 109.944 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.545 HG11 HD22 ' A' ' 26' ' ' LEU . 24.7 m -61.68 132.75 27.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.776 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.587 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 78.4 ttt180 -105.3 -35.34 7.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.203 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.23 -162.98 30.78 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.614 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -92.12 138.88 31.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 111.11 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.872 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.7 t -100.09 46.33 0.96 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.597 0.713 . . . . 0.0 110.015 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.19 -140.03 14.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.175 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -75.61 103.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 53.99 49.78 18.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.049 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.872 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.7 m-85 -135.49 146.36 48.06 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.545 HD22 HG11 ' A' ' 17' ' ' VAL . 7.8 mp -108.31 132.4 53.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.316 0.579 . . . . 0.0 110.954 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -106.58 114.71 28.98 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m -120.96 156.22 32.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.587 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 61.8 m -135.14 125.01 16.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.533 0.429 0 C-N-CA 122.881 2.387 . . . . 0.0 112.755 -179.569 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.768 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.5 pt? . . . . . 0 C--O 1.236 0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 110.454 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' CYS . . . . . 0.575 ' HB3' ' C ' ' A' ' 28' ' ' CYS . 61.1 m -75.16 163.59 27.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.581 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.1 p90 -88.58 141.12 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.591 . . . . 0.0 111.087 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.624 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 41.3 t -97.43 114.22 26.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.016 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.3 mmm180 -138.58 145.3 40.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 29.2 ttmt -67.32 -31.85 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.556 0.693 . . . . 0.0 109.524 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.56 151.32 52.24 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.152 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 45.4 m170 -72.33 68.71 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 76.7 m 71.16 145.68 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.927 0.767 . . . . 0.0 111.669 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -107.34 31.63 5.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.11 35.73 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.22 -139.4 30.78 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.911 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.71 72.67 1.26 Allowed Glycine 0 CA--C 1.517 0.169 0 C-N-CA 121.595 -0.336 . . . . 0.0 113.391 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -132.59 33.56 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 110.679 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.529 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 p -81.88 132.5 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.606 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -113.33 -11.95 13.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.691 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.72 -170.03 43.13 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.4 p -106.19 141.56 37.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 16.4 t -99.93 -140.32 0.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -156.3 1.95 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.491 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.424 HD12 HG21 ' A' ' 23' ' ' ILE . 13.0 pt -64.62 105.65 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.036 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 66.69 42.36 2.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.952 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.542 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 19.4 m-85 -132.76 140.76 48.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.576 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.2 mt -109.3 145.08 36.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.309 0.576 . . . . 0.0 111.529 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -98.92 94.54 6.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.425 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' CYS . . . . . 0.575 ' C ' ' HB3' ' A' ' 4' ' ' CYS . 10.1 m -119.96 140.48 50.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.385 . . . . 0.0 111.92 -177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 1.6 m -98.69 143.43 26.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.803 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 29' ' ' CYS . 37.2 Cg_exo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.912 2.408 . . . . 0.0 112.57 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.079 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt 49.32 -131.95 1.74 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.798 0.299 . . . . 0.0 110.861 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.0 tp -110.47 30.64 6.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.567 0.699 . . . . 0.0 109.299 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.2 m -78.21 154.02 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.994 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.597 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 3.1 p90 -135.89 140.5 44.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.726 0.774 . . . . 0.0 112.516 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.595 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 40.4 t -94.55 122.95 37.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.871 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.595 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 28.2 mmm180 -132.8 133.52 43.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.59 128.49 35.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.964 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.35 -53.12 4.8 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.307 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.85 138.49 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.827 0.314 . . . . 0.0 110.616 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.597 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 61.4 m -61.2 143.44 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.418 ' H ' ' HG3' ' A' ' 7' ' ' ARG . 75.4 mmtt -92.81 140.43 29.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 43.89 49.6 7.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.212 0.945 . . . . 0.0 112.356 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.07 128.69 1.4 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.631 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.78 42.83 1.74 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.485 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 5.6 mmp_? -125.6 63.3 1.2 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 110.427 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.589 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 4.2 p -61.89 130.34 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.447 0.641 . . . . 0.0 110.696 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.639 ' HA ' ' NE ' ' A' ' 18' ' ' ARG . 1.9 tpm_? -96.94 -26.71 14.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.35 43.39 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -82.7 135.85 34.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.963 0.411 . . . . 0.0 111.051 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.582 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 45.8 t -95.21 49.64 1.22 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.67 0.748 . . . . 0.0 109.028 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.2 -137.77 13.69 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.201 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.647 ' H ' HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -98.37 125.62 51.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 62.47 20.56 12.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.723 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.582 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -129.45 141.73 50.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.424 HD11 ' N ' ' A' ' 26' ' ' LEU . 9.9 mp -114.68 137.85 51.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.845 0.355 . . . . 0.0 110.5 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.46 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 8.5 t80 -111.45 114.95 28.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.589 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 83.0 m -117.87 143.79 45.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.374 . . . . 0.0 112.005 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.0 m -120.3 126.65 26.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.075 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.62 48.49 2.42 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.981 2.454 . . . . 0.0 112.704 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.411 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 6.0 tmm_? -98.43 -72.87 0.64 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 53.3 ttt85 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.862 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.52 ' H2 ' ' C ' ' A' ' 32' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.1 tp 68.76 -56.51 0.52 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.591 0.756 . . . . 0.0 111.969 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.78 144.47 54.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.73 0.3 . . . . 0.0 110.846 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 11.7 m -64.73 157.09 28.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.898 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.422 ' HE1' ' HA ' ' A' ' 11' ' ' CYS . 2.5 p90 -131.36 141.73 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 0.0 112.323 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.599 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 48.5 t -87.41 128.91 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.093 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.599 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.8 mmm180 -132.28 136.82 47.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 111.455 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -68.81 -36.2 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 109.964 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.47 -87.38 0.46 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.684 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.451 ' HB3' HD22 ' A' ' 26' ' ' LEU . 32.4 p-80 -179.36 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.781 0.433 . . . . 0.0 109.929 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.422 ' HA ' ' HE1' ' A' ' 5' ' ' TYR . 12.9 m 56.07 -155.74 0.29 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.373 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.426 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 4.9 mmmt -151.81 40.71 0.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 49.3 mmt-85 72.2 -58.23 0.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.013 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.53 47.91 3.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.677 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.477 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -165.32 142.51 7.77 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.032 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -103.09 134.81 45.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.471 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 3.5 p -57.32 127.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.593 0.711 . . . . 0.0 110.996 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -95.81 -27.17 15.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.566 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.36 -155.5 26.37 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.834 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -88.26 138.03 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.385 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.685 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.9 t -103.68 49.19 0.83 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.517 0.675 . . . . 0.0 109.824 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.37 -141.48 15.59 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.502 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.7 mt -86.78 112.77 23.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.49 34.96 20.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.496 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.685 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -132.89 146.65 51.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.451 HD22 ' HB3' ' A' ' 10' ' ' HIS . 7.5 mp -112.99 133.55 54.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.333 0.587 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.418 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 7.2 t80 -103.41 128.42 50.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 m -135.14 146.18 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.57 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 64.3 m -110.09 131.55 21.93 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.699 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.477 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 81.5 Cg_endo -79.05 -145.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.539 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.424 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -166.28 33.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.349 0.595 . . . . 0.0 109.588 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.52 ' C ' ' H2 ' ' A' ' 1' ' ' GLY . 48.1 ttt85 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 117.955 -1.022 . . . . 0.0 108.435 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.743 ' H2 ' HD11 ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.734 ' H ' HD23 ' A' ' 2' ' ' LEU . 1.4 pt? -77.39 62.01 2.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.228 0.537 . . . . 0.0 111.033 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.743 HD11 ' H2 ' ' A' ' 1' ' ' GLY . 0.4 OUTLIER -155.49 51.91 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.372 0.606 . . . . 0.0 110.817 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.86 159.77 33.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.179 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.497 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 0.9 OUTLIER -144.46 141.82 29.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.909 0.862 . . . . 0.0 112.864 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.59 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 39.5 t -91.37 126.86 36.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.711 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.59 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.9 mmm180 -131.69 137.15 48.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 111.211 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.44 128.0 34.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.988 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.04 -51.6 3.2 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.515 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.49 ' HA ' HD12 ' A' ' 26' ' ' LEU . 27.7 p-80 -169.21 146.62 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.51 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 71.3 m -66.55 142.72 57.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.034 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 129.25 39.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.578 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 68.56 -51.25 0.56 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.989 0.916 . . . . 0.0 112.515 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -143.47 8.57 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.059 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.23 169.76 15.09 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -87.66 114.42 24.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.77 124.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.898 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.676 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 52.3 ttt85 -90.33 -35.69 15.09 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.095 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.95 -166.51 39.19 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.599 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 p -86.9 137.9 31.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.753 0.311 . . . . 0.0 110.998 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 35.8 t -99.6 42.6 1.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.62 0.724 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -144.37 16.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.911 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tt -90.45 118.67 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.02 0.438 . . . . 0.0 111.801 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 62.98 32.79 15.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.976 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.701 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 13.2 m-85 -137.09 139.02 40.98 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.49 HD12 ' HA ' ' A' ' 10' ' ' HIS . 73.8 mt -115.77 138.27 51.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.013 0.435 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 9.9 t80 -110.7 116.79 31.91 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.29 156.46 41.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.952 0.406 . . . . 0.0 111.949 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.676 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 58.3 m -122.69 113.29 30.43 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.935 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.449 ' HG2' ' CD1' ' A' ' 3' ' ' LEU . 59.4 Cg_endo -75.68 161.95 36.05 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.505 2.137 . . . . 0.0 111.639 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.562 ' HD2' ' H ' ' A' ' 32' ' ' ARG . 0.7 OUTLIER -56.38 -47.39 79.01 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.73 0.3 . . . . 0.0 111.36 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.562 ' H ' ' HD2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.983 0 CA-C-O 116.94 -1.505 . . . . 0.0 107.488 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.676 HD11 ' HA ' ' A' ' 32' ' ' ARG . 3.8 mm? -76.36 66.78 2.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.789 0.328 . . . . 0.0 111.319 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.439 HD12 ' N ' ' A' ' 3' ' ' LEU . 11.0 mp -77.42 54.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 58.1 m -66.26 161.21 22.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.495 ' OH ' ' HA3' ' A' ' 15' ' ' GLY . 4.6 p90 -149.45 141.75 24.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.537 0.684 . . . . 0.0 112.029 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.656 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 44.5 t -93.52 119.47 32.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.577 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.656 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.3 mmm180 -135.16 138.99 44.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.062 0.458 . . . . 0.0 111.433 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.409 ' HE3' ' HB3' ' A' ' 8' ' ' LYS . 13.9 ttpp -83.44 52.24 2.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.482 0.658 . . . . 0.0 109.608 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.3 -159.15 18.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.958 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -85.45 64.11 8.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.3 m 59.18 -149.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.118 0.485 . . . . 0.0 111.951 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.489 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 25.5 mtpp -136.02 65.79 1.52 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 69.15 -100.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.479 0.487 . . . . 0.0 111.123 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.36 66.91 2.24 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.877 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.615 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -149.46 132.71 4.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.142 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -95.45 131.92 41.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.22 124.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.602 0.715 . . . . 0.0 110.806 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -90.59 -27.74 18.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.05 -157.16 28.45 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.201 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -94.37 138.81 31.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.017 0.437 . . . . 0.0 111.225 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.577 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 47.2 t -100.03 55.0 0.92 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.558 0.694 . . . . 0.0 109.212 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.66 -134.06 12.08 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.665 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.588 HG13 ' HG3' ' A' ' 24' ' ' ARG . 7.2 tp -101.65 124.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.886 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.588 ' HG3' HG13 ' A' ' 23' ' ' ILE . 59.5 mtp85 59.87 27.91 17.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.671 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.0 m-85 -135.57 143.06 45.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 26' ' ' LEU . 7.2 mp -112.3 137.96 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.229 0.538 . . . . 0.0 110.864 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -106.39 123.27 47.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.448 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 22.4 m -131.99 154.96 48.8 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.921 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 41.5 m -127.71 127.9 23.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.268 178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.615 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 25.8 Cg_endo -63.35 -35.61 60.88 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.785 2.324 . . . . 0.0 112.381 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -173.39 -154.47 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.758 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.676 ' HA ' HD11 ' A' ' 2' ' ' LEU . 79.1 mtm-85 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.51 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.8 tp -90.88 139.43 30.76 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.496 ' H ' HD22 ' A' ' 3' ' ' LEU . 2.4 pt? -62.14 135.64 57.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.034 0.445 . . . . 0.0 111.368 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.631 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 32.2 m -76.29 161.67 28.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.736 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -125.3 136.13 53.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.871 0.843 . . . . 0.0 112.598 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.576 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 51.7 t -81.02 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.769 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.576 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.2 mmm180 -132.01 140.5 48.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.088 0.47 . . . . 0.0 112.064 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.545 ' HD3' ' CE1' ' A' ' 25' ' ' PHE . 21.3 tptm -86.8 49.36 1.8 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.161 0.981 . . . . 0.0 109.228 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.62 -161.94 35.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.483 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.88 64.11 1.79 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 112.023 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.455 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 11.4 m 59.45 -153.94 0.38 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.405 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.631 ' HZ2' ' HB3' ' A' ' 12' ' ' LYS . 10.5 mtpm? -80.3 56.39 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.331 178.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 66.67 51.75 1.05 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.508 0.671 . . . . 0.0 109.865 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.68 -131.4 1.24 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.015 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 65.12 0.19 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.418 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.6 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 4.9 mmp_? -117.87 37.08 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.488 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.536 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 6.6 p -72.6 136.84 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.601 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.505 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 43.0 mtp85 -124.55 -2.65 7.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.69 178.09 48.38 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.38 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -95.13 139.36 31.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.864 0.364 . . . . 0.0 110.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.2 t -104.56 48.11 0.85 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.538 0.685 . . . . 0.0 109.845 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.38 -138.88 14.32 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.302 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.77 120.21 39.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.346 0.593 . . . . 0.0 112.143 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 56.36 38.13 29.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.559 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.78 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 11.7 m-85 -138.01 138.82 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 HD11 ' N ' ' A' ' 26' ' ' LEU . 7.4 mp -106.08 133.85 50.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.077 0.465 . . . . 0.0 111.311 -179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.549 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 11.6 t80 -97.96 101.09 12.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.536 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 57.7 m -105.45 141.37 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.776 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.505 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 80.6 m -108.22 143.82 28.19 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.745 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.631 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 55.2 Cg_exo -54.24 -51.22 11.1 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.034 2.489 . . . . 0.0 113.578 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -167.35 -51.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.265 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.926 -179.8 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.444 ' HA ' HD12 ' A' ' 2' ' ' LEU . 3.5 mm? -75.13 -45.77 38.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.77 0.319 . . . . 0.0 111.238 -179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.504 ' N ' HD23 ' A' ' 3' ' ' LEU . 3.3 mm? -78.13 130.18 36.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.357 -179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.49 164.37 18.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.494 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.478 ' CD1' ' HD3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -150.04 147.05 27.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.914 0.864 . . . . 0.0 113.026 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.612 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.0 t -77.49 128.99 35.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.597 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.612 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.2 mmm180 -129.56 136.38 49.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -69.67 125.98 28.35 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.124 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.13 -141.26 29.89 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.854 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.06 144.93 56.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.83 0.315 . . . . 0.0 110.317 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.0 m -47.81 139.02 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.701 0.626 . . . . 0.0 112.208 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.611 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . 49.2 mmtm -112.02 120.68 42.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.232 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 71.42 -48.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.968 0.792 . . . . 0.0 111.962 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.917 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -59.57 -41.03 97.09 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.745 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.89 -56.57 3.52 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.774 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -89.89 119.63 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.441 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.442 HG23 ' N ' ' A' ' 18' ' ' ARG . 5.6 p -72.58 138.3 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.997 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.442 ' N ' HG23 ' A' ' 17' ' ' VAL . 6.7 tpm_? -98.68 -30.46 12.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.422 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.06 -168.55 41.69 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.596 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 p -88.63 142.33 27.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.921 0.361 . . . . 0.0 111.2 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.506 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.3 t -113.98 47.58 1.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.6 0.714 . . . . 0.0 109.253 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 -137.8 14.0 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.894 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 pt -98.31 126.89 51.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.937 0.398 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 61.39 20.55 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.351 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.506 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 14.8 m-85 -134.44 139.42 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 25' ' ' PHE . 10.5 mp -121.82 135.63 54.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.304 0.574 . . . . 0.0 110.507 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 122.93 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.2 m -135.53 152.58 51.45 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.133 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 66.5 m -110.23 123.67 35.37 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.634 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.917 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 39.6 Cg_endo -68.91 110.94 2.5 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.969 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.8 tpp85 -88.65 36.71 0.81 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.805 0.812 . . . . 0.0 109.69 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 . . . . . 0 C--O 1.24 0.593 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.407 179.552 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.5 mt -144.88 -59.89 0.36 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.424 ' HA ' HD22 ' A' ' 3' ' ' LEU . 93.7 mt -89.3 52.44 2.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.296 0.57 . . . . 0.0 109.555 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 36.2 m -88.81 164.89 15.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.28 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -139.34 128.86 24.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.464 0.65 . . . . 0.0 110.713 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.572 ' C ' ' HD2' ' A' ' 7' ' ' ARG . 24.0 p -94.19 134.68 36.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.572 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.3 mpt_? -135.29 138.76 43.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.185 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.407 ' HD3' ' C ' ' A' ' 8' ' ' LYS . 1.7 tmtm? -74.63 -43.95 52.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.368 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.94 -61.56 3.71 Favored Glycine 0 C--N 1.319 -0.395 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.512 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -174.71 149.95 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.434 ' SG ' HG13 ' A' ' 17' ' ' VAL . 8.5 m -52.31 142.48 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.576 0.548 . . . . 0.0 110.678 179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.95 138.05 34.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 63.23 -143.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.748 0.655 . . . . 0.0 110.744 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.61 43.34 3.14 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.874 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 134.58 12.6 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.585 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -111.81 139.22 47.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.434 HG13 ' SG ' ' A' ' 11' ' ' CYS . 19.7 m -62.47 139.2 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.315 0.579 . . . . 0.0 112.118 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.406 ' HD2' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -129.93 -32.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.33 -150.33 6.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.839 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -127.72 142.54 51.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 111.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.931 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 13.2 t -91.02 42.61 1.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.19 -135.63 12.43 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.039 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 118.59 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.166 0.507 . . . . 0.0 112.252 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 60.44 27.24 16.84 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.931 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 7.9 m-85 -122.69 138.61 54.56 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.426 HD21 HG11 ' A' ' 17' ' ' VAL . 6.5 mp -101.22 132.37 46.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.846 0.355 . . . . 0.0 111.398 -179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.487 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 t80 -98.65 113.37 25.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.06 147.16 40.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.133 0.492 . . . . 0.0 112.235 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 74.6 m -120.55 140.04 29.78 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.406 ' C ' ' HD2' ' A' ' 31' ' ' ARG . 32.0 Cg_exo -58.37 -42.18 58.32 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 2.236 . . . . 0.0 112.622 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.406 ' HD2' ' C ' ' A' ' 30' ' ' PRO . 1.3 mpt_? -143.2 -114.55 0.11 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.87 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.784 -179.825 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.506 ' N ' HD21 ' A' ' 2' ' ' LEU . 2.6 pt? -164.24 -170.01 1.97 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.6 mt -71.73 128.66 36.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.943 0.401 . . . . 0.0 111.151 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 19.1 m -99.74 160.74 14.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.518 ' CE1' ' HB2' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -145.07 148.82 34.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.637 0.732 . . . . 0.0 112.381 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.634 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 7.8 p -93.81 124.98 38.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.634 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.6 mmm180 -128.58 141.84 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 39.5 ttpt -66.23 -29.08 69.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.386 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 -158.87 25.54 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.321 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -81.26 58.6 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.623 -0.339 . . . . 0.0 110.556 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.407 ' SG ' HG22 ' A' ' 17' ' ' VAL . 15.8 m 60.82 -153.28 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.766 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.518 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 8.7 mmmm -156.84 135.87 11.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.978 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.598 ' HD2' ' HB3' ' A' ' 30' ' ' PRO . 44.1 ttm180 75.63 -34.5 0.25 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 111.9 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.48 -146.8 4.53 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.756 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.94 43.83 0.69 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.216 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.727 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 78.1 ttt180 -88.63 70.58 8.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.407 HG22 ' SG ' ' A' ' 11' ' ' CYS . 11.7 t -67.91 132.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.994 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 75.4 mtp180 -115.2 -23.45 8.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.055 179.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.56 -143.89 7.83 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.343 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 p -128.91 156.19 44.11 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.753 0.311 . . . . 0.0 110.526 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.493 ' HB2' ' HB2' ' A' ' 6' ' ' CYS . 1.6 t -88.62 40.56 0.97 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.88 -57.78 3.51 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-O 121.872 0.707 . . . . 0.0 111.925 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.435 ' HB ' ' H ' ' A' ' 24' ' ' ARG . 8.8 pt -83.32 -160.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 114.359 -0.921 . . . . 0.0 110.396 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.464 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 15.8 mmp_? -80.86 51.06 1.46 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.043 0.449 . . . . 0.0 111.734 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.468 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 6.3 m-85 -129.23 135.66 49.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 26' ' ' LEU . 6.5 mp -89.28 128.69 35.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 32.4 t80 -89.75 112.55 23.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 m -135.51 153.27 51.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 111.562 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.727 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 79.6 m -98.86 142.12 24.06 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 54.1 Cg_exo -53.94 -42.78 63.89 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.93 2.42 . . . . 0.0 113.092 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.47 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 91.6 mtt180 -154.73 -153.33 0.45 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.337 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.47 ' H ' ' HB3' ' A' ' 31' ' ' ARG . 20.3 mtp-105 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.341 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.6 mt -89.05 -44.58 10.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.76 0.314 . . . . 0.0 111.373 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 48.6 tp -79.92 132.46 36.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.209 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.48 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.6 m -89.52 165.84 14.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.812 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.465 ' HD1' ' O ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.82 142.48 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.229 0.538 . . . . 0.0 110.592 177.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.616 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 17.6 p -90.33 127.98 36.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.023 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.616 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.8 mmm180 -130.55 149.99 51.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.27 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -69.41 113.53 6.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.43 178.5 17.56 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -76.62 69.53 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.109 0.454 . . . . 0.0 111.706 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.463 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 32.5 m 69.93 147.94 0.07 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.625 0.578 . . . . 0.0 112.085 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.491 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 30.3 mmtp -132.5 117.19 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.148 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 56.29 44.17 25.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.918 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.654 ' HA2' ' N ' ' A' ' 31' ' ' ARG . . . -141.13 -133.21 2.9 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.264 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.53 -46.37 0.23 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.384 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.699 ' HG3' ' HB2' ' A' ' 29' ' ' CYS . 23.7 ptt-85 -89.3 99.53 12.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.415 0.626 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.463 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 p -92.82 142.88 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.063 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 23.07 0.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' C ' ' HB3' ' A' ' 27' ' ' TYR . . . -178.0 -169.86 39.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.13 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 7.7 p -141.57 157.62 44.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.408 . . . . 0.0 109.914 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.928 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 3.8 t -117.21 38.8 3.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.98 -144.63 16.38 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.435 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 10.6 tt -82.76 123.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.203 0.525 . . . . 0.0 112.015 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.432 ' HG2' HG12 ' A' ' 23' ' ' ILE . 26.2 mmm180 61.0 36.35 18.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.448 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.928 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.0 m-85 -137.58 127.02 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.413 HD21 ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -110.67 137.99 47.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 0.0 111.387 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.551 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 42.6 t80 -98.81 103.13 15.06 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 1.5 m -133.33 155.74 48.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.151 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.699 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.6 m -88.18 142.99 32.17 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.893 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.481 ' HB2' ' HG2' ' A' ' 32' ' ' ARG . 17.2 Cg_endo -58.42 152.5 53.88 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.283 2.655 . . . . 0.0 112.662 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.654 ' N ' ' HA2' ' A' ' 14' ' ' GLY . 35.7 ttt85 -78.33 53.28 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 31.8 ptt180 . . . . . 0 C--O 1.258 1.54 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.611 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.408 ' O ' ' HG2' ' A' ' 30' ' ' PRO . . . . . . . . 0 N--CA 1.484 1.851 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.485 ' N ' HD23 ' A' ' 2' ' ' LEU . 3.8 mm? -96.97 -36.92 10.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.771 0.319 . . . . 0.0 111.02 -179.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.68 133.41 55.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.395 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.1 m -71.5 161.47 30.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.492 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.96 146.5 30.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.837 0.827 . . . . 0.0 112.664 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.642 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.7 t -80.93 126.06 30.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.209 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.642 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.3 mmm180 -130.72 128.49 40.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.956 0.408 . . . . 0.0 111.165 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 36.1 ttpt -83.03 85.04 7.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.02 -111.27 0.45 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.338 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -142.61 53.57 1.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.746 0.308 . . . . 0.0 110.565 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.548 ' SG ' HG12 ' A' ' 17' ' ' VAL . 56.7 m 63.48 -163.91 0.26 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.909 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.463 ' C ' ' H ' ' A' ' 14' ' ' GLY . 65.2 mmtt -155.88 146.07 21.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 17.5 mmt85 73.91 -24.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.076 0.551 . . . . 0.0 111.356 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.463 ' H ' ' C ' ' A' ' 12' ' ' LYS . . . 170.76 149.49 6.48 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.08 53.62 2.2 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.825 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -89.24 65.41 7.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.018 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.548 HG12 ' SG ' ' A' ' 11' ' ' CYS . 17.9 m -62.05 132.5 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.425 -179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -102.67 -35.45 8.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.436 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.04 -167.98 40.62 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 p -90.82 139.4 30.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.546 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 48.1 t -106.89 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.72 0.771 . . . . 0.0 109.24 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.67 -136.92 13.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.56 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.79 125.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 60.88 25.72 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.687 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.546 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.1 m-85 -135.16 136.55 41.95 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -114.5 135.03 54.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.176 0.512 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -93.97 121.54 35.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.4 m -132.16 156.35 46.57 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.707 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.6 m -118.94 128.8 25.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.666 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.491 ' HB2' ' H ' ' A' ' 31' ' ' ARG . 84.5 Cg_endo -84.62 -135.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.847 2.365 . . . . 0.0 112.234 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.491 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 26.2 tpt180 -175.41 -43.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.104 0.478 . . . . 0.0 110.106 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 117.558 -1.21 . . . . 0.0 109.95 179.866 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.3 mt 71.41 -60.86 0.5 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.592 0.757 . . . . 0.0 111.805 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.533 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 6.9 mp -74.72 110.14 8.77 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 72.6 m -150.95 167.73 26.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.922 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.67 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.5 p90 -153.59 133.81 13.39 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.789 0.804 . . . . 0.0 111.743 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.51 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 24.6 t -92.2 120.94 33.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.077 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.616 ' HD3' ' CD1' ' A' ' 5' ' ' TYR . 11.4 mtp-105 -151.11 141.42 22.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.863 0.363 . . . . 0.0 111.731 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.449 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 35.0 ttpt -82.18 52.07 1.92 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.729 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.86 159.74 27.47 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.969 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -49.64 148.33 3.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 111.687 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -56.99 161.41 3.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.159 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.61 128.32 35.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.229 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.82 23.58 12.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.05 -137.48 4.69 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.821 -1.18 . . . . 0.0 113.07 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.66 56.73 0.3 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.272 -0.489 . . . . 0.0 111.963 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -87.72 63.09 7.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.513 0.673 . . . . 0.0 109.828 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.89 131.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.162 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.428 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 41.7 mmm-85 -106.33 -23.64 12.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.882 0.372 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.81 -171.35 38.87 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.842 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -104.25 140.64 37.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.728 0.299 . . . . 0.0 110.313 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.672 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 34.7 t -104.65 47.9 0.86 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.605 0.717 . . . . 0.0 109.668 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.23 -137.08 13.04 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.178 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.419 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 64.3 mt -90.95 116.6 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.405 ' HG2' HG23 ' A' ' 23' ' ' ILE . 56.2 mmm-85 66.59 -0.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.672 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 10.2 m-85 -95.07 135.42 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.823 0.344 . . . . 0.0 110.511 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.58 133.62 45.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.553 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -100.61 91.25 4.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.67 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 66.7 m -96.62 149.87 21.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.489 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.489 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.5 m -133.33 118.86 15.11 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.533 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 95.9 Cg_endo -79.7 26.8 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.901 2.401 . . . . 0.0 112.282 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.8 mmt-85 -153.26 145.92 24.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.13 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.047 179.818 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.984 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.0 mt -74.61 159.36 32.24 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.529 0.331 . . . . 0.0 110.649 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.451 ' N ' HD11 ' A' ' 3' ' ' LEU . 6.9 mp -71.09 135.71 47.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.6 m -83.14 166.22 18.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.418 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 33.2 p90 -135.27 127.24 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.891 0.853 . . . . 0.0 111.601 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.692 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 15.8 t -87.13 115.45 24.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.319 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.692 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.8 mmm180 -141.07 142.68 34.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.693 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -90.23 122.33 33.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -102.81 0.27 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.853 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -159.44 40.63 0.21 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.564 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 83.2 m 69.66 150.06 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -104.59 131.59 51.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.311 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 65.24 56.77 0.97 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.542 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.26 134.77 8.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.645 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 11' ' ' CYS . . . -77.64 66.44 3.02 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.921 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -88.14 58.84 4.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.622 -0.34 . . . . 0.0 110.7 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.473 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 20.7 t -71.38 127.2 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.885 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HD2' ' C ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -130.19 2.53 4.72 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.75 -178.68 48.44 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.878 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -109.84 139.51 44.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.636 0.255 . . . . 0.0 110.327 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.1 t -104.35 111.66 24.38 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -126.68 35.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.222 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.421 ' O ' HG13 ' A' ' 23' ' ' ILE . 10.9 tp -140.75 37.39 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.334 1.064 . . . . 0.0 109.543 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.7 ' HG3' ' HD1' ' A' ' 25' ' ' PHE . 38.7 ptt180 -172.26 2.11 0.01 OUTLIER 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.273 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HD1' ' HG3' ' A' ' 24' ' ' ARG . 5.6 m-85 -129.91 160.06 34.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 110.631 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.481 ' N ' HD12 ' A' ' 26' ' ' LEU . 7.1 mp -102.1 134.77 44.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.085 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.53 96.13 8.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.418 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.0 m -94.61 139.18 31.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.662 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.1 m -134.68 120.44 14.44 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.716 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.52 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 35.0 Cg_exo -60.39 -46.02 19.79 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.251 1.968 . . . . 0.0 110.582 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 30' ' ' PRO . 32.7 mtp180 -167.49 120.72 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.77 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.587 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.518 ' H1 ' ' C ' ' A' ' 32' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 61.01 42.73 12.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.098 0.475 . . . . 0.0 110.832 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.804 ' H ' HD22 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -80.13 54.74 2.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.195 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.2 m -77.88 164.53 25.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.663 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.481 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.0 p90 -157.23 137.17 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.632 0.73 . . . . 0.0 111.808 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 52.9 t -89.58 121.95 32.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.214 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.1 mmm180 -136.0 132.29 36.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.476 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 36.2 ttmt -70.14 -29.69 66.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.31 0.576 . . . . 0.0 110.629 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 -110.16 0.2 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -143.1 67.41 1.3 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.468 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.2 m 63.9 -150.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 14.3 mmmt -136.14 44.08 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.615 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -168.4 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.643 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.83 -62.86 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.829 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.81 52.04 0.16 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.543 ' HG2' ' HA ' ' A' ' 30' ' ' PRO . 36.1 tpt85 -89.45 44.7 1.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 t -63.89 137.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.897 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -107.18 -33.59 7.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.325 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.37 -163.46 29.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.535 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 p -92.4 140.5 29.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.994 0.426 . . . . 0.0 111.371 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.695 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 46.8 t -108.51 44.94 1.06 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.624 0.726 . . . . 0.0 109.475 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.8 -139.86 14.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.14 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.711 ' H ' HD11 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -92.88 123.86 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 111.861 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 54.68 42.84 30.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.409 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.695 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -148.1 134.79 19.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.653 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.447 ' HA ' HD11 ' A' ' 26' ' ' LEU . 3.3 mm? -109.04 132.2 54.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.996 0.427 . . . . 0.0 110.136 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -97.3 115.9 28.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.481 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.9 m -112.61 148.09 35.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.953 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.2 m -142.02 112.66 6.26 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.775 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.753 ' HB2' ' HD3' ' A' ' 31' ' ' ARG . 19.9 Cg_exo -66.14 -42.76 10.06 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.884 2.389 . . . . 0.0 111.566 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.753 ' HD3' ' HB2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -168.03 159.86 11.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.176 179.051 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.518 ' C ' ' H1 ' ' A' ' 1' ' ' GLY . 3.4 ptp180 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.29 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.908 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.598 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 3.3 mm? -71.11 142.41 50.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.486 ' N ' HD23 ' A' ' 3' ' ' LEU . 3.4 mm? -74.88 152.93 38.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.797 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 38.5 m -72.19 161.75 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.612 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -152.34 138.6 18.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.146 0.498 . . . . 0.0 111.043 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 27.2 p -107.15 117.77 34.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.999 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.437 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -144.18 150.46 38.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.792 0.329 . . . . 0.0 110.718 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -68.85 104.16 1.98 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.417 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.11 -117.59 0.77 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.342 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.406 ' HA ' HD22 ' A' ' 26' ' ' LEU . 32.1 p-80 -166.87 57.08 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m 74.28 146.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.639 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 14.5 mmmm -93.54 112.97 24.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.47 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 55.2 mmt-85 71.09 -53.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.88 0.737 . . . . 0.0 112.269 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.13 140.89 5.49 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.379 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -150.34 10.68 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.658 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.3 mmt-85 -146.85 131.81 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.449 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 22.5 t -78.59 126.93 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.77 0.319 . . . . 0.0 110.192 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.821 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -115.85 -13.85 11.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.576 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.57 -149.79 8.9 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.289 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.4 p -140.71 153.16 45.82 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.752 0.311 . . . . 0.0 110.64 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.476 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 1.6 t -88.55 60.15 5.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.3 -59.0 3.84 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.163 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 tp -174.58 145.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.833 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 71.58 -39.7 0.46 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.719 0.807 . . . . 0.0 112.949 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.476 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m-85 -89.31 130.8 35.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.364 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 9.5 mp -91.62 137.01 32.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -96.01 101.56 13.25 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 91.7 m -100.61 142.77 31.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.838 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.821 ' HB2' ' HD3' ' A' ' 18' ' ' ARG . 70.1 m -121.84 116.07 30.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.03 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.598 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 3.0 Cg_exo -77.14 -22.79 10.96 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.907 2.405 . . . . 0.0 111.864 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.533 ' HG3' ' H ' ' A' ' 32' ' ' ARG . 5.5 ptp85 -61.84 -48.94 78.3 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.585 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.54 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.2 mmp_? . . . . . 0 C--O 1.247 0.924 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.556 ' H2 ' ' C ' ' A' ' 32' ' ' ARG . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.746 HD22 ' H ' ' A' ' 2' ' ' LEU . 2.2 pt? -67.66 -38.65 84.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 110.994 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.9 tp -76.19 127.81 33.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.774 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 12.7 m -86.38 158.15 19.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.572 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.564 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.9 p90 -98.95 136.46 38.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.977 0.894 . . . . 0.0 112.952 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.677 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 37.8 t -93.78 121.69 35.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.509 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.677 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.2 mmm180 -133.1 141.73 48.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -82.98 47.76 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.757 0.789 . . . . 0.0 109.715 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.82 -148.87 7.11 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.209 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -94.11 67.75 3.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.1 m 60.15 -151.75 0.4 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.546 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -149.19 110.62 4.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 54.08 45.67 27.05 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.649 0.593 . . . . 0.0 111.836 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.42 132.79 1.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.96 153.85 14.73 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -88.65 117.65 27.77 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.997 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -61.14 129.83 24.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.423 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.427 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 7.6 tpt180 -101.76 -40.41 6.97 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.568 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.7 -159.82 27.76 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.583 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 p -94.95 140.2 30.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 0.0 110.922 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.922 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.5 t -104.81 39.08 1.77 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.628 0.727 . . . . 0.0 109.81 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.83 -145.27 16.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.543 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.459 ' N ' HD13 ' A' ' 23' ' ' ILE . 4.1 mp -85.15 118.36 31.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.745 0.307 . . . . 0.0 110.968 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 57.05 46.38 19.34 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.657 0.741 . . . . 0.0 110.829 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.922 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.3 m-85 -144.6 133.34 22.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.868 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.17 133.49 54.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 9.5 t80 -100.74 106.52 17.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.564 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 4.8 m -114.85 142.37 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.404 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 61.1 m -99.09 132.98 22.53 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.17 156.17 62.9 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.894 2.396 . . . . 0.0 112.269 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.61 ' HD2' ' H ' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -61.76 -23.54 66.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.556 ' C ' ' H2 ' ' A' ' 1' ' ' GLY . 32.1 ptt85 . . . . . 0 C--O 1.245 0.852 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.455 ' HA3' ' OXT' ' A' ' 32' ' ' ARG . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.01 -44.03 20.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.649 0.261 . . . . 0.0 111.116 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -150.25 45.59 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.221 0.534 . . . . 0.0 111.563 -179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.67 159.15 26.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.537 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -132.73 142.9 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.902 0.858 . . . . 0.0 112.042 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.686 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 22.8 t -103.93 113.94 27.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.041 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 1.032 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 27.8 mmm180 -137.12 139.43 41.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.927 0.394 . . . . 0.0 110.877 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 37.5 ttmt -68.87 148.92 49.52 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.75 -65.7 2.33 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.792 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.406 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 0.5 OUTLIER 179.58 48.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.137 0.494 . . . . 0.0 109.894 179.412 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 1.032 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 75.6 m 59.2 -158.91 0.3 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.8 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -151.92 147.83 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.4 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 61.14 42.63 12.07 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.832 0.708 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.96 7.91 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.536 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 148.74 19.18 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.282 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -88.7 107.56 19.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 17' ' ' VAL . 10.8 t -60.83 125.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.617 -179.082 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.467 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 52.3 mmm-85 -99.44 -31.06 11.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.506 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.75 -155.58 26.56 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.52 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 p -91.52 140.85 29.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.839 0.352 . . . . 0.0 111.438 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.51 ' HB3' ' CB ' ' A' ' 25' ' ' PHE . 37.0 t -93.57 -137.52 0.19 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' N ' ' SG ' ' A' ' 21' ' ' CYS . . . -73.25 -147.87 0.98 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 113.464 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.848 ' H ' HD12 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -65.64 99.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.442 0.639 . . . . 0.0 112.325 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 64.34 46.68 3.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.156 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.51 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 20.7 m-85 -131.83 150.01 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.787 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.457 ' N ' HD23 ' A' ' 26' ' ' LEU . 4.3 mm? -107.85 143.2 36.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -111.77 112.79 24.73 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.955 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -129.97 145.98 51.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.429 . . . . 0.0 111.238 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.467 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 51.9 m -115.32 121.34 34.98 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.451 ' C ' ' HD3' ' A' ' 31' ' ' ARG . 20.7 Cg_endo -63.67 -35.4 58.47 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.318 2.012 . . . . 0.0 111.271 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.451 ' HD3' ' C ' ' A' ' 30' ' ' PRO . 1.0 OUTLIER -131.12 -60.68 0.95 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.868 178.578 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.455 ' OXT' ' HA3' ' A' ' 1' ' ' GLY . 19.7 mmt85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.787 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.866 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' A' ' 18' ' ' ARG . 96.8 mt -74.85 132.54 41.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.876 0.338 . . . . 0.0 110.214 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -81.92 39.17 0.55 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.063 0.459 . . . . 0.0 111.006 -179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 62.5 m -82.6 155.85 24.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.096 0.474 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 2.3 p90 -108.32 138.96 43.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.967 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.704 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.1 t -87.77 117.76 26.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.704 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.6 mmm180 -133.81 125.38 28.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.985 0.421 . . . . 0.0 111.641 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -84.42 71.85 10.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.343 0.592 . . . . 0.0 109.41 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.37 -82.25 0.06 OUTLIER Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.861 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . 0.489 ' HA ' HD23 ' A' ' 26' ' ' LEU . 11.3 p80 -172.97 61.87 0.03 OUTLIER 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.164 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.415 ' HA ' ' HE1' ' A' ' 5' ' ' TYR . 13.3 m 59.61 -159.62 0.3 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.883 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.523 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 51.9 mtpt -145.17 131.44 19.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.94 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.508 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 21.8 ttt85 60.38 29.4 18.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.462 0.649 . . . . 0.0 111.134 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.42 43.75 86.34 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.376 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.88 167.46 51.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.342 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -88.29 117.45 27.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.409 HG21 ' SG ' ' A' ' 11' ' ' CYS . 8.0 t -63.3 131.2 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.244 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' HG2' HD12 ' A' ' 2' ' ' LEU . 4.8 tpt85 -104.16 -31.69 9.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.443 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.1 -152.47 20.09 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.727 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -108.48 140.65 41.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.539 0.17 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.777 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 24.7 p -116.27 30.45 7.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.22 0.534 . . . . 0.0 111.333 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -166.61 28.41 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.32 98.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.548 0.689 . . . . 0.0 110.688 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.64 34.51 4.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.253 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.777 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 19.6 m-85 -112.66 130.46 56.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.055 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.495 HD11 ' N ' ' A' ' 26' ' ' LEU . 7.1 mp -98.97 129.88 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 0.0 111.346 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.441 ' CE2' ' HB2' ' A' ' 4' ' ' CYS . 2.4 t80 -104.04 112.02 24.84 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 m -131.39 142.09 49.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.081 -177.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -98.68 138.04 20.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.162 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.22 124.43 11.3 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.398 2.065 . . . . 0.0 112.003 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.676 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . 2.3 tpm_? -160.3 44.83 0.21 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.764 -1.112 . . . . 0.0 109.036 -179.554 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.929 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 22.5 tp 59.08 54.72 4.78 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.387 0.613 . . . . 0.0 110.564 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.58 120.89 15.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.874 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.638 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 4.6 m -69.63 151.26 46.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.011 0.434 . . . . 0.0 110.674 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.643 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 2.5 p90 -107.58 140.64 40.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.846 0.832 . . . . 0.0 113.109 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.615 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.4 t -87.96 119.66 28.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.615 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.5 mmm180 -129.55 138.96 51.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.419 0.628 . . . . 0.0 112.338 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.522 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 1.8 tmtp? -90.16 118.3 29.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.569 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.44 -52.21 3.72 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.424 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -161.59 145.87 12.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.07 0.935 . . . . 0.0 112.562 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.643 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 1.6 m -65.63 154.37 38.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.287 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 16.4 ptmt -119.44 48.69 1.46 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.441 HH21 ' C ' ' A' ' 32' ' ' ARG . 26.1 tpt180 -174.6 -42.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.086 0.47 . . . . 0.0 110.289 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.13 138.06 5.08 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.934 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 51.11 2.79 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.063 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.442 ' HD3' ' HA ' ' A' ' 16' ' ' ARG . 19.8 mmt180 -111.1 70.12 0.7 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.049 0.452 . . . . 0.0 110.475 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 22.3 t -63.96 123.32 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.644 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.529 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 9.9 tpt85 -89.87 -32.14 17.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.776 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.31 -168.55 37.25 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -93.45 138.07 32.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -102.89 120.68 41.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.18 -126.62 31.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.419 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.432 HD11 HG21 ' A' ' 23' ' ' ILE . 17.6 pt -136.64 40.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.739 0.304 . . . . 0.0 110.893 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 9.5 tpt180 179.27 -24.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.226 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.522 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 1.9 m-85 -88.69 155.33 19.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.514 HD13 ' N ' ' A' ' 26' ' ' LEU . 6.2 mp -102.11 131.1 48.79 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 8.2 t80 -101.13 90.12 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.554 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 1.8 m -100.34 142.84 31.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 18' ' ' ARG . 61.5 m -89.85 145.48 33.4 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.638 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 63.4 Cg_endo -74.12 -145.46 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.563 2.175 . . . . 0.0 113.709 -178.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.504 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 12.4 ptp180 -174.66 -156.45 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.598 HH11 ' HG2' ' A' ' 32' ' ' ARG . 34.1 ttp85 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.904 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.645 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -156.47 151.68 26.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.889 0.345 . . . . 0.0 110.149 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.2 tp -113.37 128.39 56.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.143 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.5 m -73.83 163.66 27.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -149.41 137.81 20.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.905 0.86 . . . . 0.0 112.528 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.678 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 53.9 t -88.71 124.72 34.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.351 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.678 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.1 mmm180 -132.52 141.12 48.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.319 0.581 . . . . 0.0 112.334 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.584 ' HD3' ' CZ ' ' A' ' 25' ' ' PHE . 51.3 tptt -86.42 53.11 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 122.142 0.972 . . . . 0.0 109.156 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.38 -150.12 8.81 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.911 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -91.56 20.21 5.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.58 0.69 . . . . 0.0 111.154 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.431 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 75.8 m 66.36 143.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.795 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.86 158.44 16.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.955 179.695 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 32.7 ttm105 78.44 -45.49 0.4 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.144 0.978 . . . . 0.0 111.254 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.13 131.18 2.22 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.881 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.5 51.59 3.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.668 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -87.92 69.18 9.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.107 0.48 . . . . 0.0 109.944 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.545 HG11 HD22 ' A' ' 26' ' ' LEU . 24.7 m -61.68 132.75 27.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.776 -179.187 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.587 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 78.4 ttt180 -105.3 -35.34 7.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.203 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.23 -162.98 30.78 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.614 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -92.12 138.88 31.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 111.11 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.872 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.7 t -100.09 46.33 0.96 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.597 0.713 . . . . 0.0 110.015 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.19 -140.03 14.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.175 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -75.61 103.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 53.99 49.78 18.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.049 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.872 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.7 m-85 -135.49 146.36 48.06 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.545 HD22 HG11 ' A' ' 17' ' ' VAL . 7.8 mp -108.31 132.4 53.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.316 0.579 . . . . 0.0 110.954 -179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -106.58 114.71 28.98 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m -120.96 156.22 32.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.587 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 61.8 m -135.14 125.01 16.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.645 ' HG2' ' HB2' ' A' ' 2' ' ' LEU . 61.2 Cg_endo -73.36 -132.22 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.881 2.387 . . . . 0.0 112.755 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . 0.516 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 31.0 ttp180 -171.7 -69.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.296 -1.335 . . . . 0.0 107.677 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.827 HD12 ' H ' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -79.89 -29.08 39.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.864 0.364 . . . . 0.0 110.49 179.496 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.768 HD23 ' H ' ' A' ' 3' ' ' LEU . 2.5 pt? -74.67 143.72 44.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.454 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.575 ' HB3' ' C ' ' A' ' 28' ' ' CYS . 61.1 m -75.16 163.59 27.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.581 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TYR . . . . . 0.525 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.1 p90 -88.58 141.12 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.591 . . . . 0.0 111.087 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.624 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 41.3 t -97.43 114.22 26.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.016 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.624 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.3 mmm180 -138.58 145.3 40.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 29.2 ttmt -67.32 -31.85 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.556 0.693 . . . . 0.0 109.524 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.56 151.32 52.24 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.152 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 45.4 m170 -72.33 68.71 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 76.7 m 71.16 145.68 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.927 0.767 . . . . 0.0 111.669 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -107.34 31.63 5.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.11 35.73 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.22 -139.4 30.78 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.911 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.71 72.67 1.26 Allowed Glycine 0 CA--C 1.517 0.169 0 C-N-CA 121.595 -0.336 . . . . 0.0 113.391 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -132.59 33.56 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 110.679 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.529 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 p -81.88 132.5 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.606 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -113.33 -11.95 13.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.691 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.72 -170.03 43.13 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.4 p -106.19 141.56 37.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' CYS . . . . . 0.542 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 16.4 t -99.93 -140.32 0.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -156.3 1.95 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.491 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.424 HD12 HG21 ' A' ' 23' ' ' ILE . 13.0 pt -64.62 105.65 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.036 -179.408 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 66.69 42.36 2.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.952 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.542 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 19.4 m-85 -132.76 140.76 48.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.576 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 34.2 mt -109.3 145.08 36.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.309 0.576 . . . . 0.0 111.529 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -98.92 94.54 6.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.425 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.575 ' C ' ' HB3' ' A' ' 4' ' ' CYS . 10.1 m -119.96 140.48 50.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.385 . . . . 0.0 111.92 -177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 1.6 m -98.69 143.43 26.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.803 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 29' ' ' CYS . 37.2 Cg_exo -60.17 -42.93 38.91 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.912 2.408 . . . . 0.0 112.57 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -156.67 54.86 0.54 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.883 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.119 -0.943 . . . . 0.0 109.495 -179.582 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.567 0.699 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 11.2 m -78.21 154.02 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.994 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.604 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 3.1 p90 -135.89 140.5 44.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.726 0.774 . . . . 0.0 112.516 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.606 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 40.4 t -94.55 122.95 37.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.871 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 28.2 mmm180 -132.8 133.52 43.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.59 128.49 35.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.964 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.35 -53.12 4.8 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.307 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.85 138.49 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.827 0.314 . . . . 0.0 110.616 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.604 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 61.4 m -61.2 143.44 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.437 ' H ' ' HG3' ' A' ' 7' ' ' ARG . 75.4 mmtt -92.81 140.43 29.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 43.89 49.6 7.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.212 0.945 . . . . 0.0 112.356 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.07 128.69 1.4 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.631 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.78 42.83 1.74 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.496 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 5.6 mmp_? -125.6 63.3 1.2 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 110.427 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.602 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 4.2 p -61.89 130.34 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.447 0.641 . . . . 0.0 110.696 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.662 ' NE ' ' HA ' ' A' ' 18' ' ' ARG . 1.9 tpm_? -96.94 -26.71 14.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.35 43.39 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -82.7 135.85 34.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.963 0.411 . . . . 0.0 111.051 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 45.8 t -95.21 49.64 1.22 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.67 0.748 . . . . 0.0 109.028 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.2 -137.77 13.69 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.201 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.794 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -98.37 125.62 51.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 62.47 20.56 12.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.723 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -129.45 141.73 50.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -114.68 137.85 51.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.845 0.355 . . . . 0.0 110.5 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 8.5 t80 -111.45 114.95 28.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 83.0 m -117.87 143.79 45.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.374 . . . . 0.0 112.005 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.0 m -120.3 126.65 26.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.075 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.531 0.36 0 C-N-CA 122.981 2.454 . . . . 0.0 112.704 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 11.7 m -64.73 157.09 28.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.898 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.436 ' HE1' ' HA ' ' A' ' 11' ' ' CYS . 2.5 p90 -131.36 141.73 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 0.0 112.323 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.606 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 48.5 t -87.41 128.91 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.093 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.8 mmm180 -132.28 136.82 47.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 111.455 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -68.81 -36.2 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 109.964 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.47 -87.38 0.46 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.684 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.486 ' HB3' HD22 ' A' ' 26' ' ' LEU . 32.4 p-80 -179.36 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.781 0.433 . . . . 0.0 109.929 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HA ' ' HE1' ' A' ' 5' ' ' TYR . 12.9 m 56.07 -155.74 0.29 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.373 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 4.9 mmmt -151.81 40.71 0.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 49.3 mmt-85 72.2 -58.23 0.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.013 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.53 47.91 3.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.677 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -165.32 142.51 7.77 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.032 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -103.09 134.81 45.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 3.5 p -57.32 127.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.593 0.711 . . . . 0.0 110.996 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 33.8 tpt85 -95.81 -27.17 15.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.36 -155.5 26.37 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.834 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -88.26 138.03 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.385 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.9 t -103.68 49.19 0.83 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.517 0.675 . . . . 0.0 109.824 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.37 -141.48 15.59 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.502 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.7 mt -86.78 112.77 23.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.49 34.96 20.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.496 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -132.89 146.65 51.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD22 ' HB3' ' A' ' 10' ' ' HIS . 7.5 mp -112.99 133.55 54.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.333 0.587 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 7.2 t80 -103.41 128.42 50.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 m -135.14 146.18 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.57 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 64.3 m -110.09 131.55 21.93 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.699 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 81.5 Cg_endo . . . . . 0 N--CA 1.461 -0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.539 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.657 HD13 ' HG2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.372 0.606 . . . . 0.0 110.817 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.86 159.77 33.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.179 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.484 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 0.9 OUTLIER -144.46 141.82 29.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.909 0.862 . . . . 0.0 112.864 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.598 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 39.5 t -91.37 126.86 36.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.711 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.598 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.9 mmm180 -131.69 137.15 48.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 111.211 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.44 128.0 34.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.988 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.04 -51.6 3.2 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.515 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.738 ' HA ' HD12 ' A' ' 26' ' ' LEU . 27.7 p-80 -169.21 146.62 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 71.3 m -66.55 142.72 57.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.034 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 129.25 39.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.578 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 68.56 -51.25 0.56 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.989 0.916 . . . . 0.0 112.515 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -143.47 8.57 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.059 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.23 169.76 15.09 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -87.66 114.42 24.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.77 124.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.898 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.68 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 52.3 ttt85 -90.33 -35.69 15.09 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.095 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.95 -166.51 39.19 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.599 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 p -86.9 137.9 31.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.753 0.311 . . . . 0.0 110.998 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.724 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 35.8 t -99.6 42.6 1.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.62 0.724 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -144.37 16.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.911 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tt -90.45 118.67 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.02 0.438 . . . . 0.0 111.801 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 62.98 32.79 15.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.976 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.724 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 13.2 m-85 -137.09 139.02 40.98 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 10' ' ' HIS . 73.8 mt -115.77 138.27 51.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.013 0.435 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 9.9 t80 -110.7 116.79 31.91 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.29 156.46 41.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.952 0.406 . . . . 0.0 111.949 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.68 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 58.3 m -122.69 113.29 30.43 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.935 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.657 ' HG2' HD13 ' A' ' 3' ' ' LEU . 59.4 Cg_endo . . . . . 0 N--CA 1.46 -0.48 0 C-N-CA 122.505 2.137 . . . . 0.0 111.639 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.857 0.36 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 58.1 m -66.26 161.21 22.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.506 ' OH ' ' HA3' ' A' ' 15' ' ' GLY . 4.6 p90 -149.45 141.75 24.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.537 0.684 . . . . 0.0 112.029 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.664 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 44.5 t -93.52 119.47 32.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.577 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.664 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.3 mmm180 -135.16 138.99 44.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.062 0.458 . . . . 0.0 111.433 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -83.44 52.24 2.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.482 0.658 . . . . 0.0 109.608 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.3 -159.15 18.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.958 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -85.45 64.11 8.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.3 m 59.18 -149.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.118 0.485 . . . . 0.0 111.951 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 25.5 mtpp -136.02 65.79 1.52 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 69.15 -100.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.479 0.487 . . . . 0.0 111.123 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.36 66.91 2.24 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.877 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -149.46 132.71 4.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.142 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -95.45 131.92 41.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.22 124.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.602 0.715 . . . . 0.0 110.806 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -90.59 -27.74 18.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.05 -157.16 28.45 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.201 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -94.37 138.81 31.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.017 0.437 . . . . 0.0 111.225 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 47.2 t -100.03 55.0 0.92 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.558 0.694 . . . . 0.0 109.212 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.66 -134.06 12.08 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.665 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.588 HG13 ' HG3' ' A' ' 24' ' ' ARG . 7.2 tp -101.65 124.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.886 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.588 ' HG3' HG13 ' A' ' 23' ' ' ILE . 59.5 mtp85 59.87 27.91 17.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.671 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.601 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.0 m-85 -135.57 143.06 45.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.3 137.96 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.229 0.538 . . . . 0.0 110.864 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -106.39 123.27 47.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 22.4 m -131.99 154.96 48.8 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.921 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 41.5 m -127.71 127.9 23.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.268 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.637 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 25.8 Cg_endo . . . . . 0 C--O 1.233 0.271 0 C-N-CA 122.785 2.324 . . . . 0.0 112.381 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.034 0.445 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.66 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 32.2 m -76.29 161.67 28.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.736 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -125.3 136.13 53.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.871 0.843 . . . . 0.0 112.598 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.579 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 51.7 t -81.02 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.769 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.2 mmm180 -132.01 140.5 48.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.088 0.47 . . . . 0.0 112.064 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 25' ' ' PHE . 21.3 tptm -86.8 49.36 1.8 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.161 0.981 . . . . 0.0 109.228 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.62 -161.94 35.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.483 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.88 64.11 1.79 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 112.023 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.481 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 11.4 m 59.45 -153.94 0.38 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.405 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mtpm? -80.3 56.39 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.331 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 66.67 51.75 1.05 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.508 0.671 . . . . 0.0 109.865 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.68 -131.4 1.24 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.015 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 65.12 0.19 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.418 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.611 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 4.9 mmp_? -117.87 37.08 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.488 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 6.6 p -72.6 136.84 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.601 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.503 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 43.0 mtp85 -124.55 -2.65 7.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.69 178.09 48.38 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.38 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -95.13 139.36 31.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.864 0.364 . . . . 0.0 110.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.2 t -104.56 48.11 0.85 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.538 0.685 . . . . 0.0 109.845 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.38 -138.88 14.32 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.302 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.77 120.21 39.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.346 0.593 . . . . 0.0 112.143 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 56.36 38.13 29.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.559 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.794 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 11.7 m-85 -138.01 138.82 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.08 133.85 50.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.077 0.465 . . . . 0.0 111.311 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 11.6 t80 -97.96 101.09 12.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 57.7 m -105.45 141.37 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.776 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 80.6 m -108.22 143.82 28.19 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.745 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.66 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 55.2 Cg_exo . . . . . 0 C--N 1.343 0.266 0 C-N-CA 123.034 2.489 . . . . 0.0 113.578 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.865 0.364 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.49 164.37 18.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.494 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.482 ' CD1' ' HD3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -150.04 147.05 27.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.914 0.864 . . . . 0.0 113.026 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.621 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.0 t -77.49 128.99 35.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.597 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.629 ' HE ' ' HB2' ' A' ' 12' ' ' LYS . 27.2 mmm180 -129.56 136.38 49.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -69.67 125.98 28.35 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.124 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.13 -141.26 29.89 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.854 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.06 144.93 56.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.83 0.315 . . . . 0.0 110.317 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.0 m -47.81 139.02 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.701 0.626 . . . . 0.0 112.208 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.629 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . 49.2 mmtm -112.02 120.68 42.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.232 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 71.42 -48.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.968 0.792 . . . . 0.0 111.962 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.853 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -59.57 -41.03 97.09 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.745 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.89 -56.57 3.52 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.774 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -89.89 119.63 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.441 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.58 138.3 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.997 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -98.68 -30.46 12.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.422 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.06 -168.55 41.69 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.596 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 p -88.63 142.33 27.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.921 0.361 . . . . 0.0 111.2 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.3 t -113.98 47.58 1.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.6 0.714 . . . . 0.0 109.253 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 -137.8 14.0 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.894 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 pt -98.31 126.89 51.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.937 0.398 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 61.39 20.55 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.351 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 14.8 m-85 -134.44 139.42 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.5 mp -121.82 135.63 54.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.304 0.574 . . . . 0.0 110.507 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 122.93 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.2 m -135.53 152.58 51.45 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.133 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 66.5 m -110.23 123.67 35.37 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.634 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.853 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 39.6 Cg_endo . . . . . 0 C--O 1.234 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.969 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 121.296 0.57 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 36.2 m -88.81 164.89 15.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.28 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -139.34 128.86 24.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.464 0.65 . . . . 0.0 110.713 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.576 ' C ' ' HD2' ' A' ' 7' ' ' ARG . 24.0 p -94.19 134.68 36.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.576 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.3 mpt_? -135.29 138.76 43.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.185 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' A' ' 8' ' ' LYS . 1.7 tmtm? -74.63 -43.95 52.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.368 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.94 -61.56 3.71 Favored Glycine 0 C--N 1.319 -0.395 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.512 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -174.71 149.95 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -52.31 142.48 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.576 0.548 . . . . 0.0 110.678 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.95 138.05 34.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 63.23 -143.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.748 0.655 . . . . 0.0 110.744 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.61 43.34 3.14 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.874 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 134.58 12.6 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.585 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -111.81 139.22 47.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 19.7 m -62.47 139.2 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.315 0.579 . . . . 0.0 112.118 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -129.93 -32.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.33 -150.33 6.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.839 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -127.72 142.54 51.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 111.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 13.2 t -91.02 42.61 1.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.19 -135.63 12.43 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.039 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 118.59 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.166 0.507 . . . . 0.0 112.252 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 60.44 27.24 16.84 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.963 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 7.9 m-85 -122.69 138.61 54.56 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.22 132.37 46.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.846 0.355 . . . . 0.0 111.398 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 t80 -98.65 113.37 25.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.06 147.16 40.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.133 0.492 . . . . 0.0 112.235 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 74.6 m -120.55 140.04 29.78 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 29' ' ' CYS . 32.0 Cg_exo . . . . . 0 C--N 1.342 0.207 0 C-N-CA 122.653 2.236 . . . . 0.0 112.622 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.943 0.401 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 19.1 m -99.74 160.74 14.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -145.07 148.82 34.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.637 0.732 . . . . 0.0 112.381 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.638 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 7.8 p -93.81 124.98 38.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.6 mmm180 -128.58 141.84 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 39.5 ttpt -66.23 -29.08 69.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.386 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 -158.87 25.54 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.321 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -81.26 58.6 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.623 -0.339 . . . . 0.0 110.556 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' SG ' HG22 ' A' ' 17' ' ' VAL . 15.8 m 60.82 -153.28 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.766 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 8.7 mmmm -156.84 135.87 11.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.978 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HD2' ' HB3' ' A' ' 30' ' ' PRO . 44.1 ttm180 75.63 -34.5 0.25 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 111.9 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.48 -146.8 4.53 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.756 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.94 43.83 0.69 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.216 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.743 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 78.1 ttt180 -88.63 70.58 8.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.417 HG22 ' SG ' ' A' ' 11' ' ' CYS . 11.7 t -67.91 132.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.994 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 75.4 mtp180 -115.2 -23.45 8.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.055 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.56 -143.89 7.83 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.343 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 p -128.91 156.19 44.11 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.753 0.311 . . . . 0.0 110.526 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 6' ' ' CYS . 1.6 t -88.62 40.56 0.97 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.88 -57.78 3.51 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-O 121.872 0.707 . . . . 0.0 111.925 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 pt -83.32 -160.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 114.359 -0.921 . . . . 0.0 110.396 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 15.8 mmp_? -80.86 51.06 1.46 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.043 0.449 . . . . 0.0 111.734 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 6.3 m-85 -129.23 135.66 49.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 6.5 mp -89.28 128.69 35.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 32.4 t80 -89.75 112.55 23.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 m -135.51 153.27 51.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 111.562 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.743 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 79.6 m -98.86 142.12 24.06 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.615 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 54.1 Cg_exo . . . . . 0 C--N 1.343 0.284 0 C-N-CA 122.93 2.42 . . . . 0.0 113.092 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 48.6 tp . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.6 m -89.52 165.84 14.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.812 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.461 ' O ' ' HD1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.82 142.48 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.229 0.538 . . . . 0.0 110.592 177.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 17.6 p -90.33 127.98 36.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.023 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.626 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.8 mmm180 -130.55 149.99 51.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.27 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HZ2' ' HE1' ' A' ' 25' ' ' PHE . 49.0 tttp -69.41 113.53 6.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.43 178.5 17.56 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -76.62 69.53 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.109 0.454 . . . . 0.0 111.706 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 32.5 m 69.93 147.94 0.07 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.625 0.578 . . . . 0.0 112.085 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 30.3 mmtp -132.5 117.19 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.148 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 56.29 44.17 25.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.918 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.13 -133.21 2.9 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.264 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.53 -46.37 0.23 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.384 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HG3' ' HB2' ' A' ' 29' ' ' CYS . 23.7 ptt-85 -89.3 99.53 12.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.415 0.626 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.473 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 p -92.82 142.88 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.063 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 23.07 0.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' C ' ' HB3' ' A' ' 27' ' ' TYR . . . -178.0 -169.86 39.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.13 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.513 HG22 HD13 ' A' ' 26' ' ' LEU . 7.7 p -141.57 157.62 44.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.408 . . . . 0.0 109.914 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.956 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 3.8 t -117.21 38.8 3.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.98 -144.63 16.38 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.468 HG12 ' HG2' ' A' ' 24' ' ' ARG . 10.6 tt -82.76 123.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.203 0.525 . . . . 0.0 112.015 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 23' ' ' ILE . 26.2 mmm180 61.0 36.35 18.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.448 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.956 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.0 m-85 -137.58 127.02 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.513 HD13 HG22 ' A' ' 20' ' ' THR . 4.4 mm? -110.67 137.99 47.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 0.0 111.387 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 42.6 t80 -98.81 103.13 15.06 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 1.5 m -133.33 155.74 48.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.151 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.734 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.6 m -88.18 142.99 32.17 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.893 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 123.283 2.655 . . . . 0.0 112.662 -179.645 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.853 0.359 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.1 m -71.5 161.47 30.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.492 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.96 146.5 30.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.837 0.827 . . . . 0.0 112.664 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.7 t -80.93 126.06 30.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.209 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.3 mmm180 -130.72 128.49 40.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.956 0.408 . . . . 0.0 111.165 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 36.1 ttpt -83.03 85.04 7.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.02 -111.27 0.45 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.338 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -142.61 53.57 1.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.746 0.308 . . . . 0.0 110.565 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.7 m 63.48 -163.91 0.26 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.909 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 65.2 mmtt -155.88 146.07 21.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 17.5 mmt85 73.91 -24.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.076 0.551 . . . . 0.0 111.356 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 12' ' ' LYS . . . 170.76 149.49 6.48 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.08 53.62 2.2 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.825 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -89.24 65.41 7.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.018 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 m -62.05 132.5 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.425 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -102.67 -35.45 8.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.436 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.04 -167.98 40.62 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 p -90.82 139.4 30.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 48.1 t -106.89 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.72 0.771 . . . . 0.0 109.24 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.67 -136.92 13.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.56 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.779 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -99.79 125.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 60.88 25.72 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.687 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.1 m-85 -135.16 136.55 41.95 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -114.5 135.03 54.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.176 0.512 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -93.97 121.54 35.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.4 m -132.16 156.35 46.57 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.707 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.6 m -118.94 128.8 25.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.666 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo . . . . . 0 N--CA 1.457 -0.635 0 C-N-CA 122.847 2.365 . . . . 0.0 112.234 179.798 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.54 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 6.9 mp . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 72.6 m -150.95 167.73 26.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.922 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.683 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.5 p90 -153.59 133.81 13.39 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.789 0.804 . . . . 0.0 111.743 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 24.6 t -92.2 120.94 33.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.077 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.639 ' HD3' ' CD1' ' A' ' 5' ' ' TYR . 11.4 mtp-105 -151.11 141.42 22.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.863 0.363 . . . . 0.0 111.731 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 35.0 ttpt -82.18 52.07 1.92 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.729 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.86 159.74 27.47 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.969 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -49.64 148.33 3.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 111.687 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -56.99 161.41 3.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.159 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.61 128.32 35.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.229 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.82 23.58 12.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.05 -137.48 4.69 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.821 -1.18 . . . . 0.0 113.07 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.66 56.73 0.3 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.272 -0.489 . . . . 0.0 111.963 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -87.72 63.09 7.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.513 0.673 . . . . 0.0 109.828 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.89 131.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.162 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 41.7 mmm-85 -106.33 -23.64 12.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.882 0.372 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.81 -171.35 38.87 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.842 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -104.25 140.64 37.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.728 0.299 . . . . 0.0 110.313 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 34.7 t -104.65 47.9 0.86 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.605 0.717 . . . . 0.0 109.668 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.23 -137.08 13.04 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.178 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.42 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 64.3 mt -90.95 116.6 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 66.59 -0.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.701 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 10.2 m-85 -95.07 135.42 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.823 0.344 . . . . 0.0 110.511 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.58 133.62 45.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.553 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -100.61 91.25 4.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.683 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 66.7 m -96.62 149.87 21.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.489 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.5 m -133.33 118.86 15.11 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 95.9 Cg_endo . . . . . 0 C--N 1.344 0.341 0 C-N-CA 122.901 2.401 . . . . 0.0 112.282 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.6 m -83.14 166.22 18.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.43 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 33.2 p90 -135.27 127.24 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.891 0.853 . . . . 0.0 111.601 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.699 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 15.8 t -87.13 115.45 24.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.319 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.699 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.8 mmm180 -141.07 142.68 34.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.693 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -90.23 122.33 33.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -102.81 0.27 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.853 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.44 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -159.44 40.63 0.21 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.578 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 83.2 m 69.66 150.06 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -104.59 131.59 51.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.311 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 65.24 56.77 0.97 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.542 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.26 134.77 8.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.645 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 11' ' ' CYS . . . -77.64 66.44 3.02 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.921 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -88.14 58.84 4.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.622 -0.34 . . . . 0.0 110.7 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.48 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 20.7 t -71.38 127.2 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.885 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.48 ' HD2' ' C ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -130.19 2.53 4.72 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.75 -178.68 48.44 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.878 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -109.84 139.51 44.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.636 0.255 . . . . 0.0 110.327 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.1 t -104.35 111.66 24.38 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -126.68 35.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.222 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 23' ' ' ILE . 10.9 tp -140.75 37.39 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.334 1.064 . . . . 0.0 109.543 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.714 ' HG3' ' HD1' ' A' ' 25' ' ' PHE . 38.7 ptt180 -172.26 2.11 0.01 OUTLIER 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.273 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.714 ' HD1' ' HG3' ' A' ' 24' ' ' ARG . 5.6 m-85 -129.91 160.06 34.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 110.631 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 10' ' ' HIS . 7.1 mp -102.1 134.77 44.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.085 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.53 96.13 8.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.0 m -94.61 139.18 31.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.662 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.1 m -134.68 120.44 14.44 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.716 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo . . . . . 0 N--CA 1.465 -0.202 0 C-N-CA 122.251 1.968 . . . . 0.0 110.582 179.357 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.44 ' N ' HD23 ' A' ' 3' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 111.195 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.2 m -77.88 164.53 25.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.663 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.0 p90 -157.23 137.17 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.632 0.73 . . . . 0.0 111.808 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.652 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 52.9 t -89.58 121.95 32.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.214 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.1 mmm180 -136.0 132.29 36.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 36.2 ttmt -70.14 -29.69 66.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.31 0.576 . . . . 0.0 110.629 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 -110.16 0.2 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -143.1 67.41 1.3 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.468 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.2 m 63.9 -150.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 14.3 mmmt -136.14 44.08 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.615 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -168.4 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.643 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.83 -62.86 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.829 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.81 52.04 0.16 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HG2' ' HA ' ' A' ' 30' ' ' PRO . 36.1 tpt85 -89.45 44.7 1.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 t -63.89 137.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.897 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -107.18 -33.59 7.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.325 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.37 -163.46 29.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.535 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 p -92.4 140.5 29.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.994 0.426 . . . . 0.0 111.371 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.715 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 46.8 t -108.51 44.94 1.06 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.624 0.726 . . . . 0.0 109.475 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.8 -139.86 14.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.14 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.849 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -92.88 123.86 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 111.861 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 54.68 42.84 30.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.409 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.715 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -148.1 134.79 19.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.653 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.04 132.2 54.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.996 0.427 . . . . 0.0 110.136 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -97.3 115.9 28.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.9 m -112.61 148.09 35.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.953 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.2 m -142.02 112.66 6.26 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.775 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HA ' ' HG2' ' A' ' 16' ' ' ARG . 19.9 Cg_exo . . . . . 0 C--O 1.233 0.246 0 C-N-CA 122.884 2.389 . . . . 0.0 111.566 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 38.5 m -72.19 161.75 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.612 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -152.34 138.6 18.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.146 0.498 . . . . 0.0 111.043 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 27.2 p -107.15 117.77 34.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.999 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -144.18 150.46 38.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.792 0.329 . . . . 0.0 110.718 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -68.85 104.16 1.98 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.417 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.11 -117.59 0.77 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.342 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.423 ' HA ' HD22 ' A' ' 26' ' ' LEU . 32.1 p-80 -166.87 57.08 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m 74.28 146.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.639 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 14.5 mmmm -93.54 112.97 24.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.47 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 55.2 mmt-85 71.09 -53.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.88 0.737 . . . . 0.0 112.269 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.13 140.89 5.49 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.379 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -150.34 10.68 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.658 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.3 mmt-85 -146.85 131.81 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.459 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 22.5 t -78.59 126.93 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.77 0.319 . . . . 0.0 110.192 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.811 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -115.85 -13.85 11.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.576 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.57 -149.79 8.9 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.289 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.4 p -140.71 153.16 45.82 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.752 0.311 . . . . 0.0 110.64 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 1.6 t -88.55 60.15 5.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.3 -59.0 3.84 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.163 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 tp -174.58 145.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.833 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 71.58 -39.7 0.46 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.719 0.807 . . . . 0.0 112.949 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m-85 -89.31 130.8 35.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.364 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 9.5 mp -91.62 137.01 32.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -96.01 101.56 13.25 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 91.7 m -100.61 142.77 31.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.838 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.811 ' HB2' ' HD3' ' A' ' 18' ' ' ARG . 70.1 m -121.84 116.07 30.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.03 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 3.0 Cg_exo . . . . . 0 N--CA 1.464 -0.26 0 C-N-CA 122.907 2.405 . . . . 0.0 111.864 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.9 tp . . . . . 0 C--O 1.234 0.274 0 CA-C-O 120.813 0.339 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 12.7 m -86.38 158.15 19.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.572 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.9 p90 -98.95 136.46 38.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.977 0.894 . . . . 0.0 112.952 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.681 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 37.8 t -93.78 121.69 35.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.509 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.681 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.2 mmm180 -133.1 141.73 48.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -82.98 47.76 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.757 0.789 . . . . 0.0 109.715 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.82 -148.87 7.11 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.209 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -94.11 67.75 3.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.1 m 60.15 -151.75 0.4 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.546 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -149.19 110.62 4.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 54.08 45.67 27.05 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.649 0.593 . . . . 0.0 111.836 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.42 132.79 1.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.96 153.85 14.73 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -88.65 117.65 27.77 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.997 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -61.14 129.83 24.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.423 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 7.6 tpt180 -101.76 -40.41 6.97 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.568 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.7 -159.82 27.76 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.583 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 p -94.95 140.2 30.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 0.0 110.922 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.945 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.5 t -104.81 39.08 1.77 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.628 0.727 . . . . 0.0 109.81 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.83 -145.27 16.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.543 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 23' ' ' ILE . 4.1 mp -85.15 118.36 31.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.745 0.307 . . . . 0.0 110.968 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 57.05 46.38 19.34 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.657 0.741 . . . . 0.0 110.829 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.945 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.3 m-85 -144.6 133.34 22.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.868 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.17 133.49 54.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 9.5 t80 -100.74 106.52 17.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 4.8 m -114.85 142.37 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.1 m -99.09 132.98 22.53 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 N--CA 1.463 -0.273 0 C-N-CA 122.894 2.396 . . . . 0.0 112.269 -179.68 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.221 0.534 . . . . 0.0 111.563 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.67 159.15 26.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.537 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -132.73 142.9 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.902 0.858 . . . . 0.0 112.042 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.695 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 22.8 t -103.93 113.94 27.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.041 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 1.054 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 27.8 mmm180 -137.12 139.43 41.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.927 0.394 . . . . 0.0 110.877 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 37.5 ttmt -68.87 148.92 49.52 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.75 -65.7 2.33 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.792 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 0.5 OUTLIER 179.58 48.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.137 0.494 . . . . 0.0 109.894 179.412 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 1.054 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 75.6 m 59.2 -158.91 0.3 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.8 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -151.92 147.83 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.4 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 61.14 42.63 12.07 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.832 0.708 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.96 7.91 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.536 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 148.74 19.18 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.282 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -88.7 107.56 19.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 t -60.83 125.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.617 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 52.3 mmm-85 -99.44 -31.06 11.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.506 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.75 -155.58 26.56 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.52 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 p -91.52 140.85 29.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.839 0.352 . . . . 0.0 111.438 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.512 ' HB3' ' CB ' ' A' ' 25' ' ' PHE . 37.0 t -93.57 -137.52 0.19 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' N ' ' SG ' ' A' ' 21' ' ' CYS . . . -73.25 -147.87 0.98 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 113.464 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.869 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -65.64 99.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.442 0.639 . . . . 0.0 112.325 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 64.34 46.68 3.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.156 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 20.7 m-85 -131.83 150.01 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.787 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 10' ' ' HIS . 4.3 mm? -107.85 143.2 36.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -111.77 112.79 24.73 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.955 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -129.97 145.98 51.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.429 . . . . 0.0 111.238 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 51.9 m -115.32 121.34 34.98 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.704 ' HG2' HD13 ' A' ' 3' ' ' LEU . 20.7 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 C-N-CA 122.318 2.012 . . . . 0.0 111.271 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.405 ' N ' HD23 ' A' ' 3' ' ' LEU . 2.0 pt? . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.063 0.459 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 62.5 m -82.6 155.85 24.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.096 0.474 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 2.3 p90 -108.32 138.96 43.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.967 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.712 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.1 t -87.77 117.76 26.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.712 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.6 mmm180 -133.81 125.38 28.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.985 0.421 . . . . 0.0 111.641 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -84.42 71.85 10.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.343 0.592 . . . . 0.0 109.41 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.37 -82.25 0.06 OUTLIER Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.861 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.787 ' HA ' HD22 ' A' ' 26' ' ' LEU . 11.3 p80 -172.97 61.87 0.03 OUTLIER 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.164 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.654 ' SG ' HG22 ' A' ' 17' ' ' VAL . 13.3 m 59.61 -159.62 0.3 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.883 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 51.9 mtpt -145.17 131.44 19.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.94 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 21.8 ttt85 60.38 29.4 18.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.462 0.649 . . . . 0.0 111.134 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.42 43.75 86.34 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.376 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.88 167.46 51.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.342 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -88.29 117.45 27.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.654 HG22 ' SG ' ' A' ' 11' ' ' CYS . 8.0 t -63.3 131.2 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.244 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 4.8 tpt85 -104.16 -31.69 9.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.443 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.1 -152.47 20.09 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.727 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -108.48 140.65 41.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.539 0.17 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 24.7 p -116.27 30.45 7.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.22 0.534 . . . . 0.0 111.333 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -166.61 28.41 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.32 98.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.548 0.689 . . . . 0.0 110.688 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.64 34.51 4.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.253 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.79 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 19.6 m-85 -112.66 130.46 56.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.055 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 10' ' ' HIS . 7.1 mp -98.97 129.88 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 0.0 111.346 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 4' ' ' CYS . 2.4 t80 -104.04 112.02 24.84 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.533 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 m -131.39 142.09 49.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.081 -177.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -98.68 138.04 20.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.162 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--O 1.235 0.327 0 C-N-CA 122.398 2.065 . . . . 0.0 112.003 -179.884 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.677 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 4.6 m -69.63 151.26 46.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.011 0.434 . . . . 0.0 110.674 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 2.5 p90 -107.58 140.64 40.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.846 0.832 . . . . 0.0 113.109 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.4 t -87.96 119.66 28.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.623 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.5 mmm180 -129.55 138.96 51.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.419 0.628 . . . . 0.0 112.338 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 1.8 tmtp? -90.16 118.3 29.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.569 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.44 -52.21 3.72 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.424 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -161.59 145.87 12.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.07 0.935 . . . . 0.0 112.562 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.646 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 1.6 m -65.63 154.37 38.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.287 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 16.4 ptmt -119.44 48.69 1.46 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -174.6 -42.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.086 0.47 . . . . 0.0 110.289 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.13 138.06 5.08 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.934 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 51.11 2.79 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.063 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 16' ' ' ARG . 19.8 mmt180 -111.1 70.12 0.7 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.049 0.452 . . . . 0.0 110.475 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 22.3 t -63.96 123.32 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.644 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 9.9 tpt85 -89.87 -32.14 17.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.776 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.31 -168.55 37.25 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -93.45 138.07 32.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -102.89 120.68 41.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.18 -126.62 31.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.419 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 17.6 pt -136.64 40.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.739 0.304 . . . . 0.0 110.893 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 9.5 tpt180 179.27 -24.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.226 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 1.9 m-85 -88.69 155.33 19.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.11 131.1 48.79 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.408 ' CE2' ' HB2' ' A' ' 4' ' ' CYS . 8.2 t80 -101.13 90.12 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.562 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 1.8 m -100.34 142.84 31.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 18' ' ' ARG . 61.5 m -89.85 145.48 33.4 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.677 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 63.4 Cg_endo . . . . . 0 CA--C 1.53 0.28 0 C-N-CA 122.563 2.175 . . . . 0.0 113.709 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.2 tp . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.5 m -73.83 163.66 27.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -149.41 137.81 20.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.905 0.86 . . . . 0.0 112.528 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.685 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 53.9 t -88.71 124.72 34.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.351 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.685 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.1 mmm180 -132.52 141.12 48.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.319 0.581 . . . . 0.0 112.334 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.589 ' HD3' ' CZ ' ' A' ' 25' ' ' PHE . 51.3 tptt -86.42 53.11 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 122.142 0.972 . . . . 0.0 109.156 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.38 -150.12 8.81 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.911 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -91.56 20.21 5.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.58 0.69 . . . . 0.0 111.154 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.438 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 75.8 m 66.36 143.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.795 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -90.86 158.44 16.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.955 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 32.7 ttm105 78.44 -45.49 0.4 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.144 0.978 . . . . 0.0 111.254 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.13 131.18 2.22 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.881 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.5 51.59 3.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.668 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -87.92 69.18 9.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.107 0.48 . . . . 0.0 109.944 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.68 132.75 27.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.776 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.61 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 78.4 ttt180 -105.3 -35.34 7.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.203 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.23 -162.98 30.78 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.614 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -92.12 138.88 31.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 111.11 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.901 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.7 t -100.09 46.33 0.96 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.597 0.713 . . . . 0.0 110.015 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.19 -140.03 14.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.175 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -75.61 103.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 53.99 49.78 18.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.049 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.901 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.7 m-85 -135.49 146.36 48.06 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 mp -108.31 132.4 53.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.316 0.579 . . . . 0.0 110.954 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -106.58 114.71 28.98 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m -120.96 156.22 32.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 61.8 m -135.14 125.01 16.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.533 0.429 0 C-N-CA 122.881 2.387 . . . . 0.0 112.755 -179.569 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.236 0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' CYS . . . . . 0.576 ' HB3' ' C ' ' A' ' 28' ' ' CYS . 61.1 m -75.16 163.59 27.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.581 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TYR . . . . . 0.538 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.1 p90 -88.58 141.12 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.591 . . . . 0.0 111.087 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.63 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 41.3 t -97.43 114.22 26.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.016 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.63 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.3 mmm180 -138.58 145.3 40.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 29.2 ttmt -67.32 -31.85 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.556 0.693 . . . . 0.0 109.524 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.56 151.32 52.24 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.152 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' HIS . . . . . 0.93 ' HA ' HD12 ' A' ' 26' ' ' LEU . 45.4 m170 -72.33 68.71 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.542 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 76.7 m 71.16 145.68 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.927 0.767 . . . . 0.0 111.669 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -107.34 31.63 5.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.11 35.73 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.22 -139.4 30.78 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.911 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.71 72.67 1.26 Allowed Glycine 0 CA--C 1.517 0.169 0 C-N-CA 121.595 -0.336 . . . . 0.0 113.391 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -132.59 33.56 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 110.679 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 p -81.88 132.5 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.606 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -113.33 -11.95 13.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.691 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.72 -170.03 43.13 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.4 p -106.19 141.56 37.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 16.4 t -99.93 -140.32 0.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -156.3 1.95 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.491 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 pt -64.62 105.65 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.036 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 66.69 42.36 2.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.952 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 19.4 m-85 -132.76 140.76 48.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.576 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 10' ' ' HIS . 34.2 mt -109.3 145.08 36.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.309 0.576 . . . . 0.0 111.529 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -98.92 94.54 6.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.425 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' CYS . . . . . 0.576 ' C ' ' HB3' ' A' ' 4' ' ' CYS . 10.1 m -119.96 140.48 50.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.385 . . . . 0.0 111.92 -177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 1.6 m -98.69 143.43 26.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.803 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 29' ' ' CYS . 37.2 Cg_exo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.912 2.408 . . . . 0.0 112.57 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.079 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt 49.32 -131.95 1.74 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.798 0.299 . . . . 0.0 110.861 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.0 tp -110.47 30.64 6.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.567 0.699 . . . . 0.0 109.299 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 11.2 m -78.21 154.02 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.994 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.604 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 3.1 p90 -135.89 140.5 44.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.726 0.774 . . . . 0.0 112.516 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.606 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 40.4 t -94.55 122.95 37.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.871 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 28.2 mmm180 -132.8 133.52 43.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.59 128.49 35.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.964 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.35 -53.12 4.8 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.307 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.85 138.49 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.827 0.314 . . . . 0.0 110.616 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.604 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 61.4 m -61.2 143.44 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.437 ' H ' ' HG3' ' A' ' 7' ' ' ARG . 75.4 mmtt -92.81 140.43 29.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 43.89 49.6 7.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.212 0.945 . . . . 0.0 112.356 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.07 128.69 1.4 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.631 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.78 42.83 1.74 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.496 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 5.6 mmp_? -125.6 63.3 1.2 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 110.427 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.602 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 4.2 p -61.89 130.34 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.447 0.641 . . . . 0.0 110.696 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.662 ' NE ' ' HA ' ' A' ' 18' ' ' ARG . 1.9 tpm_? -96.94 -26.71 14.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.35 43.39 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -82.7 135.85 34.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.963 0.411 . . . . 0.0 111.051 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 45.8 t -95.21 49.64 1.22 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.67 0.748 . . . . 0.0 109.028 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.2 -137.77 13.69 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.201 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.794 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -98.37 125.62 51.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 62.47 20.56 12.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.723 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -129.45 141.73 50.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -114.68 137.85 51.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.845 0.355 . . . . 0.0 110.5 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 8.5 t80 -111.45 114.95 28.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 83.0 m -117.87 143.79 45.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.374 . . . . 0.0 112.005 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.0 m -120.3 126.65 26.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.075 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.62 48.49 2.42 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.981 2.454 . . . . 0.0 112.704 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 6.0 tmm_? -98.43 -72.87 0.64 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 53.3 ttt85 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.862 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.1 tp 68.76 -56.51 0.52 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.591 0.756 . . . . 0.0 111.969 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.78 144.47 54.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.73 0.3 . . . . 0.0 110.846 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 11.7 m -64.73 157.09 28.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.898 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.436 ' HE1' ' HA ' ' A' ' 11' ' ' CYS . 2.5 p90 -131.36 141.73 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 0.0 112.323 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.606 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 48.5 t -87.41 128.91 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.093 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.8 mmm180 -132.28 136.82 47.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 111.455 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -68.81 -36.2 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 109.964 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.47 -87.38 0.46 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.684 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.486 ' HB3' HD22 ' A' ' 26' ' ' LEU . 32.4 p-80 -179.36 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.781 0.433 . . . . 0.0 109.929 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HA ' ' HE1' ' A' ' 5' ' ' TYR . 12.9 m 56.07 -155.74 0.29 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.373 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 4.9 mmmt -151.81 40.71 0.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 49.3 mmt-85 72.2 -58.23 0.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.013 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.53 47.91 3.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.677 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -165.32 142.51 7.77 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.032 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -103.09 134.81 45.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 3.5 p -57.32 127.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.593 0.711 . . . . 0.0 110.996 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 33.8 tpt85 -95.81 -27.17 15.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.36 -155.5 26.37 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.834 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -88.26 138.03 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.385 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.9 t -103.68 49.19 0.83 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.517 0.675 . . . . 0.0 109.824 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.37 -141.48 15.59 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.502 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.7 mt -86.78 112.77 23.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.49 34.96 20.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.496 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -132.89 146.65 51.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD22 ' HB3' ' A' ' 10' ' ' HIS . 7.5 mp -112.99 133.55 54.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.333 0.587 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 7.2 t80 -103.41 128.42 50.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 m -135.14 146.18 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.57 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 64.3 m -110.09 131.55 21.93 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.699 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 81.5 Cg_endo -79.05 -145.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.539 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -166.28 33.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.349 0.595 . . . . 0.0 109.588 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.1 ttt85 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 117.955 -1.022 . . . . 0.0 108.435 179.669 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.8 HD23 ' H ' ' A' ' 2' ' ' LEU . 1.4 pt? -77.39 62.01 2.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.228 0.537 . . . . 0.0 111.033 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.657 HD13 ' HG2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -155.49 51.91 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.372 0.606 . . . . 0.0 110.817 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.86 159.77 33.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.179 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.484 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 0.9 OUTLIER -144.46 141.82 29.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.909 0.862 . . . . 0.0 112.864 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.598 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 39.5 t -91.37 126.86 36.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.711 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.598 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.9 mmm180 -131.69 137.15 48.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 111.211 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.44 128.0 34.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.988 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.04 -51.6 3.2 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.515 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.738 ' HA ' HD12 ' A' ' 26' ' ' LEU . 27.7 p-80 -169.21 146.62 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 71.3 m -66.55 142.72 57.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.034 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 129.25 39.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.578 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 68.56 -51.25 0.56 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.989 0.916 . . . . 0.0 112.515 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -143.47 8.57 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.059 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.23 169.76 15.09 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -87.66 114.42 24.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.77 124.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.898 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.68 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 52.3 ttt85 -90.33 -35.69 15.09 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.095 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.95 -166.51 39.19 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.599 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 p -86.9 137.9 31.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.753 0.311 . . . . 0.0 110.998 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.724 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 35.8 t -99.6 42.6 1.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.62 0.724 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -144.37 16.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.911 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tt -90.45 118.67 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.02 0.438 . . . . 0.0 111.801 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 62.98 32.79 15.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.976 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.724 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 13.2 m-85 -137.09 139.02 40.98 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 10' ' ' HIS . 73.8 mt -115.77 138.27 51.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.013 0.435 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 9.9 t80 -110.7 116.79 31.91 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.29 156.46 41.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.952 0.406 . . . . 0.0 111.949 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.68 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 58.3 m -122.69 113.29 30.43 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.935 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.657 ' HG2' HD13 ' A' ' 3' ' ' LEU . 59.4 Cg_endo -75.68 161.95 36.05 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.505 2.137 . . . . 0.0 111.639 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.608 ' HD2' ' H ' ' A' ' 32' ' ' ARG . 0.7 OUTLIER -56.38 -47.39 79.01 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.73 0.3 . . . . 0.0 111.36 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.608 ' H ' ' HD2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.983 0 CA-C-O 116.94 -1.505 . . . . 0.0 107.488 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 32' ' ' ARG . 3.8 mm? -76.36 66.78 2.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.789 0.328 . . . . 0.0 111.319 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.42 54.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 58.1 m -66.26 161.21 22.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.506 ' OH ' ' HA3' ' A' ' 15' ' ' GLY . 4.6 p90 -149.45 141.75 24.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.537 0.684 . . . . 0.0 112.029 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.664 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 44.5 t -93.52 119.47 32.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.577 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.664 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.3 mmm180 -135.16 138.99 44.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.062 0.458 . . . . 0.0 111.433 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -83.44 52.24 2.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.482 0.658 . . . . 0.0 109.608 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.3 -159.15 18.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.958 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -85.45 64.11 8.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.3 m 59.18 -149.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.118 0.485 . . . . 0.0 111.951 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 25.5 mtpp -136.02 65.79 1.52 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 69.15 -100.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.479 0.487 . . . . 0.0 111.123 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.36 66.91 2.24 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.877 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -149.46 132.71 4.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.142 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -95.45 131.92 41.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.22 124.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.602 0.715 . . . . 0.0 110.806 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -90.59 -27.74 18.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.05 -157.16 28.45 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.201 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -94.37 138.81 31.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.017 0.437 . . . . 0.0 111.225 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 47.2 t -100.03 55.0 0.92 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.558 0.694 . . . . 0.0 109.212 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.66 -134.06 12.08 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.665 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.588 HG13 ' HG3' ' A' ' 24' ' ' ARG . 7.2 tp -101.65 124.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.886 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.588 ' HG3' HG13 ' A' ' 23' ' ' ILE . 59.5 mtp85 59.87 27.91 17.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.671 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.601 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.0 m-85 -135.57 143.06 45.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.3 137.96 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.229 0.538 . . . . 0.0 110.864 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -106.39 123.27 47.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 22.4 m -131.99 154.96 48.8 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.921 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 41.5 m -127.71 127.9 23.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.268 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.637 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 25.8 Cg_endo -63.35 -35.61 60.88 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.785 2.324 . . . . 0.0 112.381 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -173.39 -154.47 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.758 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 2' ' ' LEU . 79.1 mtm-85 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.51 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.8 tp -90.88 139.43 30.76 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.571 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.4 pt? -62.14 135.64 57.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.034 0.445 . . . . 0.0 111.368 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.66 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 32.2 m -76.29 161.67 28.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.736 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -125.3 136.13 53.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.871 0.843 . . . . 0.0 112.598 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.579 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 51.7 t -81.02 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.769 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.2 mmm180 -132.01 140.5 48.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.088 0.47 . . . . 0.0 112.064 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 25' ' ' PHE . 21.3 tptm -86.8 49.36 1.8 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.161 0.981 . . . . 0.0 109.228 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.62 -161.94 35.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.483 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.88 64.11 1.79 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 112.023 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.481 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 11.4 m 59.45 -153.94 0.38 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.405 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mtpm? -80.3 56.39 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.331 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 66.67 51.75 1.05 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.508 0.671 . . . . 0.0 109.865 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.68 -131.4 1.24 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.015 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 65.12 0.19 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.418 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.611 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 4.9 mmp_? -117.87 37.08 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.488 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 6.6 p -72.6 136.84 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.601 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.503 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 43.0 mtp85 -124.55 -2.65 7.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.69 178.09 48.38 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.38 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -95.13 139.36 31.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.864 0.364 . . . . 0.0 110.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.2 t -104.56 48.11 0.85 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.538 0.685 . . . . 0.0 109.845 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.38 -138.88 14.32 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.302 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.77 120.21 39.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.346 0.593 . . . . 0.0 112.143 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 56.36 38.13 29.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.559 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.794 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 11.7 m-85 -138.01 138.82 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.08 133.85 50.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.077 0.465 . . . . 0.0 111.311 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 11.6 t80 -97.96 101.09 12.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 57.7 m -105.45 141.37 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.776 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 80.6 m -108.22 143.82 28.19 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.745 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.66 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 55.2 Cg_exo -54.24 -51.22 11.1 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.034 2.489 . . . . 0.0 113.578 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -167.35 -51.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.265 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.926 -179.8 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.13 -45.77 38.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.77 0.319 . . . . 0.0 111.238 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.13 130.18 36.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.357 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.49 164.37 18.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.494 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.482 ' CD1' ' HD3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -150.04 147.05 27.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.914 0.864 . . . . 0.0 113.026 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.621 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.0 t -77.49 128.99 35.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.597 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.629 ' HE ' ' HB2' ' A' ' 12' ' ' LYS . 27.2 mmm180 -129.56 136.38 49.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -69.67 125.98 28.35 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.124 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.13 -141.26 29.89 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.854 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.06 144.93 56.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.83 0.315 . . . . 0.0 110.317 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.0 m -47.81 139.02 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.701 0.626 . . . . 0.0 112.208 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.629 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . 49.2 mmtm -112.02 120.68 42.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.232 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 71.42 -48.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.968 0.792 . . . . 0.0 111.962 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.853 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -59.57 -41.03 97.09 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.745 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.89 -56.57 3.52 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.774 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -89.89 119.63 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.441 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.58 138.3 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.997 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -98.68 -30.46 12.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.422 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.06 -168.55 41.69 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.596 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 p -88.63 142.33 27.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.921 0.361 . . . . 0.0 111.2 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.3 t -113.98 47.58 1.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.6 0.714 . . . . 0.0 109.253 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 -137.8 14.0 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.894 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 pt -98.31 126.89 51.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.937 0.398 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 61.39 20.55 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.351 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 14.8 m-85 -134.44 139.42 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.5 mp -121.82 135.63 54.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.304 0.574 . . . . 0.0 110.507 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 122.93 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.2 m -135.53 152.58 51.45 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.133 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 66.5 m -110.23 123.67 35.37 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.634 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.853 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 39.6 Cg_endo -68.91 110.94 2.5 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.969 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.8 tpp85 -88.65 36.71 0.81 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.805 0.812 . . . . 0.0 109.69 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 . . . . . 0 C--O 1.24 0.593 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.407 179.552 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.5 mt -144.88 -59.89 0.36 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.3 52.44 2.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.296 0.57 . . . . 0.0 109.555 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 36.2 m -88.81 164.89 15.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.28 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -139.34 128.86 24.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.464 0.65 . . . . 0.0 110.713 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.576 ' C ' ' HD2' ' A' ' 7' ' ' ARG . 24.0 p -94.19 134.68 36.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.576 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.3 mpt_? -135.29 138.76 43.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.185 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' A' ' 8' ' ' LYS . 1.7 tmtm? -74.63 -43.95 52.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.368 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.94 -61.56 3.71 Favored Glycine 0 C--N 1.319 -0.395 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.512 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -174.71 149.95 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -52.31 142.48 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.576 0.548 . . . . 0.0 110.678 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.95 138.05 34.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 63.23 -143.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.748 0.655 . . . . 0.0 110.744 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.61 43.34 3.14 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.874 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 134.58 12.6 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.585 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -111.81 139.22 47.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 19.7 m -62.47 139.2 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.315 0.579 . . . . 0.0 112.118 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -129.93 -32.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.33 -150.33 6.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.839 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -127.72 142.54 51.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 111.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 13.2 t -91.02 42.61 1.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.19 -135.63 12.43 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.039 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 118.59 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.166 0.507 . . . . 0.0 112.252 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 60.44 27.24 16.84 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.963 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 7.9 m-85 -122.69 138.61 54.56 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.22 132.37 46.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.846 0.355 . . . . 0.0 111.398 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 t80 -98.65 113.37 25.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.06 147.16 40.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.133 0.492 . . . . 0.0 112.235 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 74.6 m -120.55 140.04 29.78 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' C ' ' HD2' ' A' ' 31' ' ' ARG . 32.0 Cg_exo -58.37 -42.18 58.32 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 2.236 . . . . 0.0 112.622 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 30' ' ' PRO . 1.3 mpt_? -143.2 -114.55 0.11 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.87 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.784 -179.825 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.24 -170.01 1.97 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.6 mt -71.73 128.66 36.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.943 0.401 . . . . 0.0 111.151 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 19.1 m -99.74 160.74 14.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -145.07 148.82 34.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.637 0.732 . . . . 0.0 112.381 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.638 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 7.8 p -93.81 124.98 38.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.6 mmm180 -128.58 141.84 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 39.5 ttpt -66.23 -29.08 69.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.386 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 -158.87 25.54 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.321 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -81.26 58.6 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.623 -0.339 . . . . 0.0 110.556 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' SG ' HG22 ' A' ' 17' ' ' VAL . 15.8 m 60.82 -153.28 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.766 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 8.7 mmmm -156.84 135.87 11.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.978 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HD2' ' HB3' ' A' ' 30' ' ' PRO . 44.1 ttm180 75.63 -34.5 0.25 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 111.9 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.48 -146.8 4.53 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.756 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.94 43.83 0.69 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.216 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.743 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 78.1 ttt180 -88.63 70.58 8.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.417 HG22 ' SG ' ' A' ' 11' ' ' CYS . 11.7 t -67.91 132.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.994 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 75.4 mtp180 -115.2 -23.45 8.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.055 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.56 -143.89 7.83 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.343 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 p -128.91 156.19 44.11 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.753 0.311 . . . . 0.0 110.526 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 6' ' ' CYS . 1.6 t -88.62 40.56 0.97 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.88 -57.78 3.51 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-O 121.872 0.707 . . . . 0.0 111.925 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 pt -83.32 -160.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 114.359 -0.921 . . . . 0.0 110.396 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 15.8 mmp_? -80.86 51.06 1.46 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.043 0.449 . . . . 0.0 111.734 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 6.3 m-85 -129.23 135.66 49.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 6.5 mp -89.28 128.69 35.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 32.4 t80 -89.75 112.55 23.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 m -135.51 153.27 51.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 111.562 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.743 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 79.6 m -98.86 142.12 24.06 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.615 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 54.1 Cg_exo -53.94 -42.78 63.89 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.93 2.42 . . . . 0.0 113.092 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.439 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 91.6 mtt180 -154.73 -153.33 0.45 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.337 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 31' ' ' ARG . 20.3 mtp-105 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.341 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.6 mt -89.05 -44.58 10.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.76 0.314 . . . . 0.0 111.373 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 48.6 tp -79.92 132.46 36.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.209 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.6 m -89.52 165.84 14.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.812 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.461 ' HD1' ' O ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.82 142.48 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.229 0.538 . . . . 0.0 110.592 177.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 17.6 p -90.33 127.98 36.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.023 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.626 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.8 mmm180 -130.55 149.99 51.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.27 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HZ2' ' HE1' ' A' ' 25' ' ' PHE . 49.0 tttp -69.41 113.53 6.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.43 178.5 17.56 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -76.62 69.53 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.109 0.454 . . . . 0.0 111.706 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 32.5 m 69.93 147.94 0.07 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.625 0.578 . . . . 0.0 112.085 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 30.3 mmtp -132.5 117.19 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.148 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 56.29 44.17 25.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.918 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.667 ' HA2' ' N ' ' A' ' 31' ' ' ARG . . . -141.13 -133.21 2.9 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.264 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.53 -46.37 0.23 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.384 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HG3' ' HB2' ' A' ' 29' ' ' CYS . 23.7 ptt-85 -89.3 99.53 12.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.415 0.626 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.473 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 p -92.82 142.88 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.063 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 23.07 0.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' C ' ' HB3' ' A' ' 27' ' ' TYR . . . -178.0 -169.86 39.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.13 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.513 HG22 HD13 ' A' ' 26' ' ' LEU . 7.7 p -141.57 157.62 44.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.408 . . . . 0.0 109.914 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.956 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 3.8 t -117.21 38.8 3.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.98 -144.63 16.38 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.468 HG12 ' HG2' ' A' ' 24' ' ' ARG . 10.6 tt -82.76 123.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.203 0.525 . . . . 0.0 112.015 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 23' ' ' ILE . 26.2 mmm180 61.0 36.35 18.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.448 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.956 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.0 m-85 -137.58 127.02 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.513 HD13 HG22 ' A' ' 20' ' ' THR . 4.4 mm? -110.67 137.99 47.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 0.0 111.387 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 42.6 t80 -98.81 103.13 15.06 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 1.5 m -133.33 155.74 48.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.151 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.734 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.6 m -88.18 142.99 32.17 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.893 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 32' ' ' ARG . 17.2 Cg_endo -58.42 152.5 53.88 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.283 2.655 . . . . 0.0 112.662 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.667 ' N ' ' HA2' ' A' ' 14' ' ' GLY . 35.7 ttt85 -78.33 53.28 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 31.8 ptt180 . . . . . 0 C--O 1.258 1.54 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.611 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 30' ' ' PRO . . . . . . . . 0 N--CA 1.484 1.851 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.97 -36.92 10.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.771 0.319 . . . . 0.0 111.02 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.68 133.41 55.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.395 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.1 m -71.5 161.47 30.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.492 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.96 146.5 30.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.837 0.827 . . . . 0.0 112.664 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.7 t -80.93 126.06 30.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.209 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.3 mmm180 -130.72 128.49 40.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.956 0.408 . . . . 0.0 111.165 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 36.1 ttpt -83.03 85.04 7.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.02 -111.27 0.45 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.338 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -142.61 53.57 1.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.746 0.308 . . . . 0.0 110.565 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.7 m 63.48 -163.91 0.26 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.909 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 65.2 mmtt -155.88 146.07 21.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 17.5 mmt85 73.91 -24.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.076 0.551 . . . . 0.0 111.356 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 12' ' ' LYS . . . 170.76 149.49 6.48 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.08 53.62 2.2 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.825 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -89.24 65.41 7.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.018 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 m -62.05 132.5 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.425 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -102.67 -35.45 8.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.436 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.04 -167.98 40.62 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 p -90.82 139.4 30.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 48.1 t -106.89 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.72 0.771 . . . . 0.0 109.24 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.67 -136.92 13.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.56 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.779 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -99.79 125.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 60.88 25.72 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.687 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.1 m-85 -135.16 136.55 41.95 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -114.5 135.03 54.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.176 0.512 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -93.97 121.54 35.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.4 m -132.16 156.35 46.57 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.707 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.6 m -118.94 128.8 25.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.666 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 31' ' ' ARG . 84.5 Cg_endo -84.62 -135.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.847 2.365 . . . . 0.0 112.234 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' A' ' 31' ' ' ARG . 26.2 tpt180 -175.41 -43.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.104 0.478 . . . . 0.0 110.106 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 117.558 -1.21 . . . . 0.0 109.95 179.866 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.3 mt 71.41 -60.86 0.5 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.592 0.757 . . . . 0.0 111.805 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.54 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 6.9 mp -74.72 110.14 8.77 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 72.6 m -150.95 167.73 26.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.922 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.683 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.5 p90 -153.59 133.81 13.39 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.789 0.804 . . . . 0.0 111.743 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 24.6 t -92.2 120.94 33.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.077 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.639 ' HD3' ' CD1' ' A' ' 5' ' ' TYR . 11.4 mtp-105 -151.11 141.42 22.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.863 0.363 . . . . 0.0 111.731 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 35.0 ttpt -82.18 52.07 1.92 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.729 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.86 159.74 27.47 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.969 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -49.64 148.33 3.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 111.687 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -56.99 161.41 3.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.159 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.61 128.32 35.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.229 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.82 23.58 12.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.05 -137.48 4.69 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.821 -1.18 . . . . 0.0 113.07 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.66 56.73 0.3 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.272 -0.489 . . . . 0.0 111.963 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -87.72 63.09 7.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.513 0.673 . . . . 0.0 109.828 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.89 131.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.162 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 41.7 mmm-85 -106.33 -23.64 12.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.882 0.372 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.81 -171.35 38.87 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.842 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -104.25 140.64 37.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.728 0.299 . . . . 0.0 110.313 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 34.7 t -104.65 47.9 0.86 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.605 0.717 . . . . 0.0 109.668 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.23 -137.08 13.04 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.178 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.42 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 64.3 mt -90.95 116.6 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 66.59 -0.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.701 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 10.2 m-85 -95.07 135.42 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.823 0.344 . . . . 0.0 110.511 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.58 133.62 45.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.553 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -100.61 91.25 4.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.683 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 66.7 m -96.62 149.87 21.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.489 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.5 m -133.33 118.86 15.11 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 95.9 Cg_endo -79.7 26.8 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.901 2.401 . . . . 0.0 112.282 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.8 mmt-85 -153.26 145.92 24.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.13 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.047 179.818 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.984 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.0 mt -74.61 159.36 32.24 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.529 0.331 . . . . 0.0 110.649 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.09 135.71 47.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.6 m -83.14 166.22 18.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.43 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 33.2 p90 -135.27 127.24 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.891 0.853 . . . . 0.0 111.601 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.699 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 15.8 t -87.13 115.45 24.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.319 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.699 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.8 mmm180 -141.07 142.68 34.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.693 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -90.23 122.33 33.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -102.81 0.27 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.853 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.44 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -159.44 40.63 0.21 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.578 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 83.2 m 69.66 150.06 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -104.59 131.59 51.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.311 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 65.24 56.77 0.97 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.542 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.26 134.77 8.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.645 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 11' ' ' CYS . . . -77.64 66.44 3.02 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.921 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -88.14 58.84 4.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.622 -0.34 . . . . 0.0 110.7 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.48 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 20.7 t -71.38 127.2 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.885 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.48 ' HD2' ' C ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -130.19 2.53 4.72 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.75 -178.68 48.44 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.878 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -109.84 139.51 44.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.636 0.255 . . . . 0.0 110.327 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.1 t -104.35 111.66 24.38 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -126.68 35.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.222 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 23' ' ' ILE . 10.9 tp -140.75 37.39 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.334 1.064 . . . . 0.0 109.543 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.714 ' HG3' ' HD1' ' A' ' 25' ' ' PHE . 38.7 ptt180 -172.26 2.11 0.01 OUTLIER 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.273 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.714 ' HD1' ' HG3' ' A' ' 24' ' ' ARG . 5.6 m-85 -129.91 160.06 34.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 110.631 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 10' ' ' HIS . 7.1 mp -102.1 134.77 44.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.085 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.53 96.13 8.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.0 m -94.61 139.18 31.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.662 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.1 m -134.68 120.44 14.44 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.716 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 35.0 Cg_exo -60.39 -46.02 19.79 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.251 1.968 . . . . 0.0 110.582 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 30' ' ' PRO . 32.7 mtp180 -167.49 120.72 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.77 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.587 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 32' ' ' ARG . 3.3 mm? 61.01 42.73 12.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.098 0.475 . . . . 0.0 110.832 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.876 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -80.13 54.74 2.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.195 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.2 m -77.88 164.53 25.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.663 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.0 p90 -157.23 137.17 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.632 0.73 . . . . 0.0 111.808 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.652 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 52.9 t -89.58 121.95 32.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.214 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.1 mmm180 -136.0 132.29 36.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 36.2 ttmt -70.14 -29.69 66.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.31 0.576 . . . . 0.0 110.629 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 -110.16 0.2 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -143.1 67.41 1.3 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.468 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.2 m 63.9 -150.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 14.3 mmmt -136.14 44.08 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.615 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -168.4 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.643 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.83 -62.86 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.829 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.81 52.04 0.16 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HG2' ' HA ' ' A' ' 30' ' ' PRO . 36.1 tpt85 -89.45 44.7 1.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 t -63.89 137.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.897 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -107.18 -33.59 7.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.325 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.37 -163.46 29.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.535 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 p -92.4 140.5 29.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.994 0.426 . . . . 0.0 111.371 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.715 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 46.8 t -108.51 44.94 1.06 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.624 0.726 . . . . 0.0 109.475 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.8 -139.86 14.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.14 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.849 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -92.88 123.86 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 111.861 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 54.68 42.84 30.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.409 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.715 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -148.1 134.79 19.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.653 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.04 132.2 54.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.996 0.427 . . . . 0.0 110.136 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -97.3 115.9 28.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.9 m -112.61 148.09 35.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.953 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.2 m -142.02 112.66 6.26 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.775 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.765 ' HB2' ' HD3' ' A' ' 31' ' ' ARG . 19.9 Cg_exo -66.14 -42.76 10.06 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.884 2.389 . . . . 0.0 111.566 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.765 ' HD3' ' HB2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -168.03 159.86 11.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.176 179.051 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.423 ' HA ' HD13 ' A' ' 2' ' ' LEU . 3.4 ptp180 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.29 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.908 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 3.3 mm? -71.11 142.41 50.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.88 152.93 38.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.797 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 38.5 m -72.19 161.75 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.612 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -152.34 138.6 18.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.146 0.498 . . . . 0.0 111.043 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 27.2 p -107.15 117.77 34.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.999 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -144.18 150.46 38.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.792 0.329 . . . . 0.0 110.718 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -68.85 104.16 1.98 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.417 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.11 -117.59 0.77 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.342 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.423 ' HA ' HD22 ' A' ' 26' ' ' LEU . 32.1 p-80 -166.87 57.08 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m 74.28 146.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.639 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 14.5 mmmm -93.54 112.97 24.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.47 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 55.2 mmt-85 71.09 -53.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.88 0.737 . . . . 0.0 112.269 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.13 140.89 5.49 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.379 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -150.34 10.68 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.658 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.3 mmt-85 -146.85 131.81 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.459 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 22.5 t -78.59 126.93 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.77 0.319 . . . . 0.0 110.192 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.811 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -115.85 -13.85 11.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.576 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.57 -149.79 8.9 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.289 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.4 p -140.71 153.16 45.82 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.752 0.311 . . . . 0.0 110.64 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 1.6 t -88.55 60.15 5.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.3 -59.0 3.84 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.163 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 tp -174.58 145.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.833 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 71.58 -39.7 0.46 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.719 0.807 . . . . 0.0 112.949 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m-85 -89.31 130.8 35.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.364 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 9.5 mp -91.62 137.01 32.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -96.01 101.56 13.25 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 91.7 m -100.61 142.77 31.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.838 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.811 ' HB2' ' HD3' ' A' ' 18' ' ' ARG . 70.1 m -121.84 116.07 30.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.03 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.626 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 3.0 Cg_exo -77.14 -22.79 10.96 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.907 2.405 . . . . 0.0 111.864 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.535 ' HG3' ' H ' ' A' ' 32' ' ' ARG . 5.5 ptp85 -61.84 -48.94 78.3 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.585 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.2 mmp_? . . . . . 0 C--O 1.247 0.924 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 2' ' ' LEU . 2.2 pt? -67.66 -38.65 84.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 110.994 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.9 tp -76.19 127.81 33.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.774 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 12.7 m -86.38 158.15 19.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.572 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.9 p90 -98.95 136.46 38.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.977 0.894 . . . . 0.0 112.952 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.681 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 37.8 t -93.78 121.69 35.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.509 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.681 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.2 mmm180 -133.1 141.73 48.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -82.98 47.76 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.757 0.789 . . . . 0.0 109.715 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.82 -148.87 7.11 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.209 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -94.11 67.75 3.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.1 m 60.15 -151.75 0.4 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.546 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -149.19 110.62 4.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 54.08 45.67 27.05 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.649 0.593 . . . . 0.0 111.836 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.42 132.79 1.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.96 153.85 14.73 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -88.65 117.65 27.77 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.997 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -61.14 129.83 24.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.423 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 7.6 tpt180 -101.76 -40.41 6.97 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.568 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.7 -159.82 27.76 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.583 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 p -94.95 140.2 30.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 0.0 110.922 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.945 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.5 t -104.81 39.08 1.77 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.628 0.727 . . . . 0.0 109.81 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.83 -145.27 16.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.543 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 23' ' ' ILE . 4.1 mp -85.15 118.36 31.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.745 0.307 . . . . 0.0 110.968 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 57.05 46.38 19.34 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.657 0.741 . . . . 0.0 110.829 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.945 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.3 m-85 -144.6 133.34 22.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.868 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.17 133.49 54.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 9.5 t80 -100.74 106.52 17.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 4.8 m -114.85 142.37 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.1 m -99.09 132.98 22.53 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.17 156.17 62.9 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.894 2.396 . . . . 0.0 112.269 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.643 ' H ' ' HD2' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -61.76 -23.54 66.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.1 ptt85 . . . . . 0 C--O 1.245 0.852 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.419 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' HA3' ' OXT' ' A' ' 32' ' ' ARG . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.01 -44.03 20.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.649 0.261 . . . . 0.0 111.116 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -150.25 45.59 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.221 0.534 . . . . 0.0 111.563 -179.329 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.67 159.15 26.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.537 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -132.73 142.9 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.902 0.858 . . . . 0.0 112.042 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 22.8 t -103.93 113.94 27.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.041 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 1.054 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 27.8 mmm180 -137.12 139.43 41.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.927 0.394 . . . . 0.0 110.877 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 37.5 ttmt -68.87 148.92 49.52 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.75 -65.7 2.33 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.792 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 0.5 OUTLIER 179.58 48.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.137 0.494 . . . . 0.0 109.894 179.412 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 1.054 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 75.6 m 59.2 -158.91 0.3 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.8 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -151.92 147.83 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.4 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 61.14 42.63 12.07 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.832 0.708 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.96 7.91 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.536 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 148.74 19.18 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.282 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -88.7 107.56 19.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 t -60.83 125.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.617 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 52.3 mmm-85 -99.44 -31.06 11.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.506 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.75 -155.58 26.56 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.52 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 p -91.52 140.85 29.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.839 0.352 . . . . 0.0 111.438 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.512 ' HB3' ' CB ' ' A' ' 25' ' ' PHE . 37.0 t -93.57 -137.52 0.19 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' N ' ' SG ' ' A' ' 21' ' ' CYS . . . -73.25 -147.87 0.98 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 113.464 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.869 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -65.64 99.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.442 0.639 . . . . 0.0 112.325 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 64.34 46.68 3.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.156 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 20.7 m-85 -131.83 150.01 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.787 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 10' ' ' HIS . 4.3 mm? -107.85 143.2 36.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -111.77 112.79 24.73 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.955 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -129.97 145.98 51.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.429 . . . . 0.0 111.238 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 51.9 m -115.32 121.34 34.98 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.704 ' HG2' HD13 ' A' ' 3' ' ' LEU . 20.7 Cg_endo -63.67 -35.4 58.47 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.318 2.012 . . . . 0.0 111.271 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.559 ' HB2' HD11 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -131.12 -60.68 0.95 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.868 178.578 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.462 ' OXT' ' HA3' ' A' ' 1' ' ' GLY . 19.7 mmt85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.787 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.866 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 18' ' ' ARG . 96.8 mt -74.85 132.54 41.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.876 0.338 . . . . 0.0 110.214 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.79 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.0 pt? -81.92 39.17 0.55 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.063 0.459 . . . . 0.0 111.006 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 62.5 m -82.6 155.85 24.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.096 0.474 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 2.3 p90 -108.32 138.96 43.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.967 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.712 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.1 t -87.77 117.76 26.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.712 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.6 mmm180 -133.81 125.38 28.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.985 0.421 . . . . 0.0 111.641 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -84.42 71.85 10.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.343 0.592 . . . . 0.0 109.41 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.37 -82.25 0.06 OUTLIER Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.861 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.787 ' HA ' HD22 ' A' ' 26' ' ' LEU . 11.3 p80 -172.97 61.87 0.03 OUTLIER 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.164 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.654 ' SG ' HG22 ' A' ' 17' ' ' VAL . 13.3 m 59.61 -159.62 0.3 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.883 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 51.9 mtpt -145.17 131.44 19.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.94 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 21.8 ttt85 60.38 29.4 18.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.462 0.649 . . . . 0.0 111.134 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.42 43.75 86.34 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.376 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.88 167.46 51.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.342 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -88.29 117.45 27.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.654 HG22 ' SG ' ' A' ' 11' ' ' CYS . 8.0 t -63.3 131.2 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.244 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.55 ' HG2' HD13 ' A' ' 2' ' ' LEU . 4.8 tpt85 -104.16 -31.69 9.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.443 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.1 -152.47 20.09 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.727 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -108.48 140.65 41.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.539 0.17 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 24.7 p -116.27 30.45 7.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.22 0.534 . . . . 0.0 111.333 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -166.61 28.41 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.32 98.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.548 0.689 . . . . 0.0 110.688 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.64 34.51 4.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.253 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.79 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 19.6 m-85 -112.66 130.46 56.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.055 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 10' ' ' HIS . 7.1 mp -98.97 129.88 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 0.0 111.346 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 4' ' ' CYS . 2.4 t80 -104.04 112.02 24.84 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.533 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 m -131.39 142.09 49.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.081 -177.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -98.68 138.04 20.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.162 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.22 124.43 11.3 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.398 2.065 . . . . 0.0 112.003 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.718 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . 2.3 tpm_? -160.3 44.83 0.21 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.764 -1.112 . . . . 0.0 109.036 -179.554 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.929 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.416 HD12 ' HG2' ' A' ' 30' ' ' PRO . 22.5 tp 59.08 54.72 4.78 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.387 0.613 . . . . 0.0 110.564 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.58 120.89 15.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.874 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.677 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 4.6 m -69.63 151.26 46.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.011 0.434 . . . . 0.0 110.674 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 2.5 p90 -107.58 140.64 40.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.846 0.832 . . . . 0.0 113.109 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.4 t -87.96 119.66 28.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.623 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.5 mmm180 -129.55 138.96 51.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.419 0.628 . . . . 0.0 112.338 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 1.8 tmtp? -90.16 118.3 29.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.569 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.44 -52.21 3.72 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.424 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -161.59 145.87 12.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.07 0.935 . . . . 0.0 112.562 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.646 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 1.6 m -65.63 154.37 38.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.287 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 16.4 ptmt -119.44 48.69 1.46 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.444 HH21 ' C ' ' A' ' 32' ' ' ARG . 26.1 tpt180 -174.6 -42.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.086 0.47 . . . . 0.0 110.289 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.13 138.06 5.08 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.934 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 51.11 2.79 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.063 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 16' ' ' ARG . 19.8 mmt180 -111.1 70.12 0.7 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.049 0.452 . . . . 0.0 110.475 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 22.3 t -63.96 123.32 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.644 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 9.9 tpt85 -89.87 -32.14 17.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.776 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.31 -168.55 37.25 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -93.45 138.07 32.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -102.89 120.68 41.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.18 -126.62 31.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.419 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 17.6 pt -136.64 40.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.739 0.304 . . . . 0.0 110.893 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 9.5 tpt180 179.27 -24.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.226 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 1.9 m-85 -88.69 155.33 19.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.11 131.1 48.79 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.408 ' CE2' ' HB2' ' A' ' 4' ' ' CYS . 8.2 t80 -101.13 90.12 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.562 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 1.8 m -100.34 142.84 31.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 18' ' ' ARG . 61.5 m -89.85 145.48 33.4 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.677 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 63.4 Cg_endo -74.12 -145.46 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.563 2.175 . . . . 0.0 113.709 -178.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.431 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 12.4 ptp180 -174.66 -156.45 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.603 HH11 ' HG2' ' A' ' 32' ' ' ARG . 34.1 ttp85 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.904 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.663 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -156.47 151.68 26.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.889 0.345 . . . . 0.0 110.149 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.2 tp -113.37 128.39 56.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.143 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.5 m -73.83 163.66 27.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -149.41 137.81 20.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.905 0.86 . . . . 0.0 112.528 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.685 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 53.9 t -88.71 124.72 34.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.351 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.685 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.1 mmm180 -132.52 141.12 48.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.319 0.581 . . . . 0.0 112.334 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.589 ' HD3' ' CZ ' ' A' ' 25' ' ' PHE . 51.3 tptt -86.42 53.11 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 122.142 0.972 . . . . 0.0 109.156 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.38 -150.12 8.81 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.911 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -91.56 20.21 5.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.58 0.69 . . . . 0.0 111.154 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.438 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 75.8 m 66.36 143.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.795 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -90.86 158.44 16.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.955 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 32.7 ttm105 78.44 -45.49 0.4 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.144 0.978 . . . . 0.0 111.254 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.13 131.18 2.22 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.881 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.5 51.59 3.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.668 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -87.92 69.18 9.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.107 0.48 . . . . 0.0 109.944 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.68 132.75 27.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.776 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.61 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 78.4 ttt180 -105.3 -35.34 7.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.203 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.23 -162.98 30.78 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.614 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -92.12 138.88 31.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 111.11 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.901 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.7 t -100.09 46.33 0.96 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.597 0.713 . . . . 0.0 110.015 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.19 -140.03 14.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.175 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -75.61 103.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 53.99 49.78 18.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.049 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.901 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.7 m-85 -135.49 146.36 48.06 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 mp -108.31 132.4 53.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.316 0.579 . . . . 0.0 110.954 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -106.58 114.71 28.98 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m -120.96 156.22 32.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 61.8 m -135.14 125.01 16.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.663 ' HG2' ' HB2' ' A' ' 2' ' ' LEU . 61.2 Cg_endo -73.36 -132.22 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.881 2.387 . . . . 0.0 112.755 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 31.0 ttp180 -171.7 -69.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.296 -1.335 . . . . 0.0 107.677 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.488 ' H ' ' CD1' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -79.89 -29.08 39.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.864 0.364 . . . . 0.0 110.49 179.496 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.681 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.5 pt? -74.67 143.72 44.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.454 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.576 ' HB3' ' C ' ' A' ' 28' ' ' CYS . 61.1 m -75.16 163.59 27.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.581 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TYR . . . . . 0.538 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.1 p90 -88.58 141.12 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.591 . . . . 0.0 111.087 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.63 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 41.3 t -97.43 114.22 26.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.016 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.63 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.3 mmm180 -138.58 145.3 40.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 29.2 ttmt -67.32 -31.85 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.556 0.693 . . . . 0.0 109.524 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.56 151.32 52.24 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.152 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' HIS . . . . . 0.93 ' HA ' HD12 ' A' ' 26' ' ' LEU . 45.4 m170 -72.33 68.71 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.542 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 76.7 m 71.16 145.68 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.927 0.767 . . . . 0.0 111.669 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -107.34 31.63 5.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.11 35.73 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.22 -139.4 30.78 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.911 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.71 72.67 1.26 Allowed Glycine 0 CA--C 1.517 0.169 0 C-N-CA 121.595 -0.336 . . . . 0.0 113.391 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -132.59 33.56 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 110.679 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 p -81.88 132.5 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.606 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -113.33 -11.95 13.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.691 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.72 -170.03 43.13 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.4 p -106.19 141.56 37.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 16.4 t -99.93 -140.32 0.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -156.3 1.95 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.491 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 pt -64.62 105.65 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.036 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 66.69 42.36 2.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.952 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 19.4 m-85 -132.76 140.76 48.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.576 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 10' ' ' HIS . 34.2 mt -109.3 145.08 36.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.309 0.576 . . . . 0.0 111.529 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -98.92 94.54 6.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.425 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.576 ' C ' ' HB3' ' A' ' 4' ' ' CYS . 10.1 m -119.96 140.48 50.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.385 . . . . 0.0 111.92 -177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 1.6 m -98.69 143.43 26.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.803 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 29' ' ' CYS . 37.2 Cg_exo -60.17 -42.93 38.91 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.912 2.408 . . . . 0.0 112.57 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -156.67 54.86 0.54 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.883 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.119 -0.943 . . . . 0.0 109.495 -179.582 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.0 tp . . . . . 0 N--CA 1.455 -0.222 0 CA-C-O 121.567 0.699 . . . . 0.0 109.299 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 11.2 m -78.21 154.02 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.994 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.604 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 3.1 p90 -135.89 140.5 44.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.726 0.774 . . . . 0.0 112.516 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.606 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 40.4 t -94.55 122.95 37.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.871 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 28.2 mmm180 -132.8 133.52 43.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.59 128.49 35.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.964 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.35 -53.12 4.8 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.307 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.85 138.49 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.827 0.314 . . . . 0.0 110.616 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.604 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 61.4 m -61.2 143.44 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.437 ' H ' ' HG3' ' A' ' 7' ' ' ARG . 75.4 mmtt -92.81 140.43 29.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 43.89 49.6 7.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.212 0.945 . . . . 0.0 112.356 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.07 128.69 1.4 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.631 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.78 42.83 1.74 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.496 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 5.6 mmp_? -125.6 63.3 1.2 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 110.427 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.602 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 4.2 p -61.89 130.34 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.447 0.641 . . . . 0.0 110.696 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.662 ' NE ' ' HA ' ' A' ' 18' ' ' ARG . 1.9 tpm_? -96.94 -26.71 14.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.35 43.39 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -82.7 135.85 34.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.963 0.411 . . . . 0.0 111.051 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 45.8 t -95.21 49.64 1.22 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.67 0.748 . . . . 0.0 109.028 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.2 -137.77 13.69 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.201 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.794 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -98.37 125.62 51.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 62.47 20.56 12.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.723 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -129.45 141.73 50.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -114.68 137.85 51.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.845 0.355 . . . . 0.0 110.5 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 8.5 t80 -111.45 114.95 28.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 83.0 m -117.87 143.79 45.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.374 . . . . 0.0 112.005 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.0 m -120.3 126.65 26.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.075 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.531 0.36 0 C-N-CA 122.981 2.454 . . . . 0.0 112.704 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 mp . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.73 0.3 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 11.7 m -64.73 157.09 28.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.898 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.436 ' HE1' ' HA ' ' A' ' 11' ' ' CYS . 2.5 p90 -131.36 141.73 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 0.0 112.323 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.606 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 48.5 t -87.41 128.91 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.093 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.8 mmm180 -132.28 136.82 47.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 111.455 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -68.81 -36.2 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 109.964 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.47 -87.38 0.46 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.684 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.486 ' HB3' HD22 ' A' ' 26' ' ' LEU . 32.4 p-80 -179.36 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.781 0.433 . . . . 0.0 109.929 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HA ' ' HE1' ' A' ' 5' ' ' TYR . 12.9 m 56.07 -155.74 0.29 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.373 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 4.9 mmmt -151.81 40.71 0.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 49.3 mmt-85 72.2 -58.23 0.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.013 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.53 47.91 3.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.677 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -165.32 142.51 7.77 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.032 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -103.09 134.81 45.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 3.5 p -57.32 127.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.593 0.711 . . . . 0.0 110.996 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 33.8 tpt85 -95.81 -27.17 15.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.36 -155.5 26.37 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.834 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -88.26 138.03 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.385 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.9 t -103.68 49.19 0.83 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.517 0.675 . . . . 0.0 109.824 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.37 -141.48 15.59 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.502 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.7 mt -86.78 112.77 23.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.49 34.96 20.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.496 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -132.89 146.65 51.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD22 ' HB3' ' A' ' 10' ' ' HIS . 7.5 mp -112.99 133.55 54.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.333 0.587 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 7.2 t80 -103.41 128.42 50.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 m -135.14 146.18 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.57 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 64.3 m -110.09 131.55 21.93 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.699 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 81.5 Cg_endo . . . . . 0 N--CA 1.461 -0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.539 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.657 HD13 ' HG2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.111 0 CA-C-O 121.372 0.606 . . . . 0.0 110.817 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.86 159.77 33.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.179 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.484 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 0.9 OUTLIER -144.46 141.82 29.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.909 0.862 . . . . 0.0 112.864 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.598 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 39.5 t -91.37 126.86 36.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.711 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.598 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.9 mmm180 -131.69 137.15 48.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 111.211 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.44 128.0 34.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.988 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.04 -51.6 3.2 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.515 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.738 ' HA ' HD12 ' A' ' 26' ' ' LEU . 27.7 p-80 -169.21 146.62 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 71.3 m -66.55 142.72 57.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.034 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 129.25 39.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.578 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 68.56 -51.25 0.56 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.989 0.916 . . . . 0.0 112.515 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -143.47 8.57 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.059 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.23 169.76 15.09 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -87.66 114.42 24.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.77 124.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.898 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.68 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 52.3 ttt85 -90.33 -35.69 15.09 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.095 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.95 -166.51 39.19 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.599 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 p -86.9 137.9 31.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.753 0.311 . . . . 0.0 110.998 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.724 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 35.8 t -99.6 42.6 1.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.62 0.724 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -144.37 16.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.911 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tt -90.45 118.67 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.02 0.438 . . . . 0.0 111.801 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 62.98 32.79 15.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.976 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.724 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 13.2 m-85 -137.09 139.02 40.98 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 10' ' ' HIS . 73.8 mt -115.77 138.27 51.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.013 0.435 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 9.9 t80 -110.7 116.79 31.91 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.29 156.46 41.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.952 0.406 . . . . 0.0 111.949 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.68 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 58.3 m -122.69 113.29 30.43 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.935 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.657 ' HG2' HD13 ' A' ' 3' ' ' LEU . 59.4 Cg_endo . . . . . 0 N--CA 1.46 -0.48 0 C-N-CA 122.505 2.137 . . . . 0.0 111.639 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.857 0.36 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 58.1 m -66.26 161.21 22.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.506 ' OH ' ' HA3' ' A' ' 15' ' ' GLY . 4.6 p90 -149.45 141.75 24.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.537 0.684 . . . . 0.0 112.029 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.664 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 44.5 t -93.52 119.47 32.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.577 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.664 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.3 mmm180 -135.16 138.99 44.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.062 0.458 . . . . 0.0 111.433 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -83.44 52.24 2.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.482 0.658 . . . . 0.0 109.608 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.3 -159.15 18.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.958 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -85.45 64.11 8.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.3 m 59.18 -149.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.118 0.485 . . . . 0.0 111.951 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 25.5 mtpp -136.02 65.79 1.52 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 69.15 -100.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.479 0.487 . . . . 0.0 111.123 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.36 66.91 2.24 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.877 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -149.46 132.71 4.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.142 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -95.45 131.92 41.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.22 124.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.602 0.715 . . . . 0.0 110.806 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -90.59 -27.74 18.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.05 -157.16 28.45 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.201 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -94.37 138.81 31.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.017 0.437 . . . . 0.0 111.225 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 47.2 t -100.03 55.0 0.92 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.558 0.694 . . . . 0.0 109.212 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.66 -134.06 12.08 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.665 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.588 HG13 ' HG3' ' A' ' 24' ' ' ARG . 7.2 tp -101.65 124.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.886 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.588 ' HG3' HG13 ' A' ' 23' ' ' ILE . 59.5 mtp85 59.87 27.91 17.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.671 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.601 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.0 m-85 -135.57 143.06 45.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.3 137.96 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.229 0.538 . . . . 0.0 110.864 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -106.39 123.27 47.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 22.4 m -131.99 154.96 48.8 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.921 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 41.5 m -127.71 127.9 23.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.268 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.637 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 25.8 Cg_endo . . . . . 0 C--O 1.233 0.271 0 C-N-CA 122.785 2.324 . . . . 0.0 112.381 -179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.4 pt? . . . . . 0 C--O 1.233 0.206 0 CA-C-O 121.034 0.445 . . . . 0.0 111.368 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.66 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 32.2 m -76.29 161.67 28.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.736 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -125.3 136.13 53.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.871 0.843 . . . . 0.0 112.598 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.579 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 51.7 t -81.02 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.769 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.2 mmm180 -132.01 140.5 48.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.088 0.47 . . . . 0.0 112.064 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 25' ' ' PHE . 21.3 tptm -86.8 49.36 1.8 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.161 0.981 . . . . 0.0 109.228 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.62 -161.94 35.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.483 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.88 64.11 1.79 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 112.023 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.481 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 11.4 m 59.45 -153.94 0.38 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.405 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mtpm? -80.3 56.39 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.331 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 66.67 51.75 1.05 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.508 0.671 . . . . 0.0 109.865 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.68 -131.4 1.24 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.015 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 65.12 0.19 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.418 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.611 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 4.9 mmp_? -117.87 37.08 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.488 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 6.6 p -72.6 136.84 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.601 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.503 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 43.0 mtp85 -124.55 -2.65 7.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.69 178.09 48.38 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.38 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -95.13 139.36 31.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.864 0.364 . . . . 0.0 110.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.2 t -104.56 48.11 0.85 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.538 0.685 . . . . 0.0 109.845 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.38 -138.88 14.32 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.302 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.77 120.21 39.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.346 0.593 . . . . 0.0 112.143 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 56.36 38.13 29.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.559 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.794 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 11.7 m-85 -138.01 138.82 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.08 133.85 50.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.077 0.465 . . . . 0.0 111.311 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 11.6 t80 -97.96 101.09 12.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 57.7 m -105.45 141.37 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.776 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 80.6 m -108.22 143.82 28.19 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.745 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.66 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 55.2 Cg_exo . . . . . 0 C--N 1.343 0.266 0 C-N-CA 123.034 2.489 . . . . 0.0 113.578 -178.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.865 0.364 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.49 164.37 18.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.494 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.482 ' CD1' ' HD3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -150.04 147.05 27.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.914 0.864 . . . . 0.0 113.026 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.621 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.0 t -77.49 128.99 35.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.597 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.629 ' HE ' ' HB2' ' A' ' 12' ' ' LYS . 27.2 mmm180 -129.56 136.38 49.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -69.67 125.98 28.35 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.124 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.13 -141.26 29.89 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.854 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.06 144.93 56.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.83 0.315 . . . . 0.0 110.317 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.0 m -47.81 139.02 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.701 0.626 . . . . 0.0 112.208 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.629 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . 49.2 mmtm -112.02 120.68 42.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.232 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 71.42 -48.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.968 0.792 . . . . 0.0 111.962 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.853 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -59.57 -41.03 97.09 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.745 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.89 -56.57 3.52 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.774 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -89.89 119.63 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.441 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.58 138.3 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.997 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -98.68 -30.46 12.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.422 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.06 -168.55 41.69 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.596 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 p -88.63 142.33 27.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.921 0.361 . . . . 0.0 111.2 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.3 t -113.98 47.58 1.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.6 0.714 . . . . 0.0 109.253 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 -137.8 14.0 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.894 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 pt -98.31 126.89 51.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.937 0.398 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 61.39 20.55 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.351 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 14.8 m-85 -134.44 139.42 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.5 mp -121.82 135.63 54.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.304 0.574 . . . . 0.0 110.507 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 122.93 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.2 m -135.53 152.58 51.45 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.133 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 66.5 m -110.23 123.67 35.37 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.634 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.853 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 39.6 Cg_endo . . . . . 0 C--O 1.234 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.969 -179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.458 -0.066 0 CA-C-O 121.296 0.57 . . . . 0.0 109.555 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 36.2 m -88.81 164.89 15.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.28 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -139.34 128.86 24.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.464 0.65 . . . . 0.0 110.713 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.576 ' C ' ' HD2' ' A' ' 7' ' ' ARG . 24.0 p -94.19 134.68 36.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.576 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.3 mpt_? -135.29 138.76 43.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.185 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' A' ' 8' ' ' LYS . 1.7 tmtm? -74.63 -43.95 52.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.368 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.94 -61.56 3.71 Favored Glycine 0 C--N 1.319 -0.395 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.512 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -174.71 149.95 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -52.31 142.48 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.576 0.548 . . . . 0.0 110.678 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.95 138.05 34.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 63.23 -143.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.748 0.655 . . . . 0.0 110.744 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.61 43.34 3.14 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.874 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 134.58 12.6 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.585 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -111.81 139.22 47.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 19.7 m -62.47 139.2 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.315 0.579 . . . . 0.0 112.118 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -129.93 -32.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.33 -150.33 6.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.839 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -127.72 142.54 51.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 111.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 13.2 t -91.02 42.61 1.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.19 -135.63 12.43 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.039 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 118.59 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.166 0.507 . . . . 0.0 112.252 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 60.44 27.24 16.84 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.963 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 7.9 m-85 -122.69 138.61 54.56 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.22 132.37 46.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.846 0.355 . . . . 0.0 111.398 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 t80 -98.65 113.37 25.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.06 147.16 40.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.133 0.492 . . . . 0.0 112.235 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 74.6 m -120.55 140.04 29.78 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 29' ' ' CYS . 32.0 Cg_exo . . . . . 0 C--N 1.342 0.207 0 C-N-CA 122.653 2.236 . . . . 0.0 112.622 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.6 mt . . . . . 0 N--CA 1.455 -0.2 0 CA-C-O 120.943 0.401 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 19.1 m -99.74 160.74 14.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -145.07 148.82 34.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.637 0.732 . . . . 0.0 112.381 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.638 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 7.8 p -93.81 124.98 38.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.6 mmm180 -128.58 141.84 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 39.5 ttpt -66.23 -29.08 69.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.386 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 -158.87 25.54 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.321 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -81.26 58.6 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.623 -0.339 . . . . 0.0 110.556 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' SG ' HG22 ' A' ' 17' ' ' VAL . 15.8 m 60.82 -153.28 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.766 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 8.7 mmmm -156.84 135.87 11.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.978 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HD2' ' HB3' ' A' ' 30' ' ' PRO . 44.1 ttm180 75.63 -34.5 0.25 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 111.9 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.48 -146.8 4.53 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.756 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.94 43.83 0.69 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.216 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.743 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 78.1 ttt180 -88.63 70.58 8.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.417 HG22 ' SG ' ' A' ' 11' ' ' CYS . 11.7 t -67.91 132.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.994 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 75.4 mtp180 -115.2 -23.45 8.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.055 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.56 -143.89 7.83 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.343 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 p -128.91 156.19 44.11 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.753 0.311 . . . . 0.0 110.526 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 6' ' ' CYS . 1.6 t -88.62 40.56 0.97 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.88 -57.78 3.51 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-O 121.872 0.707 . . . . 0.0 111.925 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 pt -83.32 -160.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 114.359 -0.921 . . . . 0.0 110.396 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 15.8 mmp_? -80.86 51.06 1.46 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.043 0.449 . . . . 0.0 111.734 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 6.3 m-85 -129.23 135.66 49.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 6.5 mp -89.28 128.69 35.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 32.4 t80 -89.75 112.55 23.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 m -135.51 153.27 51.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 111.562 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.743 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 79.6 m -98.86 142.12 24.06 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.615 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 54.1 Cg_exo . . . . . 0 C--N 1.343 0.284 0 C-N-CA 122.93 2.42 . . . . 0.0 113.092 -178.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 48.6 tp . . . . . 0 C--O 1.234 0.251 0 CA-C-O 120.957 0.408 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.6 m -89.52 165.84 14.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.812 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.461 ' O ' ' HD1' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.82 142.48 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.229 0.538 . . . . 0.0 110.592 177.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 17.6 p -90.33 127.98 36.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.023 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.626 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.8 mmm180 -130.55 149.99 51.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.27 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HZ2' ' HE1' ' A' ' 25' ' ' PHE . 49.0 tttp -69.41 113.53 6.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.43 178.5 17.56 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -76.62 69.53 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.109 0.454 . . . . 0.0 111.706 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 32.5 m 69.93 147.94 0.07 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.625 0.578 . . . . 0.0 112.085 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 30.3 mmtp -132.5 117.19 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.148 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 56.29 44.17 25.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.918 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -141.13 -133.21 2.9 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.264 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.53 -46.37 0.23 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.384 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HG3' ' HB2' ' A' ' 29' ' ' CYS . 23.7 ptt-85 -89.3 99.53 12.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.415 0.626 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.473 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 p -92.82 142.88 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.063 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 23.07 0.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.46 ' C ' ' HB3' ' A' ' 27' ' ' TYR . . . -178.0 -169.86 39.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.13 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.513 HG22 HD13 ' A' ' 26' ' ' LEU . 7.7 p -141.57 157.62 44.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.408 . . . . 0.0 109.914 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.956 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 3.8 t -117.21 38.8 3.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.98 -144.63 16.38 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.468 HG12 ' HG2' ' A' ' 24' ' ' ARG . 10.6 tt -82.76 123.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.203 0.525 . . . . 0.0 112.015 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 23' ' ' ILE . 26.2 mmm180 61.0 36.35 18.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.448 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.956 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.0 m-85 -137.58 127.02 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.513 HD13 HG22 ' A' ' 20' ' ' THR . 4.4 mm? -110.67 137.99 47.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 0.0 111.387 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 42.6 t80 -98.81 103.13 15.06 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 1.5 m -133.33 155.74 48.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.151 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.734 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.6 m -88.18 142.99 32.17 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.893 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo . . . . . 0 C--O 1.234 0.314 0 C-N-CA 123.283 2.655 . . . . 0.0 112.662 -179.645 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.0 mt . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.853 0.359 . . . . 0.0 111.395 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.1 m -71.5 161.47 30.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.492 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.96 146.5 30.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.837 0.827 . . . . 0.0 112.664 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.7 t -80.93 126.06 30.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.209 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.3 mmm180 -130.72 128.49 40.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.956 0.408 . . . . 0.0 111.165 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 36.1 ttpt -83.03 85.04 7.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.02 -111.27 0.45 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.338 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -142.61 53.57 1.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.746 0.308 . . . . 0.0 110.565 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.7 m 63.48 -163.91 0.26 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.909 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 65.2 mmtt -155.88 146.07 21.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 17.5 mmt85 73.91 -24.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.076 0.551 . . . . 0.0 111.356 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 12' ' ' LYS . . . 170.76 149.49 6.48 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.08 53.62 2.2 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.825 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -89.24 65.41 7.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.018 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 m -62.05 132.5 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.425 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -102.67 -35.45 8.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.436 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.04 -167.98 40.62 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 p -90.82 139.4 30.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 48.1 t -106.89 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.72 0.771 . . . . 0.0 109.24 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.67 -136.92 13.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.56 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.779 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -99.79 125.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 60.88 25.72 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.687 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.1 m-85 -135.16 136.55 41.95 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -114.5 135.03 54.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.176 0.512 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -93.97 121.54 35.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.4 m -132.16 156.35 46.57 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.707 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.6 m -118.94 128.8 25.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.666 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo . . . . . 0 N--CA 1.457 -0.635 0 C-N-CA 122.847 2.365 . . . . 0.0 112.234 179.798 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.54 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 6.9 mp . . . . . 0 N--CA 1.455 -0.223 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 72.6 m -150.95 167.73 26.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.922 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.683 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.5 p90 -153.59 133.81 13.39 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.789 0.804 . . . . 0.0 111.743 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 24.6 t -92.2 120.94 33.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.077 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.639 ' HD3' ' CD1' ' A' ' 5' ' ' TYR . 11.4 mtp-105 -151.11 141.42 22.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.863 0.363 . . . . 0.0 111.731 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 35.0 ttpt -82.18 52.07 1.92 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.729 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.86 159.74 27.47 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.969 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -49.64 148.33 3.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 111.687 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -56.99 161.41 3.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.159 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.61 128.32 35.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.229 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.82 23.58 12.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.05 -137.48 4.69 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.821 -1.18 . . . . 0.0 113.07 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.66 56.73 0.3 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.272 -0.489 . . . . 0.0 111.963 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -87.72 63.09 7.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.513 0.673 . . . . 0.0 109.828 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.89 131.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.162 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 41.7 mmm-85 -106.33 -23.64 12.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.882 0.372 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.81 -171.35 38.87 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.842 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -104.25 140.64 37.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.728 0.299 . . . . 0.0 110.313 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 34.7 t -104.65 47.9 0.86 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.605 0.717 . . . . 0.0 109.668 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.23 -137.08 13.04 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.178 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.42 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 64.3 mt -90.95 116.6 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 66.59 -0.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.701 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 10.2 m-85 -95.07 135.42 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.823 0.344 . . . . 0.0 110.511 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.58 133.62 45.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.553 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -100.61 91.25 4.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.683 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 66.7 m -96.62 149.87 21.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.489 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.5 m -133.33 118.86 15.11 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 95.9 Cg_endo . . . . . 0 C--N 1.344 0.341 0 C-N-CA 122.901 2.401 . . . . 0.0 112.282 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.234 0.268 0 CA-C-O 120.921 0.391 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.6 m -83.14 166.22 18.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.43 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 33.2 p90 -135.27 127.24 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.891 0.853 . . . . 0.0 111.601 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.699 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 15.8 t -87.13 115.45 24.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.319 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.699 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.8 mmm180 -141.07 142.68 34.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.693 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -90.23 122.33 33.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -102.81 0.27 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.853 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.44 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -159.44 40.63 0.21 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.578 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 83.2 m 69.66 150.06 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -104.59 131.59 51.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.311 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 65.24 56.77 0.97 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.542 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.26 134.77 8.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.645 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 11' ' ' CYS . . . -77.64 66.44 3.02 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.921 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -88.14 58.84 4.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.622 -0.34 . . . . 0.0 110.7 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.48 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 20.7 t -71.38 127.2 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.885 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.48 ' HD2' ' C ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -130.19 2.53 4.72 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.75 -178.68 48.44 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.878 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -109.84 139.51 44.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.636 0.255 . . . . 0.0 110.327 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.1 t -104.35 111.66 24.38 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -126.68 35.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.222 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 23' ' ' ILE . 10.9 tp -140.75 37.39 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.334 1.064 . . . . 0.0 109.543 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.714 ' HG3' ' HD1' ' A' ' 25' ' ' PHE . 38.7 ptt180 -172.26 2.11 0.01 OUTLIER 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.273 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.714 ' HD1' ' HG3' ' A' ' 24' ' ' ARG . 5.6 m-85 -129.91 160.06 34.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 110.631 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 10' ' ' HIS . 7.1 mp -102.1 134.77 44.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.085 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.53 96.13 8.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.0 m -94.61 139.18 31.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.662 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.1 m -134.68 120.44 14.44 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.716 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo . . . . . 0 N--CA 1.465 -0.202 0 C-N-CA 122.251 1.968 . . . . 0.0 110.582 179.357 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.44 ' N ' HD23 ' A' ' 3' ' ' LEU . 1.0 OUTLIER . . . . . 0 C--O 1.233 0.196 0 CA-C-O 121.125 0.488 . . . . 0.0 111.195 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.2 m -77.88 164.53 25.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.663 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.0 p90 -157.23 137.17 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.632 0.73 . . . . 0.0 111.808 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.652 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 52.9 t -89.58 121.95 32.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.214 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.1 mmm180 -136.0 132.29 36.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 36.2 ttmt -70.14 -29.69 66.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.31 0.576 . . . . 0.0 110.629 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 -110.16 0.2 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -143.1 67.41 1.3 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.468 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.2 m 63.9 -150.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 14.3 mmmt -136.14 44.08 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.615 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -168.4 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.643 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.83 -62.86 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.829 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.81 52.04 0.16 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HG2' ' HA ' ' A' ' 30' ' ' PRO . 36.1 tpt85 -89.45 44.7 1.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 t -63.89 137.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.897 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -107.18 -33.59 7.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.325 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.37 -163.46 29.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.535 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 p -92.4 140.5 29.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.994 0.426 . . . . 0.0 111.371 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.715 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 46.8 t -108.51 44.94 1.06 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.624 0.726 . . . . 0.0 109.475 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.8 -139.86 14.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.14 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.849 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -92.88 123.86 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 111.861 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 54.68 42.84 30.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.409 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.715 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -148.1 134.79 19.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.653 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.04 132.2 54.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.996 0.427 . . . . 0.0 110.136 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -97.3 115.9 28.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.9 m -112.61 148.09 35.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.953 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.2 m -142.02 112.66 6.26 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.775 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.546 ' HA ' ' HG2' ' A' ' 16' ' ' ARG . 19.9 Cg_exo . . . . . 0 C--O 1.233 0.246 0 C-N-CA 122.884 2.389 . . . . 0.0 111.566 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.811 0.339 . . . . 0.0 110.797 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 38.5 m -72.19 161.75 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.612 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -152.34 138.6 18.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.146 0.498 . . . . 0.0 111.043 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 27.2 p -107.15 117.77 34.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.999 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -144.18 150.46 38.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.792 0.329 . . . . 0.0 110.718 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -68.85 104.16 1.98 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.417 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.11 -117.59 0.77 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.342 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.423 ' HA ' HD22 ' A' ' 26' ' ' LEU . 32.1 p-80 -166.87 57.08 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m 74.28 146.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.639 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 14.5 mmmm -93.54 112.97 24.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.47 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 55.2 mmt-85 71.09 -53.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.88 0.737 . . . . 0.0 112.269 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.13 140.89 5.49 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.379 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -150.34 10.68 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.658 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.3 mmt-85 -146.85 131.81 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.459 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 22.5 t -78.59 126.93 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.77 0.319 . . . . 0.0 110.192 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.811 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -115.85 -13.85 11.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.576 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.57 -149.79 8.9 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.289 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.4 p -140.71 153.16 45.82 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.752 0.311 . . . . 0.0 110.64 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 1.6 t -88.55 60.15 5.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.3 -59.0 3.84 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.163 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 tp -174.58 145.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.833 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 71.58 -39.7 0.46 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.719 0.807 . . . . 0.0 112.949 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m-85 -89.31 130.8 35.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.364 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 9.5 mp -91.62 137.01 32.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -96.01 101.56 13.25 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 91.7 m -100.61 142.77 31.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.838 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.811 ' HB2' ' HD3' ' A' ' 18' ' ' ARG . 70.1 m -121.84 116.07 30.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.03 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 3.0 Cg_exo . . . . . 0 N--CA 1.464 -0.26 0 C-N-CA 122.907 2.405 . . . . 0.0 111.864 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.9 tp . . . . . 0 C--O 1.234 0.274 0 CA-C-O 120.813 0.339 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 12.7 m -86.38 158.15 19.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.572 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.9 p90 -98.95 136.46 38.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.977 0.894 . . . . 0.0 112.952 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.681 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 37.8 t -93.78 121.69 35.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.509 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.681 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.2 mmm180 -133.1 141.73 48.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -82.98 47.76 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.757 0.789 . . . . 0.0 109.715 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.82 -148.87 7.11 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.209 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -94.11 67.75 3.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.1 m 60.15 -151.75 0.4 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.546 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -149.19 110.62 4.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 54.08 45.67 27.05 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.649 0.593 . . . . 0.0 111.836 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.42 132.79 1.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.96 153.85 14.73 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -88.65 117.65 27.77 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.997 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -61.14 129.83 24.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.423 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 7.6 tpt180 -101.76 -40.41 6.97 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.568 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.7 -159.82 27.76 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.583 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 p -94.95 140.2 30.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 0.0 110.922 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.945 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.5 t -104.81 39.08 1.77 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.628 0.727 . . . . 0.0 109.81 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.83 -145.27 16.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.543 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 23' ' ' ILE . 4.1 mp -85.15 118.36 31.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.745 0.307 . . . . 0.0 110.968 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 57.05 46.38 19.34 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.657 0.741 . . . . 0.0 110.829 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.945 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.3 m-85 -144.6 133.34 22.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.868 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.17 133.49 54.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 9.5 t80 -100.74 106.52 17.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 4.8 m -114.85 142.37 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.1 m -99.09 132.98 22.53 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo . . . . . 0 N--CA 1.463 -0.273 0 C-N-CA 122.894 2.396 . . . . 0.0 112.269 -179.68 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 121.221 0.534 . . . . 0.0 111.563 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.67 159.15 26.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.537 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -132.73 142.9 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.902 0.858 . . . . 0.0 112.042 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.695 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 22.8 t -103.93 113.94 27.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.041 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 1.054 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 27.8 mmm180 -137.12 139.43 41.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.927 0.394 . . . . 0.0 110.877 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 37.5 ttmt -68.87 148.92 49.52 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.75 -65.7 2.33 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.792 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 0.5 OUTLIER 179.58 48.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.137 0.494 . . . . 0.0 109.894 179.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 1.054 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 75.6 m 59.2 -158.91 0.3 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.8 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -151.92 147.83 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.4 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 61.14 42.63 12.07 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.832 0.708 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.96 7.91 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.536 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 148.74 19.18 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.282 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -88.7 107.56 19.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 t -60.83 125.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.617 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 52.3 mmm-85 -99.44 -31.06 11.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.506 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.75 -155.58 26.56 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.52 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 p -91.52 140.85 29.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.839 0.352 . . . . 0.0 111.438 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.512 ' HB3' ' CB ' ' A' ' 25' ' ' PHE . 37.0 t -93.57 -137.52 0.19 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.421 ' N ' ' SG ' ' A' ' 21' ' ' CYS . . . -73.25 -147.87 0.98 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 113.464 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.869 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -65.64 99.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.442 0.639 . . . . 0.0 112.325 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 64.34 46.68 3.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.156 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 20.7 m-85 -131.83 150.01 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.787 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 10' ' ' HIS . 4.3 mm? -107.85 143.2 36.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -111.77 112.79 24.73 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.955 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -129.97 145.98 51.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.429 . . . . 0.0 111.238 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 51.9 m -115.32 121.34 34.98 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.704 ' HG2' HD13 ' A' ' 3' ' ' LEU . 20.7 Cg_endo . . . . . 0 N--CA 1.465 -0.189 0 C-N-CA 122.318 2.012 . . . . 0.0 111.271 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.405 ' N ' HD23 ' A' ' 3' ' ' LEU . 2.0 pt? . . . . . 0 C--O 1.232 0.181 0 CA-C-O 121.063 0.459 . . . . 0.0 111.006 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 62.5 m -82.6 155.85 24.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.096 0.474 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 2.3 p90 -108.32 138.96 43.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.967 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.712 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.1 t -87.77 117.76 26.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.712 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.6 mmm180 -133.81 125.38 28.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.985 0.421 . . . . 0.0 111.641 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -84.42 71.85 10.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.343 0.592 . . . . 0.0 109.41 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.37 -82.25 0.06 OUTLIER Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.861 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.787 ' HA ' HD22 ' A' ' 26' ' ' LEU . 11.3 p80 -172.97 61.87 0.03 OUTLIER 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.164 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.654 ' SG ' HG22 ' A' ' 17' ' ' VAL . 13.3 m 59.61 -159.62 0.3 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.883 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 51.9 mtpt -145.17 131.44 19.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.94 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 21.8 ttt85 60.38 29.4 18.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.462 0.649 . . . . 0.0 111.134 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.42 43.75 86.34 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.376 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.88 167.46 51.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.342 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -88.29 117.45 27.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.654 HG22 ' SG ' ' A' ' 11' ' ' CYS . 8.0 t -63.3 131.2 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.244 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 4.8 tpt85 -104.16 -31.69 9.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.443 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.1 -152.47 20.09 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.727 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -108.48 140.65 41.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.539 0.17 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 24.7 p -116.27 30.45 7.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.22 0.534 . . . . 0.0 111.333 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -166.61 28.41 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.32 98.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.548 0.689 . . . . 0.0 110.688 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.64 34.51 4.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.253 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.79 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 19.6 m-85 -112.66 130.46 56.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.055 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 10' ' ' HIS . 7.1 mp -98.97 129.88 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 0.0 111.346 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 4' ' ' CYS . 2.4 t80 -104.04 112.02 24.84 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.533 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 m -131.39 142.09 49.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.081 -177.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -98.68 138.04 20.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.162 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 C--O 1.235 0.327 0 C-N-CA 122.398 2.065 . . . . 0.0 112.003 -179.884 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.528 0.107 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.677 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 4.6 m -69.63 151.26 46.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.011 0.434 . . . . 0.0 110.674 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 2.5 p90 -107.58 140.64 40.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.846 0.832 . . . . 0.0 113.109 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.4 t -87.96 119.66 28.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.623 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.5 mmm180 -129.55 138.96 51.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.419 0.628 . . . . 0.0 112.338 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 1.8 tmtp? -90.16 118.3 29.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.569 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.44 -52.21 3.72 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.424 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -161.59 145.87 12.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.07 0.935 . . . . 0.0 112.562 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.646 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 1.6 m -65.63 154.37 38.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.287 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 16.4 ptmt -119.44 48.69 1.46 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 26.1 tpt180 -174.6 -42.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.086 0.47 . . . . 0.0 110.289 178.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.13 138.06 5.08 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.934 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 51.11 2.79 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.063 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 16' ' ' ARG . 19.8 mmt180 -111.1 70.12 0.7 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.049 0.452 . . . . 0.0 110.475 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 22.3 t -63.96 123.32 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.644 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.533 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 9.9 tpt85 -89.87 -32.14 17.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.776 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.31 -168.55 37.25 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -93.45 138.07 32.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -102.89 120.68 41.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.18 -126.62 31.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.419 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 17.6 pt -136.64 40.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.739 0.304 . . . . 0.0 110.893 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 9.5 tpt180 179.27 -24.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.226 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 1.9 m-85 -88.69 155.33 19.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.11 131.1 48.79 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.408 ' CE2' ' HB2' ' A' ' 4' ' ' CYS . 8.2 t80 -101.13 90.12 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.562 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 1.8 m -100.34 142.84 31.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 18' ' ' ARG . 61.5 m -89.85 145.48 33.4 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.677 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 63.4 Cg_endo . . . . . 0 CA--C 1.53 0.28 0 C-N-CA 122.563 2.175 . . . . 0.0 113.709 -178.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.2 tp . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.5 m -73.83 163.66 27.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -149.41 137.81 20.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.905 0.86 . . . . 0.0 112.528 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.685 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 53.9 t -88.71 124.72 34.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.351 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.685 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.1 mmm180 -132.52 141.12 48.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.319 0.581 . . . . 0.0 112.334 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.589 ' HD3' ' CZ ' ' A' ' 25' ' ' PHE . 51.3 tptt -86.42 53.11 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 122.142 0.972 . . . . 0.0 109.156 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.38 -150.12 8.81 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.911 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -91.56 20.21 5.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.58 0.69 . . . . 0.0 111.154 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.438 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 75.8 m 66.36 143.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.795 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -90.86 158.44 16.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.955 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 32.7 ttm105 78.44 -45.49 0.4 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.144 0.978 . . . . 0.0 111.254 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.13 131.18 2.22 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.881 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.5 51.59 3.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.668 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -87.92 69.18 9.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.107 0.48 . . . . 0.0 109.944 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.68 132.75 27.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.776 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.61 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 78.4 ttt180 -105.3 -35.34 7.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.203 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.23 -162.98 30.78 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.614 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -92.12 138.88 31.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 111.11 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.901 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.7 t -100.09 46.33 0.96 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.597 0.713 . . . . 0.0 110.015 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.19 -140.03 14.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.175 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -75.61 103.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 53.99 49.78 18.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.049 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.901 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.7 m-85 -135.49 146.36 48.06 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 mp -108.31 132.4 53.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.316 0.579 . . . . 0.0 110.954 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -106.58 114.71 28.98 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m -120.96 156.22 32.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 61.8 m -135.14 125.01 16.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo . . . . . 0 CA--C 1.533 0.429 0 C-N-CA 122.881 2.387 . . . . 0.0 112.755 -179.569 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.5 pt? . . . . . 0 C--O 1.236 0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 110.454 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' CYS . . . . . 0.576 ' HB3' ' C ' ' A' ' 28' ' ' CYS . 61.1 m -75.16 163.59 27.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.581 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TYR . . . . . 0.538 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.1 p90 -88.58 141.12 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.591 . . . . 0.0 111.087 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.63 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 41.3 t -97.43 114.22 26.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.016 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.63 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.3 mmm180 -138.58 145.3 40.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 29.2 ttmt -67.32 -31.85 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.556 0.693 . . . . 0.0 109.524 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.56 151.32 52.24 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.152 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' HIS . . . . . 0.93 ' HA ' HD12 ' A' ' 26' ' ' LEU . 45.4 m170 -72.33 68.71 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.542 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 76.7 m 71.16 145.68 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.927 0.767 . . . . 0.0 111.669 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -107.34 31.63 5.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.11 35.73 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.22 -139.4 30.78 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.911 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.71 72.67 1.26 Allowed Glycine 0 CA--C 1.517 0.169 0 C-N-CA 121.595 -0.336 . . . . 0.0 113.391 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -132.59 33.56 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 110.679 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 p -81.88 132.5 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.606 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -113.33 -11.95 13.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.691 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.72 -170.03 43.13 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.4 p -106.19 141.56 37.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 16.4 t -99.93 -140.32 0.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -156.3 1.95 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.491 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 pt -64.62 105.65 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.036 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 66.69 42.36 2.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.952 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 19.4 m-85 -132.76 140.76 48.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.576 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 10' ' ' HIS . 34.2 mt -109.3 145.08 36.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.309 0.576 . . . . 0.0 111.529 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -98.92 94.54 6.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.425 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' CYS . . . . . 0.576 ' C ' ' HB3' ' A' ' 4' ' ' CYS . 10.1 m -119.96 140.48 50.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.385 . . . . 0.0 111.92 -177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 1.6 m -98.69 143.43 26.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.803 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 29' ' ' CYS . 37.2 Cg_exo . . . . . 0 C--N 1.345 0.373 0 C-N-CA 122.912 2.408 . . . . 0.0 112.57 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.079 0 N-CA-C 111.43 -0.668 . . . . 0.0 111.43 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 96.0 mt 49.32 -131.95 1.74 Allowed 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.798 0.299 . . . . 0.0 110.861 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 27.0 tp -110.47 30.64 6.61 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.567 0.699 . . . . 0.0 109.299 178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.408 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 11.2 m -78.21 154.02 31.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.994 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.604 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 3.1 p90 -135.89 140.5 44.15 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.726 0.774 . . . . 0.0 112.516 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.606 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 40.4 t -94.55 122.95 37.67 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.181 -1.372 . . . . 0.0 108.871 179.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 28.2 mmm180 -132.8 133.52 43.5 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.757 0.313 . . . . 0.0 110.826 -179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 25.9 ttpp -72.59 128.49 35.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.964 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 84.35 -53.12 4.8 Favored Glycine 0 C--N 1.317 -0.524 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.307 179.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -168.85 138.49 2.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.827 0.314 . . . . 0.0 110.616 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.604 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 61.4 m -61.2 143.44 55.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.214 179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.437 ' H ' ' HG3' ' A' ' 7' ' ' ARG . 75.4 mmtt -92.81 140.43 29.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.289 179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 20.2 ptt85 43.89 49.6 7.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 124.212 0.945 . . . . 0.0 112.356 -179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -176.07 128.69 1.4 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.631 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.78 42.83 1.74 Allowed Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 111.486 -0.646 . . . . 0.0 111.486 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.496 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 5.6 mmp_? -125.6 63.3 1.2 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.939 0.399 . . . . 0.0 110.427 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.602 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 4.2 p -61.89 130.34 26.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.447 0.641 . . . . 0.0 110.696 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.662 ' NE ' ' HA ' ' A' ' 18' ' ' ARG . 1.9 tpm_? -96.94 -26.71 14.95 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.522 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.37 -176.35 43.39 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.689 179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.1 p -82.7 135.85 34.9 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.963 0.411 . . . . 0.0 111.051 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.602 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 45.8 t -95.21 49.64 1.22 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.67 0.748 . . . . 0.0 109.028 178.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.2 -137.77 13.69 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.634 -0.793 . . . . 0.0 111.201 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.794 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -98.37 125.62 51.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 120.991 0.424 . . . . 0.0 111.706 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 62.47 20.56 12.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.723 179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -129.45 141.73 50.95 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mp -114.68 137.85 51.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.845 0.355 . . . . 0.0 110.5 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.463 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 8.5 t80 -111.45 114.95 28.41 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 83.0 m -117.87 143.79 45.99 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.886 0.374 . . . . 0.0 112.005 -178.425 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 75.0 m -120.3 126.65 26.7 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.075 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.62 48.49 2.42 Favored 'Trans proline' 0 CA--C 1.531 0.36 0 C-N-CA 122.981 2.454 . . . . 0.0 112.704 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.421 ' O ' ' HB2' ' A' ' 32' ' ' ARG . 6.0 tmm_? -98.43 -72.87 0.64 Allowed 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.421 ' HB2' ' O ' ' A' ' 31' ' ' ARG . 53.3 ttt85 . . . . . 0 C--O 1.252 1.197 0 CA-C-O 117.494 -1.241 . . . . 0.0 108.862 179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.794 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 55.1 tp 68.76 -56.51 0.52 Allowed 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.591 0.756 . . . . 0.0 111.969 179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 mp -68.78 144.47 54.33 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.73 0.3 . . . . 0.0 110.846 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 11.7 m -64.73 157.09 28.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.898 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.436 ' HE1' ' HA ' ' A' ' 11' ' ' CYS . 2.5 p90 -131.36 141.73 49.95 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.595 0.712 . . . . 0.0 112.323 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.606 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 48.5 t -87.41 128.91 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.093 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.606 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.8 mmm180 -132.28 136.82 47.19 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.927 0.394 . . . . 0.0 111.455 -178.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 11.1 tptp -68.81 -36.2 77.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.168 0.509 . . . . 0.0 109.964 178.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.47 -87.38 0.46 Allowed Glycine 0 N--CA 1.449 -0.455 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.684 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.486 ' HB3' HD22 ' A' ' 26' ' ' LEU . 32.4 p-80 -179.36 99.5 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 122.781 0.433 . . . . 0.0 109.929 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.436 ' HA ' ' HE1' ' A' ' 5' ' ' TYR . 12.9 m 56.07 -155.74 0.29 Allowed 'General case' 0 C--O 1.236 0.394 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.373 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.429 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 4.9 mmmt -151.81 40.71 0.66 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.269 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 49.3 mmt-85 72.2 -58.23 0.6 Allowed 'General case' 0 N--CA 1.473 0.697 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.013 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -84.53 47.91 3.95 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.065 -0.588 . . . . 0.0 111.677 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.521 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -165.32 142.51 7.77 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.032 -179.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -103.09 134.81 45.9 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.483 ' HA ' ' SG ' ' A' ' 28' ' ' CYS . 3.5 p -57.32 127.24 16.11 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 121.593 0.711 . . . . 0.0 110.996 -179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.416 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 33.8 tpt85 -95.81 -27.17 15.35 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 114.971 -1.013 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 156.36 -155.5 26.37 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.413 -0.812 . . . . 0.0 111.834 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.2 p -88.26 138.03 31.8 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.873 0.368 . . . . 0.0 111.385 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.7 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.9 t -103.68 49.19 0.83 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.517 0.675 . . . . 0.0 109.824 179.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.37 -141.48 15.59 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.502 -179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.7 mt -86.78 112.77 23.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.8 mtm180 60.49 34.96 20.35 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.496 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.7 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.5 m-85 -132.89 146.65 51.99 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD22 ' HB3' ' A' ' 10' ' ' HIS . 7.5 mp -112.99 133.55 54.9 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.333 0.587 . . . . 0.0 110.878 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 7.2 t80 -103.41 128.42 50.54 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' A' ' 17' ' ' VAL . 48.5 m -135.14 146.18 48.54 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.57 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 64.3 m -110.09 131.55 21.93 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.699 178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 81.5 Cg_endo -79.05 -145.92 0.03 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.401 0 C-N-CA 122.635 2.223 . . . . 0.0 112.539 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.454 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -166.28 33.39 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.349 0.595 . . . . 0.0 109.588 179.476 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 48.1 ttt85 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 117.955 -1.022 . . . . 0.0 108.435 179.669 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.693 0 N-CA-C 111.714 -0.554 . . . . 0.0 111.714 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.8 HD23 ' H ' ' A' ' 2' ' ' LEU . 1.4 pt? -77.39 62.01 2.31 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.228 0.537 . . . . 0.0 111.033 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.657 HD13 ' HG2' ' A' ' 30' ' ' PRO . 0.4 OUTLIER -155.49 51.91 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.372 0.606 . . . . 0.0 110.817 -179.638 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.8 m -72.86 159.77 33.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.179 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.484 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 0.9 OUTLIER -144.46 141.82 29.86 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.909 0.862 . . . . 0.0 112.864 -179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.598 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 39.5 t -91.37 126.86 36.6 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.711 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.598 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.9 mmm180 -131.69 137.15 48.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.068 0.461 . . . . 0.0 111.211 -178.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -71.44 128.0 34.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.988 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 77.04 -51.6 3.2 Favored Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.239 -0.892 . . . . 0.0 113.515 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.738 ' HA ' HD12 ' A' ' 26' ' ' LEU . 27.7 p-80 -169.21 146.62 3.61 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 110.294 -0.261 . . . . 0.0 110.294 -179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 71.3 m -66.55 142.72 57.41 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.034 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.5 129.25 39.16 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.578 -178.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 52.8 mmm-85 68.56 -51.25 0.56 Allowed 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 123.989 0.916 . . . . 0.0 112.515 179.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 164.44 -143.47 8.57 Favored Glycine 0 N--CA 1.443 -0.87 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.059 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.23 169.76 15.09 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 11.9 tpt180 -87.66 114.42 24.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.8 t -63.77 124.96 19.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.898 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.68 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 52.3 ttt85 -90.33 -35.69 15.09 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.095 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 166.95 -166.51 39.19 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.599 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.8 p -86.9 137.9 31.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.753 0.311 . . . . 0.0 110.998 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.724 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 35.8 t -99.6 42.6 1.1 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.62 0.724 . . . . 0.0 109.325 179.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.93 -144.37 16.6 Favored Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.911 -178.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.8 tt -90.45 118.67 36.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.02 0.438 . . . . 0.0 111.801 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.6 mtm180 62.98 32.79 15.33 Favored 'General case' 0 N--CA 1.468 0.449 0 CA-C-N 115.624 -0.716 . . . . 0.0 111.976 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.724 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 13.2 m-85 -137.09 139.02 40.98 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.738 HD12 ' HA ' ' A' ' 10' ' ' HIS . 73.8 mt -115.77 138.27 51.29 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.013 0.435 . . . . 0.0 110.843 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.416 ' HB2' ' HB2' ' A' ' 21' ' ' CYS . 9.9 t80 -110.7 116.79 31.91 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.6 m -127.29 156.46 41.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.952 0.406 . . . . 0.0 111.949 -178.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.68 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 58.3 m -122.69 113.29 30.43 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.935 178.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.657 ' HG2' HD13 ' A' ' 3' ' ' LEU . 59.4 Cg_endo -75.68 161.95 36.05 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.505 2.137 . . . . 0.0 111.639 179.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.608 ' HD2' ' H ' ' A' ' 32' ' ' ARG . 0.7 OUTLIER -56.38 -47.39 79.01 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-O 120.73 0.3 . . . . 0.0 111.36 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.608 ' H ' ' HD2' ' A' ' 31' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.983 0 CA-C-O 116.94 -1.505 . . . . 0.0 107.488 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.596 0 N-CA-C 111.74 -0.544 . . . . 0.0 111.74 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.485 HD13 ' HA ' ' A' ' 32' ' ' ARG . 3.8 mm? -76.36 66.78 2.48 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.789 0.328 . . . . 0.0 111.319 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 mp -77.42 54.62 1.17 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 58.1 m -66.26 161.21 22.71 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.822 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.506 ' OH ' ' HA3' ' A' ' 15' ' ' GLY . 4.6 p90 -149.45 141.75 24.15 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.537 0.684 . . . . 0.0 112.029 -178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.664 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 44.5 t -93.52 119.47 32.62 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.968 -1.014 . . . . 0.0 108.577 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.664 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.3 mmm180 -135.16 138.99 44.22 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.062 0.458 . . . . 0.0 111.433 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 13.9 ttpp -83.44 52.24 2.18 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.482 0.658 . . . . 0.0 109.608 178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -172.3 -159.15 18.13 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.958 -179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 17.7 t-160 -85.45 64.11 8.46 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 16.3 m 59.18 -149.68 0.45 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.118 0.485 . . . . 0.0 111.951 178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.504 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 25.5 mtpp -136.02 65.79 1.52 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.021 -179.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 69.15 -100.93 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 O-C-N 123.479 0.487 . . . . 0.0 111.123 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -75.36 66.91 2.24 Favored Glycine 0 N--CA 1.452 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 112.877 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -149.46 132.71 4.15 Favored Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.142 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 37.0 mmt180 -95.45 131.92 41.08 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.4 p -60.22 124.17 14.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.602 0.715 . . . . 0.0 110.806 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 33.8 tpt85 -90.59 -27.74 18.91 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.569 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 160.05 -157.16 28.45 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.201 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -94.37 138.81 31.88 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.017 0.437 . . . . 0.0 111.225 179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 47.2 t -100.03 55.0 0.92 Allowed 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.558 0.694 . . . . 0.0 109.212 179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.66 -134.06 12.08 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.665 -178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.588 HG13 ' HG3' ' A' ' 24' ' ' ARG . 7.2 tp -101.65 124.91 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 121.137 0.494 . . . . 0.0 111.886 -179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.588 ' HG3' HG13 ' A' ' 23' ' ' ILE . 59.5 mtp85 59.87 27.91 17.32 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.298 -0.864 . . . . 0.0 112.671 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.601 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.0 m-85 -135.57 143.06 45.45 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.2 mp -112.3 137.96 49.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.229 0.538 . . . . 0.0 110.864 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.9 t80 -106.39 123.27 47.81 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 22.4 m -131.99 154.96 48.8 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.634 -0.426 . . . . 0.0 111.921 -178.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 41.5 m -127.71 127.9 23.96 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.268 178.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.637 ' HA ' ' HA2' ' A' ' 15' ' ' GLY . 25.8 Cg_endo -63.35 -35.61 60.88 Favored 'Trans proline' 0 C--O 1.233 0.271 0 C-N-CA 122.785 2.324 . . . . 0.0 112.381 -179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -173.39 -154.47 0.07 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.758 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.485 ' HA ' HD13 ' A' ' 2' ' ' LEU . 79.1 mtm-85 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.208 -0.901 . . . . 0.0 109.51 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.571 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 16.8 tp -90.88 139.43 30.76 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.571 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.4 pt? -62.14 135.64 57.59 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.034 0.445 . . . . 0.0 111.368 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.66 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 32.2 m -76.29 161.67 28.55 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.736 179.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 6.9 p90 -125.3 136.13 53.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.871 0.843 . . . . 0.0 112.598 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.579 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 51.7 t -81.02 129.57 34.6 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.769 179.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.579 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.2 mmm180 -132.01 140.5 48.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.088 0.47 . . . . 0.0 112.064 -178.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.555 ' HD3' ' CE1' ' A' ' 25' ' ' PHE . 21.3 tptm -86.8 49.36 1.8 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.161 0.981 . . . . 0.0 109.228 178.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.62 -161.94 35.38 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 114.667 -1.151 . . . . 0.0 111.483 -179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -75.88 64.11 1.79 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.17 0.51 . . . . 0.0 112.023 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.481 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 11.4 m 59.45 -153.94 0.38 Allowed 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.405 179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 10.5 mtpm? -80.3 56.39 2.48 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.331 178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 66.67 51.75 1.05 Allowed 'General case' 0 CA--C 1.529 0.166 0 CA-C-O 121.508 0.671 . . . . 0.0 109.865 -179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.68 -131.4 1.24 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.015 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -168.02 65.12 0.19 Allowed Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.418 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.611 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 4.9 mmp_? -117.87 37.08 4.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.224 0.535 . . . . 0.0 110.488 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.533 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 6.6 p -72.6 136.84 24.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.601 179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.503 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 43.0 mtp85 -124.55 -2.65 7.91 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.816 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.69 178.09 48.38 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.268 -0.968 . . . . 0.0 112.38 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.0 p -95.13 139.36 31.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.864 0.364 . . . . 0.0 110.559 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.2 t -104.56 48.11 0.85 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.538 0.685 . . . . 0.0 109.845 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 93.38 -138.88 14.32 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.302 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 tt -90.77 120.21 39.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-O 121.346 0.593 . . . . 0.0 112.143 -179.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 25.2 mmt85 56.36 38.13 29.45 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 115.244 -0.889 . . . . 0.0 112.559 179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.794 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 11.7 m-85 -138.01 138.82 39.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.08 133.85 50.13 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.077 0.465 . . . . 0.0 111.311 -179.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.561 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 11.6 t80 -97.96 101.09 12.48 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.533 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 57.7 m -105.45 141.37 37.07 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.776 -177.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.503 ' SG ' ' HD3' ' A' ' 18' ' ' ARG . 80.6 m -108.22 143.82 28.19 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.745 178.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.66 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 55.2 Cg_exo -54.24 -51.22 11.1 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.034 2.489 . . . . 0.0 113.578 -178.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -167.35 -51.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 121.048 -0.261 . . . . 0.0 111.265 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.552 -0.737 . . . . 0.0 109.926 -179.8 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.795 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -75.13 -45.77 38.82 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.77 0.319 . . . . 0.0 111.238 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -78.13 130.18 36.07 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.357 -179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 31.7 m -84.49 164.37 18.84 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.782 -0.645 . . . . 0.0 109.494 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.482 ' CD1' ' HD3' ' A' ' 7' ' ' ARG . 0.1 OUTLIER -150.04 147.05 27.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.914 0.864 . . . . 0.0 113.026 -179.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.621 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.0 t -77.49 128.99 35.13 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.597 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.629 ' HE ' ' HB2' ' A' ' 12' ' ' LYS . 27.2 mmm180 -129.56 136.38 49.75 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.337 -0.246 . . . . 0.0 110.337 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -69.67 125.98 28.35 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-O 121.116 0.484 . . . . 0.0 110.124 179.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 73.13 -141.26 29.89 Favored Glycine 0 N--CA 1.45 -0.41 0 CA-C-N 115.199 -0.91 . . . . 0.0 111.854 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -65.06 144.93 56.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.83 0.315 . . . . 0.0 110.317 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 70.0 m -47.81 139.02 7.97 Favored 'General case' 0 C--N 1.329 -0.296 0 O-C-N 123.701 0.626 . . . . 0.0 112.208 -179.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.629 ' HB2' ' HE ' ' A' ' 7' ' ' ARG . 49.2 mmtm -112.02 120.68 42.71 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.232 179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 24.1 tpp180 71.42 -48.42 0.67 Allowed 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.968 0.792 . . . . 0.0 111.962 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.853 ' HA2' ' HA ' ' A' ' 30' ' ' PRO . . . -59.57 -41.03 97.09 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 121.414 -0.422 . . . . 0.0 112.745 -179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 76.89 -56.57 3.52 Favored Glycine 0 CA--C 1.519 0.33 0 C-N-CA 121.517 -0.373 . . . . 0.0 113.774 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 19.3 tpp85 -89.89 119.63 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.366 0.603 . . . . 0.0 111.441 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.6 p -72.58 138.3 21.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.997 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.7 tpm_? -98.68 -30.46 12.45 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.422 179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.06 -168.55 41.69 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.596 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 1.7 p -88.63 142.33 27.78 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.921 0.361 . . . . 0.0 111.2 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.517 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 49.3 t -113.98 47.58 1.18 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.6 0.714 . . . . 0.0 109.253 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 -137.8 14.0 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.587 -0.816 . . . . 0.0 111.894 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.0 pt -98.31 126.89 51.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.937 0.398 . . . . 0.0 112.007 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.8 mmt180 61.39 20.55 11.23 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.351 179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.517 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 14.8 m-85 -134.44 139.42 45.52 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 10.5 mp -121.82 135.63 54.91 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.304 0.574 . . . . 0.0 110.507 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.7 t80 -89.75 122.93 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.2 m -135.53 152.58 51.45 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.104 -0.638 . . . . 0.0 112.133 -177.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 66.5 m -110.23 123.67 35.37 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.634 179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.853 ' HA ' ' HA2' ' A' ' 14' ' ' GLY . 39.6 Cg_endo -68.91 110.94 2.5 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.561 2.174 . . . . 0.0 112.969 -179.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 14.8 tpp85 -88.65 36.71 0.81 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.805 0.812 . . . . 0.0 109.69 178.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.0 tpt180 . . . . . 0 C--O 1.24 0.593 0 CA-C-N 114.936 -1.029 . . . . 0.0 108.407 179.552 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.588 0 N-CA-C 111.814 -0.514 . . . . 0.0 111.814 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 77.5 mt -144.88 -59.89 0.36 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 93.7 mt -89.3 52.44 2.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.296 0.57 . . . . 0.0 109.555 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 36.2 m -88.81 164.89 15.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.28 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -139.34 128.86 24.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.464 0.65 . . . . 0.0 110.713 179.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.576 ' C ' ' HD2' ' A' ' 7' ' ' ARG . 24.0 p -94.19 134.68 36.39 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.599 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.576 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.3 mpt_? -135.29 138.76 43.8 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.185 -179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.4 ' C ' ' HD3' ' A' ' 8' ' ' LYS . 1.7 tmtm? -74.63 -43.95 52.88 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.368 -178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -71.94 -61.56 3.71 Favored Glycine 0 C--N 1.319 -0.395 0 CA-C-N 115.765 -0.652 . . . . 0.0 113.512 -178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t-80 -174.71 149.95 1.27 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 8.5 m -52.31 142.48 16.94 Favored 'General case' 0 C--N 1.328 -0.354 0 O-C-N 123.576 0.548 . . . . 0.0 110.678 179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 73.7 mmtt -95.95 138.05 34.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.512 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 63.8 mtp85 63.23 -143.89 0.35 Allowed 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.748 0.655 . . . . 0.0 110.744 -179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -83.61 43.34 3.14 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.874 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.86 134.58 12.6 Favored Glycine 0 N--CA 1.448 -0.529 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.585 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 24.0 mmt85 -111.81 139.22 47.47 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.419 ' O ' ' HD2' ' A' ' 18' ' ' ARG . 19.7 m -62.47 139.2 21.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-O 121.315 0.579 . . . . 0.0 112.118 -179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.419 ' HD2' ' O ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -129.93 -32.29 1.87 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.212 179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.33 -150.33 6.1 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.913 -0.661 . . . . 0.0 111.839 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -127.72 142.54 51.3 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.861 0.362 . . . . 0.0 111.344 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.963 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 13.2 t -91.02 42.61 1.11 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 179.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.19 -135.63 12.43 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.039 -178.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.9 tt -87.6 118.59 33.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.166 0.507 . . . . 0.0 112.252 -179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 10.6 mpt_? 60.44 27.24 16.84 Favored 'General case' 0 N--CA 1.472 0.66 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 178.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.963 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 7.9 m-85 -122.69 138.61 54.56 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.5 mp -101.22 132.37 46.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.846 0.355 . . . . 0.0 111.398 -179.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 8.5 t80 -98.65 113.37 25.4 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.06 147.16 40.51 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.133 0.492 . . . . 0.0 112.235 -177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 74.6 m -120.55 140.04 29.78 Favored Pre-proline 0 C--N 1.322 -0.596 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.409 ' C ' ' HD2' ' A' ' 31' ' ' ARG . 32.0 Cg_exo -58.37 -42.18 58.32 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.653 2.236 . . . . 0.0 112.622 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.409 ' HD2' ' C ' ' A' ' 30' ' ' PRO . 1.3 mpt_? -143.2 -114.55 0.11 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.87 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.0 mtp85 . . . . . 0 C--O 1.247 0.949 0 CA-C-O 118.363 -0.827 . . . . 0.0 110.784 -179.825 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.557 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -164.24 -170.01 1.97 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 97.6 mt -71.73 128.66 36.5 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.943 0.401 . . . . 0.0 111.151 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.429 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 19.1 m -99.74 160.74 14.07 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.532 ' CE1' ' HB2' ' A' ' 12' ' ' LYS . 0.3 OUTLIER -145.07 148.82 34.1 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.637 0.732 . . . . 0.0 112.381 -178.825 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.638 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 7.8 p -93.81 124.98 38.17 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.266 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.638 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.6 mmm180 -128.58 141.84 51.24 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 39.5 ttpt -66.23 -29.08 69.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.104 0.478 . . . . 0.0 111.386 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -82.75 -158.87 25.54 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.321 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -81.26 58.6 3.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.623 -0.339 . . . . 0.0 110.556 179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' SG ' HG22 ' A' ' 17' ' ' VAL . 15.8 m 60.82 -153.28 0.38 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.766 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.532 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 8.7 mmmm -156.84 135.87 11.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.978 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.615 ' HD2' ' HB3' ' A' ' 30' ' ' PRO . 44.1 ttm180 75.63 -34.5 0.25 Allowed 'General case' 0 N--CA 1.472 0.663 0 O-C-N 124.028 0.83 . . . . 0.0 111.9 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -155.48 -146.8 4.53 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.756 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -150.94 43.83 0.69 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.479 -0.867 . . . . 0.0 112.216 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.743 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 78.1 ttt180 -88.63 70.58 8.85 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.417 HG22 ' SG ' ' A' ' 11' ' ' CYS . 11.7 t -67.91 132.9 32.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.994 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HD3' ' SG ' ' A' ' 29' ' ' CYS . 75.4 mtp180 -115.2 -23.45 8.95 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.055 179.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 171.56 -143.89 7.83 Favored Glycine 0 CA--C 1.504 -0.609 0 C-N-CA 120.239 -0.981 . . . . 0.0 112.343 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 12.0 p -128.91 156.19 44.11 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.753 0.311 . . . . 0.0 110.526 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.482 ' HB2' ' HB2' ' A' ' 6' ' ' CYS . 1.6 t -88.62 40.56 0.97 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.813 -0.439 . . . . 0.0 109.813 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.88 -57.78 3.51 Favored Glycine 0 CA--C 1.507 -0.411 0 CA-C-O 121.872 0.707 . . . . 0.0 111.925 -178.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.8 pt -83.32 -160.66 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.306 -1.321 0 CA-C-N 114.359 -0.921 . . . . 0.0 110.396 178.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.456 ' HA ' ' NE ' ' A' ' 24' ' ' ARG . 15.8 mmp_? -80.86 51.06 1.46 Allowed 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 121.043 0.449 . . . . 0.0 111.734 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 8' ' ' LYS . 6.3 m-85 -129.23 135.66 49.09 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 6.5 mp -89.28 128.69 35.88 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.902 0.382 . . . . 0.0 110.429 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 32.4 t80 -89.75 112.55 23.88 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 m -135.51 153.27 51.79 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.17 0.51 . . . . 0.0 111.562 -178.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.743 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 79.6 m -98.86 142.12 24.06 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.615 ' HB3' ' HD2' ' A' ' 13' ' ' ARG . 54.1 Cg_exo -53.94 -42.78 63.89 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.93 2.42 . . . . 0.0 113.092 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.439 ' HB3' ' H ' ' A' ' 32' ' ' ARG . 91.6 mtt180 -154.73 -153.33 0.45 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.337 179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 31' ' ' ARG . 20.3 mtp-105 . . . . . 0 C--O 1.247 0.95 0 CA-C-O 118.372 -0.823 . . . . 0.0 110.341 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 N-CA-C 111.653 -0.579 . . . . 0.0 111.653 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.6 mt -89.05 -44.58 10.26 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.76 0.314 . . . . 0.0 111.373 -179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 48.6 tp -79.92 132.46 36.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.209 -179.398 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 68.6 m -89.52 165.84 14.04 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.812 179.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.461 ' HD1' ' O ' ' A' ' 5' ' ' TYR . 0.2 OUTLIER -134.82 142.48 46.66 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.229 0.538 . . . . 0.0 110.592 177.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.626 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 17.6 p -90.33 127.98 36.32 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.023 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.626 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.8 mmm180 -130.55 149.99 51.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.27 -178.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HZ2' ' HE1' ' A' ' 25' ' ' PHE . 49.0 tttp -69.41 113.53 6.81 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 117.43 178.5 17.56 Favored Glycine 0 C--N 1.314 -0.676 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 -178.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 19.2 t-160 -76.62 69.53 3.04 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 117.109 0.454 . . . . 0.0 111.706 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.473 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 32.5 m 69.93 147.94 0.07 Allowed 'General case' 0 N--CA 1.468 0.435 0 O-C-N 123.625 0.578 . . . . 0.0 112.085 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.498 ' HB2' ' HG3' ' A' ' 7' ' ' ARG . 30.3 mmtp -132.5 117.19 17.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.148 179.243 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.6 mmm-85 56.29 44.17 25.22 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.918 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.667 ' HA2' ' N ' ' A' ' 31' ' ' ARG . . . -141.13 -133.21 2.9 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.264 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 168.53 -46.37 0.23 Allowed Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.384 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.734 ' HG3' ' HB2' ' A' ' 29' ' ' CYS . 23.7 ptt-85 -89.3 99.53 12.51 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.415 0.626 . . . . 0.0 111.255 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.473 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 2.5 p -92.82 142.88 12.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.063 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.13 23.07 0.85 Allowed 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.815 -0.354 . . . . 0.0 111.256 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.46 ' C ' ' HB3' ' A' ' 27' ' ' TYR . . . -178.0 -169.86 39.47 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 119.884 -1.151 . . . . 0.0 113.13 179.052 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.513 HG22 HD13 ' A' ' 26' ' ' LEU . 7.7 p -141.57 157.62 44.87 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 122.719 0.408 . . . . 0.0 109.914 179.35 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.956 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 3.8 t -117.21 38.8 3.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.404 0.621 . . . . 0.0 109.622 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 101.98 -144.63 16.38 Favored Glycine 0 N--CA 1.446 -0.647 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.224 -179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.468 HG12 ' HG2' ' A' ' 24' ' ' ARG . 10.6 tt -82.76 123.43 38.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 121.203 0.525 . . . . 0.0 112.015 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.468 ' HG2' HG12 ' A' ' 23' ' ' ILE . 26.2 mmm180 61.0 36.35 18.62 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.448 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.956 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.0 m-85 -137.58 127.02 24.91 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.328 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.513 HD13 HG22 ' A' ' 20' ' ' THR . 4.4 mm? -110.67 137.99 47.63 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.031 0.443 . . . . 0.0 111.387 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 6' ' ' CYS . 42.6 t80 -98.81 103.13 15.06 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 17' ' ' VAL . 1.5 m -133.33 155.74 48.88 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.151 -177.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.734 ' HB2' ' HG3' ' A' ' 16' ' ' ARG . 1.6 m -88.18 142.99 32.17 Favored Pre-proline 0 C--N 1.32 -0.7 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.893 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 32' ' ' ARG . 17.2 Cg_endo -58.42 152.5 53.88 Favored 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 123.283 2.655 . . . . 0.0 112.662 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.667 ' N ' ' HA2' ' A' ' 14' ' ' GLY . 35.7 ttt85 -78.33 53.28 1.24 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 179.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.509 ' HG2' ' HB2' ' A' ' 30' ' ' PRO . 31.8 ptt180 . . . . . 0 C--O 1.258 1.54 0 CA-C-N 114.769 -1.105 . . . . 0.0 108.611 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' O ' ' HG2' ' A' ' 30' ' ' PRO . . . . . . . . 0 N--CA 1.484 1.851 0 N-CA-C 111.707 -0.557 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -96.97 -36.92 10.38 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.771 0.319 . . . . 0.0 111.02 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.68 133.41 55.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.395 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 24.1 m -71.5 161.47 30.98 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.492 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -146.96 146.5 30.12 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.837 0.827 . . . . 0.0 112.664 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.648 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.7 t -80.93 126.06 30.9 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.209 179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.648 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.3 mmm180 -130.72 128.49 40.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.956 0.408 . . . . 0.0 111.165 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 36.1 ttpt -83.03 85.04 7.25 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.02 -111.27 0.45 Allowed Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.338 -179.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 75.8 m-70 -142.61 53.57 1.41 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.746 0.308 . . . . 0.0 110.565 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 56.7 m 63.48 -163.91 0.26 Allowed 'General case' 0 C--O 1.236 0.369 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.909 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.441 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 65.2 mmtt -155.88 146.07 21.58 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 17.5 mmt85 73.91 -24.02 0.21 Allowed 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 123.076 0.551 . . . . 0.0 111.356 -178.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.435 ' H ' ' C ' ' A' ' 12' ' ' LYS . . . 170.76 149.49 6.48 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.08 53.62 2.2 Favored Glycine 0 CA--C 1.519 0.32 0 C-N-CA 121.343 -0.456 . . . . 0.0 112.825 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 73.2 mtt85 -89.24 65.41 7.27 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.128 0.489 . . . . 0.0 110.018 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.9 m -62.05 132.5 27.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.425 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 13.2 tpt180 -102.67 -35.45 8.69 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.436 179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.04 -167.98 40.62 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.437 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.7 p -90.82 139.4 30.77 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.982 0.42 . . . . 0.0 110.906 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.557 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 48.1 t -106.89 46.74 0.91 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.72 0.771 . . . . 0.0 109.24 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.67 -136.92 13.53 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.56 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.779 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -99.79 125.91 53.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-O 121.093 0.473 . . . . 0.0 111.703 -179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 75.1 mtp180 60.88 25.72 15.64 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.414 -0.812 . . . . 0.0 112.687 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 17.1 m-85 -135.16 136.55 41.95 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.211 -0.662 . . . . 0.0 109.211 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -114.5 135.03 54.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.176 0.512 . . . . 0.0 111.2 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -93.97 121.54 35.56 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 178.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.4 m -132.16 156.35 46.57 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.65 -0.42 . . . . 0.0 111.707 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 69.6 m -118.94 128.8 25.76 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.666 179.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 31' ' ' ARG . 84.5 Cg_endo -84.62 -135.1 0.02 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.847 2.365 . . . . 0.0 112.234 179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.425 ' HD2' ' HA ' ' A' ' 31' ' ' ARG . 26.2 tpt180 -175.41 -43.47 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.104 0.478 . . . . 0.0 110.106 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.2 ptm180 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 117.558 -1.21 . . . . 0.0 109.95 179.866 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.75 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 94.3 mt 71.41 -60.86 0.5 Allowed 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.592 0.757 . . . . 0.0 111.805 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.54 ' O ' ' HD2' ' A' ' 30' ' ' PRO . 6.9 mp -74.72 110.14 8.77 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 72.6 m -150.95 167.73 26.71 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.922 -179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.683 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.5 p90 -153.59 133.81 13.39 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.789 0.804 . . . . 0.0 111.743 179.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.519 ' O ' ' HG3' ' A' ' 7' ' ' ARG . 24.6 t -92.2 120.94 33.25 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.437 -1.256 . . . . 0.0 109.077 179.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.639 ' HD3' ' CD1' ' A' ' 5' ' ' TYR . 11.4 mtp-105 -151.11 141.42 22.36 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.863 0.363 . . . . 0.0 111.731 -178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.463 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 35.0 ttpt -82.18 52.07 1.92 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.593 0.711 . . . . 0.0 109.729 178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.86 159.74 27.47 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.223 -0.899 . . . . 0.0 111.969 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 16.5 p-80 -49.64 148.33 3.01 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.026 0.441 . . . . 0.0 111.687 -179.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 3.3 m -56.99 161.41 3.01 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.356 -0.838 . . . . 0.0 112.159 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -71.61 128.32 35.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.229 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 59.82 23.58 12.54 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 113.312 0.856 . . . . 0.0 113.312 178.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.05 -137.48 4.69 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 119.821 -1.18 . . . . 0.0 113.07 179.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -161.66 56.73 0.3 Allowed Glycine 0 N--CA 1.445 -0.709 0 C-N-CA 121.272 -0.489 . . . . 0.0 111.963 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 53.3 ttm-85 -87.72 63.09 7.33 Favored 'General case' 0 C--O 1.239 0.519 0 CA-C-O 121.513 0.673 . . . . 0.0 109.828 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.3 t -69.89 131.48 34.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 114.922 -1.035 . . . . 0.0 110.162 -179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HA ' ' HD2' ' A' ' 18' ' ' ARG . 41.7 mmm-85 -106.33 -23.64 12.49 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.882 0.372 . . . . 0.0 110.415 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.81 -171.35 38.87 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.599 -0.81 . . . . 0.0 111.842 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.5 p -104.25 140.64 37.56 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.728 0.299 . . . . 0.0 110.313 179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 34.7 t -104.65 47.9 0.86 Allowed 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.605 0.717 . . . . 0.0 109.668 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.23 -137.08 13.04 Favored Glycine 0 N--CA 1.444 -0.83 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.178 -179.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.42 ' O ' ' HD1' ' A' ' 25' ' ' PHE . 64.3 mt -90.95 116.6 32.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 111.911 0.338 . . . . 0.0 111.911 -179.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 56.2 mmm-85 66.59 -0.57 1.52 Allowed 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.701 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 10.2 m-85 -95.07 135.42 36.63 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.823 0.344 . . . . 0.0 110.511 179.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -101.58 133.62 45.98 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.553 -179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -100.61 91.25 4.57 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.683 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 66.7 m -96.62 149.87 21.3 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.489 -178.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.519 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 61.5 m -133.33 118.86 15.11 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 178.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.54 ' HD2' ' O ' ' A' ' 3' ' ' LEU . 95.9 Cg_endo -79.7 26.8 0.55 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.901 2.401 . . . . 0.0 112.282 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 67.8 mmt-85 -153.26 145.92 24.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.592 -0.731 . . . . 0.0 109.13 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 . . . . . 0 C--O 1.245 0.842 0 CA-C-O 118.103 -0.951 . . . . 0.0 110.047 179.818 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.984 0 N-CA-C 112.109 -0.397 . . . . 0.0 112.109 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.0 mt -74.61 159.36 32.24 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 122.529 0.331 . . . . 0.0 110.649 179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.09 135.71 47.85 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 67.6 m -83.14 166.22 18.85 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.47 179.456 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.43 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 33.2 p90 -135.27 127.24 29.61 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.891 0.853 . . . . 0.0 111.601 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.699 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 15.8 t -87.13 115.45 24.53 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.319 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.699 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.8 mmm180 -141.07 142.68 34.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.693 -179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -90.23 122.33 33.06 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 145.6 -102.81 0.27 Allowed Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.637 -0.792 . . . . 0.0 111.853 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.44 ' HA ' HD22 ' A' ' 26' ' ' LEU . 0.6 OUTLIER -159.44 40.63 0.21 Allowed 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 179.558 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.578 ' HB2' ' HA2' ' A' ' 15' ' ' GLY . 83.2 m 69.66 150.06 0.08 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.087 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -104.59 131.59 51.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.311 179.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 28.5 tpt180 65.24 56.77 0.97 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.406 0.622 . . . . 0.0 110.542 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 102.26 134.77 8.53 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.645 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 11' ' ' CYS . . . -77.64 66.44 3.02 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 121.727 -0.273 . . . . 0.0 112.921 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -88.14 58.84 4.98 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 122.622 -0.34 . . . . 0.0 110.7 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.48 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 20.7 t -71.38 127.2 33.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.885 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.48 ' HD2' ' C ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -130.19 2.53 4.72 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 121.004 -0.278 . . . . 0.0 110.885 179.815 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.75 -178.68 48.44 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.933 -0.651 . . . . 0.0 111.878 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.6 p -109.84 139.51 44.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.636 0.255 . . . . 0.0 110.327 179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 52.1 t -104.35 111.66 24.38 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.596 -0.52 . . . . 0.0 109.596 179.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 63.56 -126.68 35.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.418 -0.896 . . . . 0.0 111.222 -178.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 23' ' ' ILE . 10.9 tp -140.75 37.39 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.334 1.064 . . . . 0.0 109.543 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.714 ' HG3' ' HD1' ' A' ' 25' ' ' PHE . 38.7 ptt180 -172.26 2.11 0.01 OUTLIER 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.273 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.714 ' HD1' ' HG3' ' A' ' 24' ' ' ARG . 5.6 m-85 -129.91 160.06 34.74 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.718 0.294 . . . . 0.0 110.631 -179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.44 HD22 ' HA ' ' A' ' 10' ' ' HIS . 7.1 mp -102.1 134.77 44.82 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.085 179.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -95.53 96.13 8.86 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.43 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.0 m -94.61 139.18 31.54 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.662 -177.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 51.1 m -134.68 120.44 14.44 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.716 179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.521 ' O ' ' HG3' ' A' ' 31' ' ' ARG . 35.0 Cg_exo -60.39 -46.02 19.79 Favored 'Trans proline' 0 N--CA 1.465 -0.202 0 C-N-CA 122.251 1.968 . . . . 0.0 110.582 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.521 ' HG3' ' O ' ' A' ' 30' ' ' PRO . 32.7 mtp180 -167.49 120.72 0.94 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 114.512 -1.222 . . . . 0.0 107.77 179.005 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.037 0 CA-C-O 117.94 -1.028 . . . . 0.0 110.587 -179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.813 0 N-CA-C 112.225 -0.35 . . . . 0.0 112.225 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.423 HD13 ' HA ' ' A' ' 32' ' ' ARG . 3.3 mm? 61.01 42.73 12.26 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.098 0.475 . . . . 0.0 110.832 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.876 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -80.13 54.74 2.0 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.195 179.962 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 81.2 m -77.88 164.53 25.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.663 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.485 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.0 p90 -157.23 137.17 12.5 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.632 0.73 . . . . 0.0 111.808 179.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.652 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 52.9 t -89.58 121.95 32.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.214 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.652 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 29.1 mmm180 -136.0 132.29 36.11 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.663 0.268 . . . . 0.0 111.02 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 36.2 ttmt -70.14 -29.69 66.67 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.31 0.576 . . . . 0.0 110.629 179.253 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -78.55 -110.16 0.2 Allowed Glycine 0 N--CA 1.45 -0.376 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.584 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 77.2 m-70 -143.1 67.41 1.3 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.918 0.389 . . . . 0.0 110.468 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 29.2 m 63.9 -150.54 0.31 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.986 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 14.3 mmmt -136.14 44.08 2.47 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.615 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -168.4 -37.08 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.643 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 171.83 -62.86 0.15 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.339 -0.934 . . . . 0.0 112.829 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -172.81 52.04 0.16 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.921 -179.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.546 ' HG2' ' HA ' ' A' ' 30' ' ' PRO . 36.1 tpt85 -89.45 44.7 1.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.0 t -63.89 137.67 24.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.897 -178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.8 tpm_? -107.18 -33.59 7.39 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.398 -0.819 . . . . 0.0 109.325 179.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.37 -163.46 29.81 Favored Glycine 0 N--CA 1.447 -0.575 0 CA-C-N 115.47 -0.787 . . . . 0.0 111.535 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.3 p -92.4 140.5 29.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.994 0.426 . . . . 0.0 111.371 179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.715 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 46.8 t -108.51 44.94 1.06 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.624 0.726 . . . . 0.0 109.475 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 94.8 -139.86 14.73 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.14 -179.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.849 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -92.88 123.86 45.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.112 0.482 . . . . 0.0 111.861 -179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 54.68 42.84 30.95 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.409 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.715 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 15.2 m-85 -148.1 134.79 19.91 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.653 179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -109.04 132.2 54.34 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.996 0.427 . . . . 0.0 110.136 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 10.2 t80 -97.3 115.9 28.5 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.485 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 14.9 m -112.61 148.09 35.31 Favored 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.953 -178.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 73.2 m -142.02 112.66 6.26 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.775 178.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.765 ' HB2' ' HD3' ' A' ' 31' ' ' ARG . 19.9 Cg_exo -66.14 -42.76 10.06 Favored 'Trans proline' 0 C--O 1.233 0.246 0 C-N-CA 122.884 2.389 . . . . 0.0 111.566 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.765 ' HD3' ' HB2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -168.03 159.86 11.55 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.176 179.051 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.423 ' HA ' HD13 ' A' ' 2' ' ' LEU . 3.4 ptp180 . . . . . 0 C--O 1.247 0.971 0 CA-C-O 119.051 -0.5 . . . . 0.0 111.29 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.908 0 N-CA-C 111.266 -0.734 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.626 ' HB2' ' HB2' ' A' ' 30' ' ' PRO . 3.3 mm? -71.11 142.41 50.78 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.88 152.93 38.85 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.797 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 38.5 m -72.19 161.75 30.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.612 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 37.3 p90 -152.34 138.6 18.4 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.146 0.498 . . . . 0.0 111.043 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.539 ' HA ' ' O ' ' A' ' 26' ' ' LEU . 27.2 p -107.15 117.77 34.96 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.945 -0.57 . . . . 0.0 109.999 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.442 ' HD2' ' C ' ' A' ' 6' ' ' CYS . 1.0 OUTLIER -144.18 150.46 38.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.792 0.329 . . . . 0.0 110.718 -179.26 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -68.85 104.16 1.98 Allowed 'General case' 0 C--O 1.235 0.334 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.417 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 163.11 -117.59 0.77 Allowed Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.342 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.423 ' HA ' HD22 ' A' ' 26' ' ' LEU . 32.1 p-80 -166.87 57.08 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 58.6 m 74.28 146.69 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.639 -179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' A' ' 13' ' ' ARG . 14.5 mmmm -93.54 112.97 24.99 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.47 -179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 12' ' ' LYS . 55.2 mmt-85 71.09 -53.52 0.68 Allowed 'General case' 0 N--CA 1.47 0.531 0 O-C-N 123.88 0.737 . . . . 0.0 112.269 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -175.13 140.89 5.49 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.379 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 175.89 -150.34 10.68 Favored Glycine 0 N--CA 1.446 -0.7 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.658 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 70.3 mmt-85 -146.85 131.81 18.16 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.459 ' C ' ' HD2' ' A' ' 18' ' ' ARG . 22.5 t -78.59 126.93 38.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 120.77 0.319 . . . . 0.0 110.192 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.811 ' HD3' ' HB2' ' A' ' 29' ' ' CYS . 0.2 OUTLIER -115.85 -13.85 11.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.576 -179.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.57 -149.79 8.9 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.152 -1.023 . . . . 0.0 112.289 179.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 6.4 p -140.71 153.16 45.82 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.752 0.311 . . . . 0.0 110.64 179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.52 ' HB3' ' HB2' ' A' ' 25' ' ' PHE . 1.6 t -88.55 60.15 5.48 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.3 -59.0 3.84 Favored Glycine 0 CA--C 1.504 -0.647 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.163 -178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.2 tp -174.58 145.44 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.23 0 CA-C-N 115.079 -0.561 . . . . 0.0 110.833 179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 43.2 ttm180 71.58 -39.7 0.46 Allowed 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 123.719 0.807 . . . . 0.0 112.949 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' HB2' ' HB3' ' A' ' 21' ' ' CYS . 3.0 m-85 -89.31 130.8 35.64 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.364 -179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 6' ' ' CYS . 9.5 mp -91.62 137.01 32.71 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.931 0.396 . . . . 0.0 110.923 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -96.01 101.56 13.25 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 91.7 m -100.61 142.77 31.62 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.838 -178.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.811 ' HB2' ' HD3' ' A' ' 18' ' ' ARG . 70.1 m -121.84 116.07 30.41 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.03 178.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.626 ' HB2' ' HB2' ' A' ' 2' ' ' LEU . 3.0 Cg_exo -77.14 -22.79 10.96 Favored 'Trans proline' 0 N--CA 1.464 -0.26 0 C-N-CA 122.907 2.405 . . . . 0.0 111.864 -179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.535 ' HG3' ' H ' ' A' ' 32' ' ' ARG . 5.5 ptp85 -61.84 -48.94 78.3 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.585 -179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.568 ' HA ' ' NE ' ' A' ' 32' ' ' ARG . 4.2 mmp_? . . . . . 0 C--O 1.247 0.924 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.694 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.655 HD23 ' H ' ' A' ' 2' ' ' LEU . 2.2 pt? -67.66 -38.65 84.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.848 0.356 . . . . 0.0 110.994 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 53.9 tp -76.19 127.81 33.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.774 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 27' ' ' TYR . 12.7 m -86.38 158.15 19.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.572 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.573 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 9.9 p90 -98.95 136.46 38.89 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.977 0.894 . . . . 0.0 112.952 -178.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.681 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 37.8 t -93.78 121.69 35.49 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.457 -1.247 . . . . 0.0 108.509 178.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.681 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.2 mmm180 -133.1 141.73 48.33 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.079 0.466 . . . . 0.0 112.163 -178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -82.98 47.76 1.27 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.757 0.789 . . . . 0.0 109.715 178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -175.82 -148.87 7.11 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.2 -0.909 . . . . 0.0 112.209 -179.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 59.6 m-70 -94.11 67.75 3.66 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 -179.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 11.1 m 60.15 -151.75 0.4 Allowed 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.546 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 mmmm -149.19 110.62 4.45 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.125 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 53.0 mmt-85 54.08 45.67 27.05 Favored 'General case' 0 N--CA 1.467 0.41 0 O-C-N 123.649 0.593 . . . . 0.0 111.836 179.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.42 132.79 1.4 Allowed Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.586 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -176.96 153.85 14.73 Favored Glycine 0 N--CA 1.444 -0.774 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 18.6 tpt180 -88.65 117.65 27.77 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.743 -0.383 . . . . 0.0 109.997 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 15.6 m -61.14 129.83 24.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.423 179.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 18' ' ' ARG . 7.6 tpt180 -101.76 -40.41 6.97 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.568 -179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 175.7 -159.82 27.76 Favored Glycine 0 N--CA 1.446 -0.634 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.583 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 2.6 p -94.95 140.2 30.27 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.873 0.368 . . . . 0.0 110.922 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.945 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 29.5 t -104.81 39.08 1.77 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.628 0.727 . . . . 0.0 109.81 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.83 -145.27 16.09 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.543 -179.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.412 ' N ' HD12 ' A' ' 23' ' ' ILE . 4.1 mp -85.15 118.36 31.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-O 120.745 0.307 . . . . 0.0 110.968 -179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 57.05 46.38 19.34 Favored 'General case' 0 CA--C 1.531 0.217 0 CA-C-O 121.657 0.741 . . . . 0.0 110.829 179.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.945 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 12.3 m-85 -144.6 133.34 22.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.868 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.2 mp -112.17 133.49 54.28 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 4' ' ' CYS . 9.5 t80 -100.74 106.52 17.96 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.573 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 4.8 m -114.85 142.37 46.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.968 0.413 . . . . 0.0 111.074 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 61.1 m -99.09 132.98 22.53 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.286 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -70.17 156.17 62.9 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.894 2.396 . . . . 0.0 112.269 -179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.643 ' H ' ' HD2' ' A' ' 31' ' ' ARG . 0.3 OUTLIER -61.76 -23.54 66.24 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.155 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 32.1 ptt85 . . . . . 0 C--O 1.245 0.852 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.419 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' HA3' ' OXT' ' A' ' 32' ' ' ARG . . . . . . . . 0 N--CA 1.48 1.599 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.5 mt -80.01 -44.03 20.9 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.649 0.261 . . . . 0.0 111.116 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.704 HD13 ' HG2' ' A' ' 30' ' ' PRO . 0.5 OUTLIER -150.25 45.59 0.89 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.221 0.534 . . . . 0.0 111.563 -179.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 17.1 m -79.67 159.15 26.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.537 179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -132.73 142.9 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.902 0.858 . . . . 0.0 112.042 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.695 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 22.8 t -103.93 113.94 27.84 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.117 -1.401 . . . . 0.0 109.041 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 1.054 ' HB2' ' HA ' ' A' ' 11' ' ' CYS . 27.8 mmm180 -137.12 139.43 41.21 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.927 0.394 . . . . 0.0 110.877 -179.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.444 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 37.5 ttmt -68.87 148.92 49.52 Favored 'General case' 0 C--O 1.238 0.465 0 CA-C-O 121.593 0.711 . . . . 0.0 111.344 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 91.75 -65.7 2.33 Favored Glycine 0 C--N 1.319 -0.407 0 CA-C-N 114.68 -1.145 . . . . 0.0 112.792 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.444 ' HA ' ' HG ' ' A' ' 26' ' ' LEU . 0.5 OUTLIER 179.58 48.64 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.137 0.494 . . . . 0.0 109.894 179.412 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 1.054 ' HA ' ' HB2' ' A' ' 7' ' ' ARG . 75.6 m 59.2 -158.91 0.3 Allowed 'General case' 0 C--O 1.24 0.586 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.8 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.6 mmtm -151.92 147.83 27.04 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.4 -178.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 75.4 mtt85 61.14 42.63 12.07 Favored 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.832 0.708 . . . . 0.0 110.821 -179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.81 -118.96 7.91 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.536 -179.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 89.26 148.74 19.18 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.282 179.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -88.7 107.56 19.01 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 179.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.8 t -60.83 125.96 17.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.617 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HG3' ' SG ' ' A' ' 29' ' ' CYS . 52.3 mmm-85 -99.44 -31.06 11.84 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.506 179.269 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.75 -155.58 26.56 Favored Glycine 0 N--CA 1.444 -0.831 0 C-N-CA 120.231 -0.985 . . . . 0.0 112.52 179.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.2 p -91.52 140.85 29.34 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.839 0.352 . . . . 0.0 111.438 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.512 ' HB3' ' CB ' ' A' ' 25' ' ' PHE . 37.0 t -93.57 -137.52 0.19 Allowed 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.421 ' N ' ' SG ' ' A' ' 21' ' ' CYS . . . -73.25 -147.87 0.98 Allowed Glycine 0 CA--C 1.523 0.589 0 CA-C-N 116.23 -0.441 . . . . 0.0 113.464 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.869 ' H ' HD13 ' A' ' 23' ' ' ILE . 0.2 OUTLIER -65.64 99.3 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 121.442 0.639 . . . . 0.0 112.325 -179.257 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? 64.34 46.68 3.37 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.156 179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CB ' ' HB3' ' A' ' 21' ' ' CYS . 20.7 m-85 -131.83 150.01 52.28 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.787 179.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.444 ' HG ' ' HA ' ' A' ' 10' ' ' HIS . 4.3 mm? -107.85 143.2 36.78 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -111.77 112.79 24.73 Favored 'General case' 0 C--O 1.24 0.599 0 CA-C-N 116.304 -0.407 . . . . 0.0 109.955 -179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 8.2 m -129.97 145.98 51.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.0 0.429 . . . . 0.0 111.238 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.49 ' SG ' ' HG3' ' A' ' 18' ' ' ARG . 51.9 m -115.32 121.34 34.98 Favored Pre-proline 0 C--N 1.323 -0.556 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 178.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.704 ' HG2' HD13 ' A' ' 3' ' ' LEU . 20.7 Cg_endo -63.67 -35.4 58.47 Favored 'Trans proline' 0 N--CA 1.465 -0.189 0 C-N-CA 122.318 2.012 . . . . 0.0 111.271 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.559 ' HB2' HD11 ' A' ' 3' ' ' LEU . 1.0 OUTLIER -131.12 -60.68 0.95 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.868 178.578 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.462 ' OXT' ' HA3' ' A' ' 1' ' ' GLY . 19.7 mmt85 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.107 -0.949 . . . . 0.0 109.787 179.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.866 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.55 HD13 ' HG2' ' A' ' 18' ' ' ARG . 96.8 mt -74.85 132.54 41.59 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.876 0.338 . . . . 0.0 110.214 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.79 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.0 pt? -81.92 39.17 0.55 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.063 0.459 . . . . 0.0 111.006 -179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 29' ' ' CYS . 62.5 m -82.6 155.85 24.23 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.096 0.474 . . . . 0.0 110.273 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.533 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 2.3 p90 -108.32 138.96 43.73 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.967 179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.712 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 43.1 t -87.77 117.76 26.82 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.712 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 27.6 mmm180 -133.81 125.38 28.32 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.985 0.421 . . . . 0.0 111.641 -179.128 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 2.9 tmtp? -84.42 71.85 10.66 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.343 0.592 . . . . 0.0 109.41 178.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -177.37 -82.25 0.06 OUTLIER Glycine 0 C--N 1.315 -0.624 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.861 -179.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.787 ' HA ' HD22 ' A' ' 26' ' ' LEU . 11.3 p80 -172.97 61.87 0.03 OUTLIER 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.82 0.343 . . . . 0.0 111.164 -179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.654 ' SG ' HG22 ' A' ' 17' ' ' VAL . 13.3 m 59.61 -159.62 0.3 Allowed 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.883 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.546 ' HG3' ' HG3' ' A' ' 7' ' ' ARG . 51.9 mtpt -145.17 131.44 19.54 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.869 -0.605 . . . . 0.0 109.94 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.507 ' O ' ' HG2' ' A' ' 13' ' ' ARG . 21.8 ttt85 60.38 29.4 18.98 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.462 0.649 . . . . 0.0 111.134 179.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.42 43.75 86.34 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.376 179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -70.88 167.46 51.07 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 121.214 -0.517 . . . . 0.0 112.342 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -88.29 117.45 27.21 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.888 0.375 . . . . 0.0 110.414 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.654 HG22 ' SG ' ' A' ' 11' ' ' CYS . 8.0 t -63.3 131.2 28.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.244 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.55 ' HG2' HD13 ' A' ' 2' ' ' LEU . 4.8 tpt85 -104.16 -31.69 9.51 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.866 -0.607 . . . . 0.0 109.443 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.1 -152.47 20.09 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.727 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 16.9 p -108.48 140.65 41.5 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.539 0.17 . . . . 0.0 110.794 179.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.79 ' SG ' ' HB3' ' A' ' 25' ' ' PHE . 24.7 p -116.27 30.45 7.33 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.22 0.534 . . . . 0.0 111.333 -179.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 147.01 -166.61 28.41 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.347 179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.9 tt -71.32 98.81 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.314 0 CA-C-O 121.548 0.689 . . . . 0.0 110.688 179.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 67.64 34.51 4.48 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.253 -178.462 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.79 ' HB3' ' SG ' ' A' ' 21' ' ' CYS . 19.6 m-85 -112.66 130.46 56.04 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.055 178.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.787 HD22 ' HA ' ' A' ' 10' ' ' HIS . 7.1 mp -98.97 129.88 45.3 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.181 0.515 . . . . 0.0 111.346 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.458 ' CE2' ' HB2' ' A' ' 4' ' ' CYS . 2.4 t80 -104.04 112.02 24.84 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 178.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.533 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 2.7 m -131.39 142.09 49.98 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 120.655 -0.418 . . . . 0.0 112.081 -177.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 4' ' ' CYS . 1.7 m -98.68 138.04 20.68 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.162 178.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -69.22 124.43 11.3 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.398 2.065 . . . . 0.0 112.003 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.718 ' HA ' ' HE ' ' A' ' 31' ' ' ARG . 2.3 tpm_? -160.3 44.83 0.21 Allowed 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.462 -0.569 . . . . 0.0 109.462 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 67.7 ttt-85 . . . . . 0 C--O 1.248 0.98 0 CA-C-O 117.764 -1.112 . . . . 0.0 109.036 -179.554 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.929 0 N-CA-C 111.138 -0.785 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.416 HD12 ' HG2' ' A' ' 30' ' ' PRO . 22.5 tp 59.08 54.72 4.78 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-O 121.387 0.613 . . . . 0.0 110.564 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.58 120.89 15.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.874 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.677 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 4.6 m -69.63 151.26 46.13 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.011 0.434 . . . . 0.0 110.674 -179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.646 ' HE1' ' HB3' ' A' ' 11' ' ' CYS . 2.5 p90 -107.58 140.64 40.26 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.846 0.832 . . . . 0.0 113.109 -178.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.623 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 42.4 t -87.96 119.66 28.53 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 177.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.623 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 26.5 mmm180 -129.55 138.96 51.6 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.419 0.628 . . . . 0.0 112.338 -178.017 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.53 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 1.8 tmtp? -90.16 118.3 29.58 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.166 -0.925 . . . . 0.0 109.569 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 89.44 -52.21 3.72 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 121.063 -0.589 . . . . 0.0 114.424 179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -161.59 145.87 12.97 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 118.07 0.935 . . . . 0.0 112.562 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.646 ' HB3' ' HE1' ' A' ' 5' ' ' TYR . 1.6 m -65.63 154.37 38.98 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.287 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 16.4 ptmt -119.44 48.69 1.46 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.444 HH21 ' C ' ' A' ' 32' ' ' ARG . 26.1 tpt180 -174.6 -42.02 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.086 0.47 . . . . 0.0 110.289 178.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -164.13 138.06 5.08 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.729 -0.748 . . . . 0.0 111.934 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -76.1 51.11 2.79 Favored Glycine 0 CA--C 1.519 0.314 0 C-N-CA 121.542 -0.361 . . . . 0.0 113.063 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 16' ' ' ARG . 19.8 mmt180 -111.1 70.12 0.7 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.049 0.452 . . . . 0.0 110.475 179.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 28' ' ' CYS . 22.3 t -63.96 123.32 16.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.644 179.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.533 ' HB2' ' SG ' ' A' ' 29' ' ' CYS . 9.9 tpt85 -89.87 -32.14 17.01 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.194 -0.457 . . . . 0.0 109.776 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.31 -168.55 37.25 Favored Glycine 0 N--CA 1.445 -0.728 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.581 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.2 p -93.45 138.07 32.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.947 0.403 . . . . 0.0 111.221 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . . . . . . . . . 43.5 t -102.89 120.68 41.04 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 65.18 -126.62 31.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 119.935 -1.126 . . . . 0.0 110.419 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.417 ' O ' ' HB2' ' A' ' 24' ' ' ARG . 17.6 pt -136.64 40.32 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 120.739 0.304 . . . . 0.0 110.893 179.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 9.5 tpt180 179.27 -24.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 112.226 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.53 ' CE2' ' HB2' ' A' ' 8' ' ' LYS . 1.9 m-85 -88.69 155.33 19.66 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.959 -178.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 mp -102.11 131.1 48.79 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.408 ' CE2' ' HB2' ' A' ' 4' ' ' CYS . 8.2 t80 -101.13 90.12 4.04 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.562 ' HB2' ' CE1' ' A' ' 5' ' ' TYR . 1.8 m -100.34 142.84 31.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.806 -179.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.533 ' SG ' ' HB2' ' A' ' 18' ' ' ARG . 61.5 m -89.85 145.48 33.4 Favored Pre-proline 0 C--N 1.316 -0.856 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.677 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 63.4 Cg_endo -74.12 -145.46 0.02 OUTLIER 'Trans proline' 0 CA--C 1.53 0.28 0 C-N-CA 122.563 2.175 . . . . 0.0 113.709 -178.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.431 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 12.4 ptp180 -174.66 -156.45 0.06 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -179.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.603 HH11 ' HG2' ' A' ' 32' ' ' ARG . 34.1 ttp85 . . . . . 0 C--O 1.252 1.235 0 CA-C-O 117.963 -1.018 . . . . 0.0 108.904 178.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.852 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.663 ' HB2' ' HG2' ' A' ' 30' ' ' PRO . 0.0 OUTLIER -156.47 151.68 26.47 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.889 0.345 . . . . 0.0 110.149 179.707 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 57.2 tp -113.37 128.39 56.44 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.143 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 64.5 m -73.83 163.66 27.66 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.652 179.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -149.41 137.81 20.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.905 0.86 . . . . 0.0 112.528 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.685 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 53.9 t -88.71 124.72 34.38 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 114.158 -1.383 . . . . 0.0 108.351 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.685 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.1 mmm180 -132.52 141.12 48.62 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.319 0.581 . . . . 0.0 112.334 -178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.589 ' HD3' ' CZ ' ' A' ' 25' ' ' PHE . 51.3 tptt -86.42 53.11 2.69 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 122.142 0.972 . . . . 0.0 109.156 178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -179.38 -150.12 8.81 Favored Glycine 0 C--N 1.315 -0.608 0 CA-C-N 114.564 -1.198 . . . . 0.0 110.911 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -91.56 20.21 5.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.58 0.69 . . . . 0.0 111.154 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.438 ' HA ' ' HG3' ' A' ' 7' ' ' ARG . 75.8 m 66.36 143.32 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.497 -0.774 . . . . 0.0 112.795 178.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.412 ' O ' ' HB3' ' A' ' 13' ' ' ARG . 0.1 OUTLIER -90.86 158.44 16.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.955 179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.412 ' HB3' ' O ' ' A' ' 12' ' ' LYS . 32.7 ttm105 78.44 -45.49 0.4 Allowed 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.144 0.978 . . . . 0.0 111.254 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -169.13 131.18 2.22 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.56 -0.829 . . . . 0.0 111.881 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -78.5 51.59 3.7 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.363 -0.446 . . . . 0.0 112.668 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 49.0 mtp85 -87.92 69.18 9.42 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.107 0.48 . . . . 0.0 109.944 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.7 m -61.68 132.75 27.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.776 -179.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.61 ' HD2' ' SG ' ' A' ' 29' ' ' CYS . 78.4 ttt180 -105.3 -35.34 7.57 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.203 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 178.23 -162.98 30.78 Favored Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.614 179.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 p -92.12 138.88 31.17 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.064 0.459 . . . . 0.0 111.11 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.901 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 44.7 t -100.09 46.33 0.96 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 121.597 0.713 . . . . 0.0 110.015 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.19 -140.03 14.82 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.432 -0.889 . . . . 0.0 113.175 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 45.0 mm -75.61 103.49 3.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 -178.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 17.9 tpt180 53.99 49.78 18.18 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 115.362 -0.836 . . . . 0.0 112.049 178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.901 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 5.7 m-85 -135.49 146.36 48.06 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 179.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.8 mp -108.31 132.4 53.74 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.316 0.579 . . . . 0.0 110.954 -179.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 22.8 t80 -106.58 114.71 28.98 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 40.1 m -120.96 156.22 32.58 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.198 0.444 . . . . 0.0 112.198 -178.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.61 ' SG ' ' HD2' ' A' ' 18' ' ' ARG . 61.8 m -135.14 125.01 16.76 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 115.561 -0.745 . . . . 0.0 109.604 178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.663 ' HG2' ' HB2' ' A' ' 2' ' ' LEU . 61.2 Cg_endo -73.36 -132.22 0.01 OUTLIER 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.881 2.387 . . . . 0.0 112.755 -179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . 0.5 ' H ' ' HB2' ' A' ' 30' ' ' PRO . 31.0 ttp180 -171.7 -69.32 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.201 0 CA-C-O 117.296 -1.335 . . . . 0.0 107.677 179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.877 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.488 ' H ' ' CD1' ' A' ' 2' ' ' LEU . 0.0 OUTLIER -79.89 -29.08 39.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.864 0.364 . . . . 0.0 110.49 179.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.681 ' H ' HD23 ' A' ' 3' ' ' LEU . 2.5 pt? -74.67 143.72 44.11 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.454 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.576 ' HB3' ' C ' ' A' ' 28' ' ' CYS . 61.1 m -75.16 163.59 27.38 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.581 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TYR . . . . . 0.538 ' CE1' ' HB2' ' A' ' 28' ' ' CYS . 6.1 p90 -88.58 141.12 28.78 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.342 0.591 . . . . 0.0 111.087 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.63 ' O ' ' HD2' ' A' ' 7' ' ' ARG . 41.3 t -97.43 114.22 26.03 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.237 -0.892 . . . . 0.0 109.016 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.63 ' HD2' ' O ' ' A' ' 6' ' ' CYS . 25.3 mmm180 -138.58 145.3 40.43 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.259 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.505 ' HA ' ' HA ' ' A' ' 25' ' ' PHE . 29.2 ttmt -67.32 -31.85 72.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.556 0.693 . . . . 0.0 109.524 178.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -66.56 151.32 52.24 Favored Glycine 0 N--CA 1.446 -0.671 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.152 178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' HIS . . . . . 0.93 ' HA ' HD12 ' A' ' 26' ' ' LEU . 45.4 m170 -72.33 68.71 0.77 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 111.607 0.225 . . . . 0.0 111.607 -179.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.542 ' SG ' ' HB ' ' A' ' 17' ' ' VAL . 76.7 m 71.16 145.68 0.07 Allowed 'General case' 0 N--CA 1.463 0.215 0 O-C-N 123.927 0.767 . . . . 0.0 111.669 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -107.34 31.63 5.26 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.659 179.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -164.11 35.73 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.726 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 70.22 -139.4 30.78 Favored Glycine 0 N--CA 1.451 -0.353 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.911 179.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -73.71 72.67 1.26 Allowed Glycine 0 CA--C 1.517 0.169 0 C-N-CA 121.595 -0.336 . . . . 0.0 113.391 -179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 22.4 mmt85 -132.59 33.56 3.77 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.172 0.51 . . . . 0.0 110.679 179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.542 ' HB ' ' SG ' ' A' ' 11' ' ' CYS . 5.9 p -81.88 132.5 31.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.606 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.4 mmt180 -113.33 -11.95 13.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.691 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.72 -170.03 43.13 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.62 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 11.4 p -106.19 141.56 37.33 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.621 0.248 . . . . 0.0 110.785 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' CYS . . . . . 0.569 ' HB3' ' HB3' ' A' ' 25' ' ' PHE . 16.4 t -99.93 -140.32 0.33 Allowed 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -70.86 -156.3 1.95 Allowed Glycine 0 CA--C 1.523 0.589 0 C-N-CA 121.372 -0.442 . . . . 0.0 113.491 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.0 pt -64.62 105.65 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.14 0.495 . . . . 0.0 112.036 -179.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 63.3 mmt-85 66.69 42.36 2.71 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.952 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' HB3' ' HB3' ' A' ' 21' ' ' CYS . 19.4 m-85 -132.76 140.76 48.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.576 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 10' ' ' HIS . 34.2 mt -109.3 145.08 36.58 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.309 0.576 . . . . 0.0 111.529 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 35.7 t80 -98.92 94.54 6.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.087 -0.96 . . . . 0.0 108.425 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.576 ' C ' ' HB3' ' A' ' 4' ' ' CYS . 10.1 m -119.96 140.48 50.86 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.907 0.385 . . . . 0.0 111.92 -177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 30' ' ' PRO . 1.6 m -98.69 143.43 26.32 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.803 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 29' ' ' CYS . 37.2 Cg_exo -60.17 -42.93 38.91 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.912 2.408 . . . . 0.0 112.57 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 23.5 ptt-85 -156.67 54.86 0.54 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.925 -0.579 . . . . 0.0 109.883 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 60.2 ttt-85 . . . . . 0 C--O 1.246 0.918 0 CA-C-O 118.119 -0.943 . . . . 0.0 109.495 -179.582 . . . . . . . . 0 0 . 1 stop_ save_